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ABSTRACT 
The assessment of malnutrition in patients is controversial. The principal questions 
of this thesis are: what is the prevalence of malnutrition of macronutrients and micronu-
trients in non-surgical patients, and what is the validity of the methods to assess malnut-
rition? The last question can be separated into: - Can the currently available methods to 
determine nutritional deficiency distinguish between nutritional depletion and a normal 
nutritional status? - Can the currently available methods to determine nutritional defi-
ciency distinguish nutritional status from disease activity? 
We demonstrated that malnutrition was present in 40 to 60 % of the non-surgical 
hospitalized patients at admission, depending on the method that was applied for the 
assessment of malnutrition. Over 50% of the patients with active inflammatory bowel dis-
ease were malnourished. Malnourished patients suffered a higher risk of complications. In 
part this correlation between malnutrition and complications, could be explained by the 
disease process. A study in healthy volunteers was performed, using the same methods. 
Less than 5 % of the healthy volunteers were malnourished, except for elderly persons in 
which the percentage was more. 
The prevalence of malnutrition of zinc was studied in patients with Crohn 's disease. 
A decrease of serum zinc concentration, one of the most important micronutrients, was 
observed in 68% of the patients with more or less active Crohn's disease. The question 
whether the currently available method may distinguish nutritional status from disease 
activity, was studied in rats. Serum zinc concentration was influenced by the zinc status, 
but also by the inflammatory process caused by a redistribution of zinc into the liver and 
a decrease of the zinc transporting serum protein: albumin. 
We studied the in vitro uptake of zinc by blood cells of rats fed a zinc deficient diet, 
rats with a decrease in serum zinc induced by an inflammation, and control rats. We 
demonstrated that by this method nutritional depletion could be distinguished from a 
normal zinc status. This method could also distinguish real zinc deficiency from apparent 
zinc deficiency caused by inflammation. 
Alkaline phosphatase is a zinc dependent metallo-enzyme. In case of zinc deficiency 
serum alkaline phosphatase activity is decreased. In rats total serum alkaline phosphatase 
activity was decreased in zinc deficiency, but alkaline phosphatase activity was also influ-
enced by growth and acute inflammation, but not by chronic inflammation. Zinc defi-
ciency influenced the activity of the enzyme. Other factors like growth are mainly influ-
encing the concentration of the enzyme. We hypothesized that the difference in serum 
alkaline phosphatase activity, using buffers low and high in zinc, was greater in case of zinc 
deficiency. This hypothesis was confirmed. This method thus can differentiate between 
zinc deficiency and the normal zinc status. This hypothesis was also confirmed in a situ-
ation with an change in the alkaline phosphatase enzyme concentration: growth. 
In conclusion, malnutrition of both macronutrients and micronutrients is frequent, 
but outcomes of methods frequently used to determine malnutrition are also influenced by 
the disease itself. Especially for zinc, new methods were studied which are less influenced 
by the disease process. 
ABBREVIATIONS 
MNC = Mononuclear Cells 
PMNC = Polymorphonuclear cells 
G PB = Glucose Phosphate Buffer 
CDAJ = Crohn's Disease Activity Index 

CHAPTER 1 
AIM OF THE THESIS 

One of the essential phenomena in all living organisms is the intake of nutritional 
substances for the generation of energy and for growth and maintenance of the organism. 
Insufficient food intake will result in malnutrition, and subsequently in disease and death. 
In Third World Countries the symptoms of malnutrition are well known. It is less obvious 
that malnutrition may occur in patients in prosperous countries such as the Netherlands. 
Weight loss and deficiency of specific nutrients are in most cases attributed to the disease 
process. But the classical symptoms of malnutrition may also be caused by insufficient food 
intake or malabsorption of nutrients from the gut lumen. Furthermore the disease may 
have an influence on the metabolism of the organism. 
The central questions of this thesis are: 
What is the prevalence of malnutrition of macronutrients and micronutrients in non-sur-
gical patients, and what is the validity of the methods to assess malnutrition? 
The second question can be divided into the following questions: 
- Can the currently available methods to determine nutritional deficiency distinguish 
between nutritional depletion and a normal nutritional status? 
- Can the currently available methods distinguish nutritional deficiency caused by poor 
nutritional intake from that caused by disease activity? 
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CHAPTER 2 
INTRODUCTION TO MALNUTRITION 
with special emphasis on macronutrients and micronutrients in general, 
and zinc in particular. 
Published in part 
Naber AHJ, Kruimel JW. Vormen en oorzaken van ondervoeding. 
In Naber AHJ, Van der Hout S, Keyser-Huijts В, "Ondervoeding: van 
theorie naar praktijk", PAOG Heyendaal, Nijmegen, 1996: 6-13. 

INTRODUCTION 
In this thesis the assessment of malnutrition, both of macronutrients and micronutrients, 
in patients will be discussed. 
In this chapter an introduction is provided to the definition of the terminology, nutritional 
depletion of macronutrients and micronutrients, the influence of disease on metabolism, 
the assessment of the nutritional status and the relevance of the assessment of malnutri-
tion. This is essential to comprehend the next chapters of this thesis. 
DEFINITION OF TERMINOLOGY 
Malnutrition can be defined as a status resulting from a shortage of nutrients, resul-
ting in reduction in biological functions. The expression 'malnutrition' suggests a shortage 
of food intake. The expression 'malnutrition' does not do enough justice to the effect of 
the disease process in the patient. A disease process may cause anorexia, maldigestion and 
malabsorption, all resulting in a reduction of food intake. A disease process may also result 
in an increase in loss of nutrients or an increase in metabolism of these substances, all cau-
sing an increase of need for these nutrients (1,2,3). The stock of the nutrients will decrea-
se if the intake of nutrients is not increased. This is why the term 'nutritional depletion' is 
mote suitable for this situation of 'malnutrition' in patients. But 'malnutrition' is a more 
suitable word in clinical practice. In the next chapters frequently the expression 'malnutri-
tion' will be used. By 'malnutrition', 'nutritional depletion' is meant. 
Besides malnutrition and nutritional depletion, the terms deficiency and nutritional 
status are used. In most cases depletion and deficiency are exchangeable terms but in some 
cases deficiency is used with a special adjective, indicating special conditions of deficiency: 
subclinical deficiency and apparent deficiency. Subclinical deficiency is the status in which 
laboratory methods do not reveal abnormalities, and no symptoms of deficiency are pre-
sent, but these symptoms become present in a situation of increased needs. The classical 
example is the refceding syndrome, in patients suffering a significant loss of weight. For 
example, in a malnourished patient with Crohn's disease a stenosis is resected and the 
patient gains weight. Although the scrum concentrations of trace elements and minerals 
were normal before the surgical procedure, a fast decrease in serum calcium, potassium, 
phosphate, magnesium and zinc may occur, with clinical symptoms of deficiencies. In this 
situation the stock of these nutrients was decreased before the surgical intervention. 
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Apparent deficiency is a situation in which laboratory data suggest a deficiency, but no 
symptoms of deficiency are present. For example, in case of inflammation serum albumin 
is decreased. Albumin is the main transporting protein for calcium in the serum, so the 
total serum calcium concentration will be decreased during inflammation. The concentra-
tion of free calcium still remains normal and clinical symptoms (tetany) will not occur. 
There is a need for methods that can differentiate real from apparent deficiencies. 
The total of all of these expressions can be summarized by the term nutritional status 
which also includes the normal situation and the situation of intoxication. 
NUTRITIONAL DEPLETION OF MACRONUTRIENTS 
AND MICRONUTRIENTS 
Macronutrients 
Nutritional depletion is subdivided into depletion of macronutrients and depletion of 
micronutrients or single depletions. Depletion of macronutrients may be divided into 
caloric malnutrition: i.e. depletion of carbohydrates and fat, and protein malnutrition: 
depletion of amino acids. This subdivision has been derived from tropical medicine: 
marasmus and kwashiorkor referring to respectively, too little intake of food in general, and 
too little intake of protein owing to a cheap one-sided diet. 
In patients the cause of nutritional depletion is related to the disease process itself. If the 
patient is anorectic, if the absorption of nutrients is disturbed or if the need for caloric 
nutrients is increased, a marasmus-like nutritional depletion will develop. This type of nut-
ritional depletion is often seen in patients with chronic diseases and will develop in a 
period of months to years. The diagnosis is not difficult because weight loss is evident. 
Marasmus-like nutritional depletion has a low mortality risk. 
In general in Western Countries the nutritional intake is well balanced and in healthy sub-
jects protein malnutrition (kwashiorkor) is very rare; but in patients a kwashiorkor-like 
type of nutritional depletion is seen frequently. This is caused by an inflammatory process. 
In case of inflammation the production of albumin will be down regulated immediately 
and serum albumin is leaking out of the capillary arteries (1, 4-6). Serum albumin will 
decrease and the colloid osmotic pressure in the capillaries will decrease. Fluids will leave 
the capillaries for the extracellular space, resulting in oedema. This situation may develop 
within a day. Sometimes this type of nutritional depletion is difficult to recognize because 
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the patient is not losing weight (5-7). Kwashiorkor-like nutritional depletion has a high 
mortality rate. In many patients an intermediate type of nutritional depletion is present. 
The terms protein-caloric-malnutrition and marasmus-like-kwashiorkor are used. This 
condition is the consequence of chronic nutritional depletion complicated by an acute dis­
ease: both weight loss and oedema are present (3-5,7). These features are connected with 
a very high mortality rate (4). 
Micronutrients 
Trace elements are defined as those elements whose individual total body quantity 
accounts for less than 0.01% of dry bodyweight. Some are non-essential, like lead, and 
others are essential for normal health, function and development. Both essential and non­
essential elements can be toxic in case of high concentrations in tissues and fluids. Zinc is 
one of the most prominent of the at least ten essential trace elements in man (Fe, Zn, Se, 
Mo, Mn, Cr, Co, Cu, I, F). 
Zinc absorption takes place in the small intestine both by saturable, specific carrier-
mediated mechanisms and by non-specific pathways. Most of the zinc is lost by the stools. 
The urinary zinc loss is about 300 μg and the loss by hair, skin and transpiration is about 
500 μg out of a total loss of 1.5 to 4 mg per day. 
Expressed as concentration the zinc content is highest in spermatozoa, prostate and 
ovaries. In absolute quantity most zinc is found in muscle, bone, skin/hair and liver (Table 
1 (8)). The total body quantity of zinc is 1.5 to 4 g of which 98% is intracellular. An adult 
needs 12 to 15 nig of zinc per day, of which about 30 % is absorbed. The availability of 
zinc in food is highly variable (Tabic 2 (9)). 
Zinc is important for the function of more than 200 enzymes (metallo-enzymes) like alka­
line phosphatase, alcohol dehydrogenase, carboanhydrase, glutamate dehydrogenase, etc), 
and a cofactor in zinc finger proteins, important for the transcription of DNA. Without 
zinc, the synthesis of RNA and subsequently of proteins is limited. Zinc is also important 
for the stabilisation of cell membranes, because it is essential for an optimal function of the 
membrane enzymes superoxide dismutase, hydroperoxides, glutathione peroxidase and 
protein kinase C. The activation of receptors by hormones like insulin, growth hormone 
and steroids is zinc dependent. Because zinc is a structural part in many enzymes/proteins, 
zinc is important for optimal function of the sensorium (taste, sense of hearing, visual 
faculty), cell growth and differentiation, immune function and sexual function. 
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Table 1 
Zinc in tissues in man 
Muscle 
Bone 
Skin and hair 
Liver 
Brain 
Gastrointestinal tract and pancreas 
Kidney 
Heart 
Spleen 
Blood plasma 
Total Zn content 
1.53 
0.77 
0.21 
0.13 
0.04 
0.03 
0.02 
0.01 
0.003 
<0.01 
% of total be 
57 
28 
6 
5 
1.5 
1 
0.7 
0.3 
0.01 
0.01 
Zinc deficiency is caused by 
1) inadequate intake, 
2) maldigestion and malabsorption, 
3) increased loss and 
4) increased utilisation (10). 
Its deficiency causes hair loss, acrodermatitis enteropathica and other skin lesions (11), 
dysfunction of the immune system (12), behaviour disorders (13), hypogonadism (10), 
diarrhoea and growth retardation (14). In patients with wounds, treatment with zinc sul-
phate will accelerate wound healing (15). In the USA, zinc deficiency is estimated to be 
present in 2% of the population (16). Zinc deficiency has been demonstrated in congeni-
tal absorption disorders (acrodermatitis enteropathica), liver diseases, chronic inflammato-
ry bowel disease, coeliac disease, severe diarrhoea especially in children, chronic renal dis-
eases, and parenteral nutrition (17). 
Zinc intoxication is rare. In one case history a person ingested 12 g of zinc and became 
lethargic and light-headed with staggering and difficulty in writing (18). It may cause nau-
sea, vomiting, abdominal pain and bloody diarrhoea (19). Zinc salts can be caustic in high 
concentrations, if ingested by mouth. Lower dosages of zinc ingested for therapy may 
induce copper deficiency (20,21). 
The function of zinc can be illustrated by animal experiments. In growing rats a zinc-defi-
cient diet will reduce the food intake after four days (22). After six days growth will slow 
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Table 2 
Zinc concentrations in food (mg/100g) 
good zinc source 
cheese 
milk powder 
eggs 
cows meat 
shrimps 
oysters 
2-4 
2-4 
1.3 
4 
2.3 
> 7 
fair zinc source 
milk 
chicken 
pork meat 
liver 
fish 
white bread 
white beans 
vegetables 
potatoes 
fruit 
chocolate 
0.4 
0.9 
2 
5-Θ 
0.5-1.5 
0.5 
3 
0.2-1 
0.27 
0.1-0.25 
2 
poor zinc source 
brown bread 
wheat 
dry peas 
oats 
soya milk 
cocoa powder 
4 
13 
4 
4 
5 
3.5 
down and after ten days growth is completely ceased. After 40 to 50 days the rat will die. 
When in zinc-deficient rats zinc is added to the diet, rats will start eating within hours, and 
within days the skin lesions will disappear. Because in this situation only 1% of the total 
body zinc has been supplied, this rapid reaction is an argument for activation of enzymes. 
Growth retardation can be explained by the reduction in food intake due to anorexia cau­
sed by zinc deficiency. But in rats which are given forced tube feeding also growth retar­
dation is observed. If this forced tube feeding is continued the rats will die after 12 days 
(40 to 50 days in case of a free diet), so the reduction in food intake prevents rats from 
dying in an early phase. Zinc-deficient rats prefer a diet low in proteins. In zinc-deficient 
rats blood urea and ammonia concentrations are increased. The nitrogen loss in stools is 
higher in zinc-deficient diet, which in part is explained by less activity of enzymes active 
in the digestion process. This increase of nitrogen loss by stools can not explain the growth 
retardation completely. This indicates an influence of zinc on the intermediate metabolism. 
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NUTRITIONAL DEPLETION EXPLAINED BY 
THE INFLUENCE OF DISEASE ON METABOLISM 
The influence of disease on metabolism can be divided into effects on protein, glucose and 
fat metabolism, together with the influence on the metabolism of trace elements, vitamins 
and minerals. 
Carbohydrate metabolism 
Severe disease is accompanied by hyperglycaemia, an increased production of glucose out 
of glycogen and proteins in the cell, and glucose intollerance. Glucose production may 
increase from about 250 g/day to 400-500 g/day. The sensitivity of the peripheral body cell 
for insulin may be reduced. In case of insulin resistance the uptake of glucose by the cell 
is decreased and hyperglycaemia is the result. Consequently the administration of glucose 
in patients with severe disease will have less effect than in healthy volunteers. The excess of 
glucose in the extracellular space will be taken up by the liver, because the uptake of gluco-
se by the liver cell is insulin independent. In the liver cell, glucose will be converted into fat. 
In part, this insulin resistance can be compensated by administration of exogenous insulin. 
Fat metabolism 
Fat is made out of triglycerides: three fatty acids are attached to one glycerol molecule. It 
is hydrolysed into free fatty acids and glycerol. Both can be used as an energy source. In 
acute disease lipolysis may increase two fold. This will result in an increase of VLDL and 
free fatty acids production, which are used as a source of oxidation. Free fatty acids are used 
as an energy source by lung, muscle, kidney and liver. Oxidation, to generate energy, takes 
place in the mitochondria of the cell. The uptake of long-chain fatty acids in the mito-
chondria requires carnitine. In periods of acute disease the concentration of carnitine is 
decreased, so that the uptake of long chain fatty acids by the mitochondria and subsequent 
oxidation are also decreased. For oxidation of medium-chain fatty acids, carnitine is not 
necessary and in theory medium-chain fatty acids are utilized better by the cells in case of 
severe disease. 
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Protein metabolism 
During illness in general the net result of protein synthesis and breakdown is a negative 
protein balance manifesting itself with a loss of muscle mass and of functional capacity. 
The endogenic protein break-down is increased by the influence of a disease process. In 
most cases a disease process will decrease protein synthesis. In acute disease the consump-
tion of amino acids by the liver is increased. These amino acids are used for the produc-
tion of acute phase proteins like ceruloplasmin, fibrinogen and (Xl-macroglobulin. The 
production of albumin by the liver will be severely depressed. 
Large quantities of parenteral nutrition can reduce but rarely abolish this difference. 
Protein synthesis is stimulated to a maximum by 1.7 g of protein per kilogram bodyweight, 
per day. Protein synthesis can be stimulated by growth hormone. Insulin administration 
may reduce the breakdown of proteins. 
Metabolism of trace elements and minerah 
A disease process may decrease the uptake, increase the loss, and increase the need for trace 
elements and minerals, but may also cause a shift from one body compartment to another. 
In acute disease the serum zinc concentration will decrease because of a decrease of the zinc 
transporting protein albumin, like in calcium metabolism, and because of a shift of serum 
zinc into the liver (23). In the liver, zinc will be bound up by metallothionin. The increa-
se of zinc uptake by the liver can be explained by the involvement of zinc in the produc-
tion of acute phase proteins in the liver, but zinc can also be stored in the liver for later use, 
in case of an anabolic situation later on. In acute disease the excretion of zinc by urine will 
be increased resulting from leakage of amino acids, like histidine, by the kidneys and zinc 
will be excreted as a zinc amino acid complex. The nitrogen balance is reduced in zinc defi-
ciency. In part this can be explained by an increase in nitrogen loss in stools, but also by 
the influence of zinc on metabolism. Metabolism is regulated by hormones. Growth hor-
mone and subsequently the insulin growth factor I are essential for growth. In zinc-defi-
cient rats the IGF I concentration is decreased (24). Also the cell binding of growth hor-
mone is reduced. Insulin has a positive effect on protein synthesis. In zinc-deficient rats the 
insulin concentration is reduced (24). Zinc is also on influence in protein synthesis by 
other actions. DNA polymerase and thymidine kinase are zinc dependent enzymes. Zinc 
is of influence on the gene transcription by zinc finger proteins, transcription factor IIIA 
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and RNA-polymerase. For the signal transfer of hormones, inositol triphosphate and cal-
modulin are essential. The calmodulin activity is reduced in zinc-deficient rats (25). 
Concentrations of other trace-elements and minerals also change. The copper concentra-
tion will increase because of an increase of the transporting protein, ceruloplasmin, which 
is an acute phase protein (26). Iron will pass from the blood into the liver and the reticu-
lo-endothelial system. 
In conclusion a disease process will influence all parts of the metabolism and consequent-
ly the nutritional status. This will result in a decrease of fat and protein mass. The reduc-
tion in muscle mass will result in a reduction in the functional capacities of the organism. 
In part this catabolic process can be reversed by nutritional intervention: administration of 
additional nutrients, growth hormone and insulin. Therefore it is essential to determine 
the nutritional status, and start nutritional intervention in case of nutritional depletion. 
THE ASSESSMENT OF THE NUTRITIONAL STATUS 
The assessment of nutritional depletion of macronutrients. 
For the assessment of the nutritional status no 'Gold Standard' is available (27-30). 
Subjective parameters are medical and nutritional questionnaires and physical examina-
tion. Objective parameters, not influenced by the personal opinion of the patient or the 
investigator, are also used and listed in table 3. Besides laboratory methods like blood con-
Table 3 
Objective parameters 
Blood 
- albumin 
- pre-albumin 
- transferrin 
- retinol binding 
protein 
- total protein 
concentration 
- cholesterol 
Anthropometry 
- weight loss 
- % ideal weight 
- triceps skin fold 
thickness 
- mid arm circumference 
- squeeze force of 
the hand 
- weight-height index 
Immune system 
- total number of 
lymphocytes 
- delayed type skin 
hypersensitivity 
Urine 
- nitrogen balance 
- creatinine-height 
index 
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centrations of nutrients or serum proteins, tests of the immune system and urine analysis, 
anthropometry and the assessment of the body composition (31) using isotopes, radiolo-
gical methods and bio-impedance of the body are used. Currently much attention is being 
paid to the functional capacity: for instance respiratory function and hand grip. 
None of these parameters is in itself specific and sensitive enough to determine the nutri-
tional status. Serum albumin for instance is influenced by the nutritional status but also 
by the disease process, as has been explained previously. The total number of lymphocytes 
will decrease in case of malnutrition but increase if the malnourished patient is suffering 
an infection cause by a virus. 
By combining individual parameters, multivariate methods (indices) have been developed 
(32-40). These indices were developed and used in healthy volunteers, or, on the contrary, 
developed and used in patients with a specific disease. It is not evident if the index, just as 
the single parameters, is influenced by the disease, and validation of the method by deter-
mination of specificity and (if possible) sensitivity has in most cases not been performed. 
A validation of methods used for assessment of the nutritional status in patients has not 
been performed in healthy volunteers. Also the aim of the indices varies: assessment of the 
nutritional status, monitoring the nutritional status or prediction of postoperative compli-
cations. Table 4 lists the most frequently used indices, their constituents and aims. 
The prevalence of nutritional depletion in hospitals has been studied frequently but 
mainly in surgical patients. Table 5 (41-59) shows the most important studies with the pre-
valence of malnutrition and the methods by which the nutritional status is assessed: indi-
vidual parameters or an index. The number of studies concerning non-surgical patients is 
limited. Various methods are used so the results are difficult to compare. None of the stu-
dies compares these indices by application of different indices to the same population. The 
present studies indicate that nutritional depletion is not infrequent (median surgical 
patients 41%, geriatric patients 33 % and general population 44% prevalence of malnut-
rition), but its clinical relevance must be established. 
The assessment of nutritional depletion of micronutrients, in particular of zinc 
Several methods are used to determine the zinc status, e.g., serum zinc (60), serum 
alkaline phosphatase activity levels (61), zinc concentrations in urine (62), hair (63), and 
blood cells (64). All of these methods have their limitations. The serum zinc concentration 
is used most frequently, but besides by the zinc status serum zinc is influenced by other 
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Table 4 
Indices for Nutritional Status 
PNI 32 
HPI 33 
NIM 34 
NRI 35,36 
LOM-score 37 
IUN 3Θ 
SGA 28, 39, 40 
Full name 
Prognostic 
Nutritional 
Index 
Hospital 
Prognostic 
Index 
Nutritional 
Index 
Maastricht 
Nutritional 
Risk 
Index 
Likelihood of 
Malnutrition 
Score 
Index of 
Undernutrition 
Subjective 
Global 
Assessment 
Constituents 
albumin 
delayed type skin 
hypersensitivity 
transferrin 
tnceps skin fold thickness 
albumin 
delayed type skin 
hypersensitivity 
inflammation 
cancer 
albumin 
pre-albumin 
total number of 
lymphocytes 
% ideal weight 
albumin 
% of usual weight 
folate 
ascorbic acid 
albumin 
% of ideal weight 
tnceps skin fold thickness 
mid arm circumference 
total number of 
lymphocytes 
weight loss 
mid arm circumference 
tnceps skin fold thickness 
albumin 
transfemn 
questionnaire 
physical examination 
Aim 
prediction of 
complications 
prediction of mortality 
assessment of 
nutritional status 
identification of patients 
with an increased risk 
of complications 
identification of 
malnutrition 
prediction of 
complications 
identification of 
malnutrition 
factors like inflammation. Apparent zinc deficiency, expressed by a low serum zinc level 
without symptoms of zinc deficiency, may be the result of a low serum albumin concen­
tration, because over 70% of serum zinc is bound to albumin (65), and/or redistribution 
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Table 5 
Published figures for the prevalence of malnutrition in random samples 
of hospitalized patients 
Patients Reference 
Surgical 
Individual 
parameters 
Index 
Postma (41) 
Hall (38) 
Pettigrew (42) 
McWhirter (43) 
Bistrian (44) 
Detsky (45) 
Reilly (46) 
Buzby (47) 
Mean 
W/H.DSH 
W/H,TSF,MAC,UW 
D,A,W/H,ALB,TSF,MAC 
Prevalence 
NIM 
IOU 
-
-
-
CI 
LOM 
PNI 
422 
367 
198 
200 
131 
202 
406 
100 
23% 
29% 
32% 
33% 
40% 
44% 
48% 
62% 
4 1 % 
Geriatric 
Larsson (48) 
Fullöp (49) 
Constane (50) 
Sullivan (51) 
Mean 
General Medicine 
Larsson* (52) 
Willard* (53) 
Coats (54) 
McWhirter (43) 
Weinsier (55) 
Robinson (56) 
Reilly (46) 
Bistrian (57) 
Mean 
W/H,TSF,MAC,ALB,PALB,DSH 
ALB.PALB 
MAC,TSF,ALB,RBP 
ALB,W/H,CHOL 
-
IDEAL,W/H,TSF,MAC,ALB,TLC 
-
W/H,TSF,MAC,UW 
-
-
-
W/H, TSF, MAC, ALB, Ht 
-
-
-
-
CI 
-
LOM 
-
LOM 
CI 
LOM 
-
500 
552 
324 
110 
382 
200 
228 
300 
134 
100 
365 
251 
29% 
34% 
37% 
38% 
33% 
29% 
32% 
38% 
45% 
48% 
56% 
59% 
44% 
44% 
* = part of these samples were surgical patients. 
ALB = albumin, CHOL = cholesterol, D = diagnosis, UW = Usual weight, W/H = weight/height, IDEAL = ideal weight, 
A = age, MAC = mid arm circumference, PALB = pre-albumin, RBE = retinol binding protein, TSF = triceps skin fold, 
DSH = delayed type skin hypersensitivity, TLC = total lymphocyte count, CI = clinical impression. 
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of zinc into the liver as a result of inflammation (23,66,67). The zinc concentration in 
urine shows no correlation with the degree of zinc deficiency (67). The concentration of 
zinc in hair is decreased in the early phase of zinc deficiency, but, because zinc deficiency 
can slow down hair growth, the zinc concentration may return to normal (68). The acti-
vity of zinc dependent enzymes, e.g., serum alkaline phosphatase will, in theory, be influ-
enced by many other factors such as liver function and bone turnover. Tissue zinc con-
centrations may be a more appropriate standard to determine the zinc status but tissue spe-
cimens are difficult to obtain in general. In addition, as a reaction to certain pathophysio-
logical circumstances, the changes in concentration of macro- and micronutrients in an 
organism, may vary from tissue to tissue. 
Blood cells, which are more easily obtained, are a kind of tissue, so maybe the con-
centration of zinc in these cells reflect the zinc status. However, zinc concentrations in 
mononuclear cell suspensions and polymorphonuclear cell suspensions are low. Also the 
risk of zinc contamination of the suspension is high. Therefore determination of zinc in 
blood cells is difficult (69), although this method is widely used in humans to determine 
the zinc status. 
The whole-body retention as a function of time of a parenteral dose of ' Zn seems to 
reflect the zinc status: retention and zinc deficiency appear to increase simultaneously (70). 
It may be a suitable tool for research but not for daily clinical practice (71). 
There is a need for new methods to determine zinc deficiency that can distinguish 
between real and apparent zinc deficiency and can be applied in clinical practice. 
THE CLINICAL RELEVANCE OF NUTRITIONAL DEPLETION 
What is the purpose of determining the nutritional status; what is the underlying 
goal? Many studies focused on the improvement of nutritional parameters. This includes 
the hypothesis that by improvement of the nutritional parameters the nutritional status 
will improve as well. But improvement of the nutritional status as a single phenomenon 
only is not really important. The aim of nutritional assessment and subsequent nutrition-
al intervention should be an improvement of the nutritional status of a patient which 
results in a better quality of life: less mortality and morbidity, and improvement of func-
tional capacities of a person in all of respects. This has been studied rarely, and mainly in 
surgical patients. 
Only in a limited number of studies the correlation between nutritional depletion 
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and complications has been determined in surgical patients (46,58). Several studies were 
performed in populations of geriatric patients. Sullivan performed studies (51,59,72) in 
which he demonstrated that a decrease of serum albumin and functional status are pro-
gnostic for complications. Serum albumin and pre-albumin are also prognostic for morta-
lity (49,50). Larsson (52) recently studied the prevalence of malnutrition in Swedish hos-
pitals in both surgical and non-surgical patients, and correlated complications with the 
nutritional status according to the Subjective Global Assessment. The relative risk of com-
plications was 1.92 for malnourished patients versus well-nourished patients. Reilly (46), 
in a retrospective study, calculated a relative risk of 2.6 in malnourished patients according 
to the LOM. Concerning the population of "general medical patients" it should be stres-
sed that such a population mentioned in these studies is not always identical to a popula-
tion in a ward for internal patients in a Dutch hospital. 
In a malnourished patient, the question arises, to what extent nutritional deficiency, 
and to what extent the disease process is responsible for complications during the course 
of a disease. Can the currently available methods to determine nutritional deficiency dis-
tinguish nutritional status from disease activity? The answer to this question is important 
because if complications are (in part) caused by nutritional deficiency, the number of com-
plications could be reduced by improving of the nutritional status. None of presently avai-
lable studies answers this important question. 
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ABSTRACT 
The prevalence of malnutrition and its predictive value for the incidence of compli­
cations was determined in 155 patients hospitalized for internal or gastrointestinal disea­
ses. Malnutrition was present at admission in 45% of patients according to Subjective 
Global Assessment (physical examination plus questionnaire), in 57% according to the 
Nutrition Risk Index ((1.5 χ albumin) + (41.7 χ present/usual weight)), and in 62% accor­
ding to the Maastricht Index ((21 - (0.24 χ albumin) - (19 χ transthyretin (pre-albumin)) 
- (1.9 χ lymphocytes) - (0.04 χ ideal weight)). More than 50% of the patients with inf­
lammatory bowel disease were malnourished. Crude Odds Ratio's for the incidence of any 
complication in malnourished versus well-nourished patients during hospitalization were 
2.7 (95% confidence interval 1.4 to 5.3) for the Subjective Global Assessment, 2.8 (1.5 to 
5.5) for the Nutritional Risk Index and 3.1 (1.5 to 6.4) for the Maastricht Index. Odds 
Ratio's were reduced to 1.7 (0.8 to 3.6), 1.6 (0.7 to 3.3) and 2.4 (1.1 to 5.4), respectively, 
after a multivariate analysis that included disease category and disease severity. Because the 
confounding factors adjusted for are not only a measure of the severity of the disease but 
may also be influenced by malnutrition itself, the actual risk for complications due to mal­
nutrition could be higher than the adjusted Odds Ratio's. 
In conclusion, malnutrition was frequent in gastrointestinal and internal medicine 
patients at the time of admission. The severity of malnutrition predicted the occurrence of 
complications during hospital stay, and this association was not completely explained by 
confounding factors. 
INTRODUCTION 
Many hospitalized patients are malnourished. However, the relation between mal­
nutrition, disease, and complications is unclear, especially for non-surgical patients. 
About 30 % of patients on surgical wards have been found to be malnourished at 
admission (1-10). There is limited information about the nutritional status of non-surgi­
cal hospital patients (5, 7, 11, 12, 13). Nutritional depletion is usually caused by the joint 
action of an underlying disease, e.g. cancer, and dietary deficiency (Figure 1). It is not clear 
to which extent each of these two factors is responsible. If insufficient food intake is a fac­
tor in the development of nutritional depletion and also of the associated complications, 
then treatment should not only be focused on the disease but also on nutritional inter-
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vention. In malnourished surgical patients peri-operative parenteral nutrition may indeed 
reduce the rate of post-operative complications (14,15). The association between malnut-
rition and occurrence of complications in non-surgical patients is less clear. We therefore 
assessed the nutritional status of patients at admission to a ward for internal diseases and a 
gastro-intestinal ward, and the association of nutritional status with the subsequent deve-
lopment of complications. 
METHODS 
Design 
The University Hospital of Nijmegen University Medical School serves as the tertia-
ry referral hospital for an area of 30 by 60 miles in the South-Eastern part of the 
Netherlands with a catchment population of 2.3 million. We assessed nutritional status in 
patients admitted to the gastrointestinal and internal medicine wards over one 4 months 
period and another 2.5 months period 9 months later. No nutrition support team was acti-
ve on the wards. The nutritional status at entry was evaluated; during the first study period 
the nutritional status was also evaluated at discharge. No single nutritional index is consi-
dered a reference standard; we therefore applied three previously investigated well-esta-
blished methods simultaneously. The occurrence of disease complications during hospital 
stay was studied as a function of the nutrition status at entry. 
DISEASE 
NUTRITIONAL STATUS « COMPLICATIONS 
Figure 1 - Mutual rektions between nutritional status, underlying disease and complications 
during the course of the disease. 
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Patients 
Only seriously ill patients are nowadays hospitalized in the Netherlands; others are 
treated as outpatients. We excluded patients admitted only for observation after endosco­
pic treatment, patients who were unconscious or clinically unstable, and all those unable 
or unwilling to give their informed consent. All 155 eligible patients who gave their infor­
med consent entered the study. Nutritional status was assessed within 24 hours after 
admission. The study was approved by the Committee for Ethics and Research in Humans. 
Assessment of nutritional status 
The Subjective Global Assessment (2,16,17) is a clinical score. It was performed by a 
trained independent physician, using a standardized questionnaire concerning food intake 
and complaints such as vomiting, diarrhoea, and loss of weight. A physical examination 
focused on nutritional status, and weights were corrected for oedema, ascites and dehy­
dration. Based on these data the physician classified the patient as not, mildly, moderate­
ly or severely malnourished (see appendix). The physician had no knowledge of the medi­
cal history, diagnosis, results of laboratory tests, or the reason for admission of the patient 
in question. 
The Nutritional Risk Index (18,19) is derived from the serum albumin concentration 
and the ratio of actual to usual weight using the equation 
Nutritional Risk Index = (1.489 χ serum albumin (g/L)) + 
(41.7 χ (present weight/ usual weight)). 
A Nutritional Risk Index > 100 indicates that the patient is not malnourished; 100-97.5 
is mild malnourishment; 83.5 - <97.5 is moderate malnourishment and <83.5 is severe 
malnourishment. The usual weight was defined as the stable weight at least 6 months befo­
re admission. The actual weight was determined with the patient sitting on a calibrated 
Seca balance (Hamburg, Germany). 
The Maastricht Index (20) involves serum albumin and transthyretin (pre-albumin) 
concentrations, blood lymphocyte count and percentage of ideal weight using the 
equation: 
Maastricht Index = 20.68 - (0.24 χ albumin (g/L)) - (19.21 χ 
transthyretin (pre-albumin) (g/L)) - (1.86 χ lymphocytes (107L)) 
- (4 χ present weight/ideal weight)). 
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This index was called Nutritional Index by the investigators in Maastricht (20) who deve-
loped it; we use the term 'Maastricht Index' to avoid confusion with the Nutritional Risk 
Index. Patients with a Maastricht Index of > 0 are considered malnourished. We measured 
height (Seca, Hamburg, Germany) and wrist circumference (Stanley Tools, New Britain, 
Connecticut, USA) and then derived ideal weight from the tables of the Metropolitan Life 
Insurance Company were used (21). The nutritional status was graded as malnourished or 
not malnourished in the Maastricht Index, and as none, mild, moderate or severe in the 
other two methods. 
In the 90 patients studied in the first four-month period nutritional status was asses-
sed twice, once at admission and once at discharge. We also assessed the Nutritional Risk 
Index and the Maastricht Index in 175 healthy blood donors and in 34 healthy elderly par-
ticipants in the strenuous Nijmegen Four Days Walking March. In these 209 healthy sub-
jects the apparent percentage of malnourished persons was 1.9% according to the 
Nutritional Risk Index and 3.8% according to the Maastricht Index. These low values 
show that in our hands a high percentage of malnutrition in patients is not likely to be cau-
sed by false-positive diagnoses (22). 
We also merged the results of the Subjective Global Assessment, the Nutritional Risk 
Index and the Maastricht Index into a single combined index. We considered a patient 
malnourished according to this combined method (COMBI) if he was malnourished to 
any degree according to at least two of the three underlying methods. 
Albumin was determined by photometry on a BM Hitachi 747 automatic analyzer 
(Hitachi, Tokyo, Japan), transthyretin (pre-albumin) by immunonephelometry (Cobas 
Fara II, Hoffmann-La Roche, Basel, Switzerland) using a rabbit anti-human transthyretin 
(pre-albumin) anti-serum (Dako, Copenhagen, Denmark), and total number of blood 
lymphocytes by an automatic blood cell counter (Sysmex NE 8000, TOA Medical 
Electronics, Kobe, Japan). A pool of serum from 209 healthy donors was used as working 
standard for transthyretin (pre-albumin). It was calibrated against the CRM-470 (CRM = 
Certified Reference Material) international reference preparation of transthyretin (pre-
albumin) of the International Federation of Clinical Chemistry. In the present study albu-
min and transthyretin (pre-albumin) serum concentrations were correlated with each other 
(r=0.39, p=0.001). 
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Confounding variables and complications 
We recorded the presence or absence of cancer or non-malignant disease as a poten-
tial determinant of complications. Non-malignant disease was further divided into 'gast-
rointestinal' and 'non-gastrointestinal' (Table 1). 
In case of multiple diagnoses, the diagnosis which was the reason for admission was cho-
sen. We recorded 'number of drugs used', 'duration of hospital stay' and 'functional capa-
city' as proxies of the severity of the disease. The functional capacity was graded into three 
categories: 
Category I: the patient can take care of his/her personal hygiene such as washing and sha-
ving, can eat without help and has no limitation in his/her daily activities such as walking 
and reading. Category II: the patient needs assistance for his/her personal hygiene and in 
Table 1 
Diagnoses of the 155 patients at admission to a non-surgical ward 
Non- malignant 
Gastro-intestinal 
Crohn's disease 
Abdominal pain e.c.i.* 
Liver cirrhosis 
Hepatic encephalopathy 
Pancreatitis 
Ulcerative colitis 
Short bowel syndrome 
Rectal bleeding 
Gastrointestinal bleeding 
Acute pancreatitis 
Vomiting 
Gastro-enteritis 
Gastric ulcer 
Oesophageal bleeding 
Others 
Subtotal 
Grand total 
10 
8 
5 
3 
3 
3 
3 
3 
3 
2 
2 
2 
4 
2 
30 
83 
Non-gastrointestinal 
Diabetes 
Hypo-y-globulinemia 
Anaemia 
Cardiac decompensation 
Pneumonia 
Thrombosis 
AIDS 
COPD" 
Hypertension 
Fever e.c.i.* 
Others 
10 
4 
4 
4 
3 
3 
3 
2 
2 
2 
12 
49 
Cancer 
Oesophagus 
Pancreas 
Hepatocellular 
Colon 
Gastric 
Lung 
Osteosarcoma 
Leukaemia 
M. Kahler 
Non-Hodgkin 
Thyroid 
4 
4 
3 
3 
2 
2 
23 
155 
" E.c.i. = of unknown origin; " COPD = Chronic Obstructive Pulmonary Disease 
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Table 2 
Number of new complications occurring in 155 patients on a non-surgical ward during hospi-
tal stay. In 74 patient no complications occurred. One patient could have more than one com-
plication. 
Infectious complications 
Severe 
Pneumonia 
Septicaemia 
Abdominal abscess 
Subtotal 
Less severe: 
Cystitis 
Local candidiasis 
Wound infection 
Conjunctivitis 
Laryngitis 
Onychia 
Furuncle 
Cholangitis 
Subtotal 
Total 
Grand total: all complicat 
7 
5 
2 
14 
5 
4 
3 
2 
1 
1 
1 
1 
18 
32 
ions 
Non-infectious complications 
Severe 
Fever (not bacterial) 
Intestinal bleeding 
Dehydration 
Kidney failure 
Decubitus ulcer 
Heart failure 
Hemoptysis 
Venous thrombosis 
TIA 
Pancreatitis 
Fistula 
Vaso-vagal collapse 
Lung embolism 
CVA 
Epileptic insult 
Ileus 
Cutaneous ulcus 
18 
6 
4 
4 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
Liver decompensation 1 
Pleural fluid 
59 
Less severe 
Vomiting 11 
Dermatosis 10 
Diarrhoea 9 
Obstipation 9 
Phlebitis 9 
Anaemia 6 
Mild intestinal bleeding 4 
Oedema 4 
Hyper/hypoglycaemia 4 
Delayed wound healing 4 
Rhinorrhagia 3 
Arthralgia 3 
Atelectases 3 
Thrombo- and/or leucopenla 3 
Oral mucosal defects 2 
Minor decubitus ulcer 2 
Mild cardiac arrhythmias 2 
Otorrhoea 2 
Muscle cramps 2 
Mild metabolic deterioration 2 
Others 8 
104 
195 
eating and is limited in his/her daily activities. Category III: the patient is completely 
dependent on assistance for his/her personal hygiene and eating. 
A complication was defined as: a state in which a disease or accident is added to an 
existing illness without being related specifically to this illness (23). Complications were 
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Mild Moderate Severe Total 
Subject ive 
Global 
Assessment 
Nutr i t ional 
Risk 
Index 
Maastricht 
Index 
20 40 60 80 
Percentage Malnourished 
100 
Figure 2 - Prevalence of malnutrition in 155 non-surgical hospitalized patients at admission. 
The Maastricht Index does not specify grades of malnutrition 
divided into 'mild' and 'severe' and also into 'infectious' and 'non-infectious'. A list of rele-
vant complications had been compiled before the start of the study (table 2). Physicians 
and nurses were instructed to record all new complications in the patients' files. The results 
of the assessment of the nutritional status were kept hidden from attending physicians and 
nurses, so as not to influence the treatment of the patient. The occurrence, type and sever-
ity of complications which occurred after admission were derived from the patients' files 
after discharge. 
Data analysis 
A Chi-square test was used to compare the results of the various indices. To analyze 
the association between the complications and the nutritional status graded for severity the 
non-parametric Spearman test and the Kruskal-Wallis test were used, because the group 
^ 
Table 3 
Characteristics (mean (SD)) of 155 patients on a ward for internal and gastrointestinal 
diseases, by nutritional status at admission. "Yes" is malnourished, "No" is not malnourished. 
Characteristic 
η 
Age 
(years) 
Duration of 
hospital stay 
(days) 
Number of dif­
ferent drugs 
used (per day) 
Cancer " 
(% of patients) 
Decreased 
Presence of malnutrition at admission 
Subjective Nutritional 
Global 
Assessment 
Yes No 
70 
57.3 
(17.0) 
18.4* 
(13.1) 
7.7"* 
(4.7) 
21* 
60** 
functional capacity 
(% of patients) 
Surgery within 
3 months before 
admission 
12 
85 
57.0 
(19.5) 
14.2 
(11.3) 
5.1 
(3.4) 
10 
35 
6 
Risk 
Index 
Yes 
88 
59.3 
(17.1) 
18.4** 
(14.4) 
7.2" 
(4.2) 
18 
59*** 
12 
No 
67 
53.4 
(18.9) 
13 
(9.3) 
5 
(4) 
10 
26 
5 
, by nutritional index 
Maastricht COMBI 
Index 
Yes 
93 
57.1 
(17.6) 
18.6* 
(14) 
7.1* 
(4.3) 
17 
51 
10 
No 
62 
56.4 
(18.8) 
13.8 
(9.4) 
5.5 
(4) 
12 
37 
8 
Index 
Yes 
90 
58 
(17.4) 
20*** 
(13.9) 
7.6** 
(4.2) 
20* 
60*"* 
12 
No 
65 
54.9 
(19.2) 
12.6 
(7.9) 
5.1 
(4) 
9 
25 
6 
Differences between means were tested using Student's t-test The variables expressed as percentages were tested 
using a Chi-square test (*p<0 05, "p<0 01, *"p<0 001) Decreased functional capacity refers to categones II and III com­
bined (see methods) " = No differences were seen between disease categones gastrointestinal and non-gastrointestinal 
size in some groups was too small for an individual comparison between all separate 
groups. Odds Ratio's with 95% confidence intervals were calculated for the development 
of complications in malnourished versus well-nourished patients. Multivariate logistic 
regression analysis with backwards variable exclusion was used to adjust for confounding 
factors (SAS Procedure (24)). Dichotomous variables were coded as 0 or 1. 
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RESULTS 
During the total catchment period of 5.5 months 330 patients were admitted. We 
excluded 93 patients who were admitted exclusively for observation after endoscopic 
treatment and who were discharged within 3 days, and 13 patients who were unconscious 
or clinically unstable and thus unable to give their informed consent, or to answer the 
questions of the questionnaire (see appendix). Another eighteen patients refused to parti­
cipate. In 51 patients nutritional status could not be assessed within 24 hours after admis­
sion. Most of these were acute admissions over the weekend; their nutritional status may 
therefore have been worse than that of the patients who did enter the study. The remai­
ning 155 patients, 65 female and 90 male, with a mean age of 57.1 years (range 21-93 
years, SD 18.2), were included in the study. Table 1 shows the diagnoses of these 155 
patients. The mean duration of hospital stay was 16.1 days. 
The frequency of any degree of malnutrition at hospital admission varied from 45% 
as assessed by the Subjective Global Assessment to 62% for the Maastricht Index (Figure 
2). The severity of malnutrition diverged between indices, with the Subjective Global 
40 
35 
30 
w 
I 25 
α 
о. 
о 20 
Ф 
| 15 
3 
ζ 
10 
5 
0 
1 2 3 4 5 6 7 
Number of Complications 
Figure 3 - Number of complications per patient occurring in 81 of the 155 patients at a non­
surgical ward, during an average hospital stay of 16 days. In the 74 other patients no compli­
cations occurred 
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Figure 4 - Mean number of complications per patient during hospital stay in patients malnou­
rished (solid bar) or well-nourished (shaded bar) at entry according to various methods of nut­
ritional assessment Upper left severe complications, lower left non-severe complications, upper 
right infectious complications, lower right non-infectious complications The x-axis on the left 
handpaneL· runs from 0 to 1 2 and that on the right hand from 0 to 1 6 (*p<0 05, **p<0 01, 
***p<0 001) 
Assessment scoring most cases as "mild" while the Nutritional Risk Index scored most cases 
as "moderate" or "severe" 
During the first 4-month period data were gathered on ninety patients both at admis-
sion and at discharge. The nutritional status showed a small but significant improvement 
during hospital stay (64% malnourishment at admission, 53% at discharge, p<0.05) accor-
ding to the Maastricht Index. The Subjective Global Assessment and the Nutritional Risk 
Index did not show a significant changes (41% versus 51% and 52% versus 49%, respec-
tively). According to the Subjective Global Assessment more of the gastrointestinal patients 
were malnourished than of the internal medicine patients (61% versus 30%). As the other 
methods did not reveal a significant difference (Nutritional Risk Index 59% versus 47%, 
Maastricht Index 65% versus 64%), the results of the patients at the two wards were taken 
together. In the second period the Subjective Global Assessment was assessed by a different 
physician, but the percentage of patients malnourished at admission was similar to that in 
the first part of the study namely 46% versus 4 1 % . 
The severity of malnutrition was related with the diagnosis. According to the 
Subjective Global assessment, malnutrition was present in 54% of the patients with in-
flammatory bowel disease; 23% of them was moderately malnourished and 15% was sever-
ely malnourished. According to the Nutritional Risk Index, malnutrition was present in 
77% of these patients; 31 % were moderately and 46% were severely malnourished. 
According to the Maastricht Index 90% of the patients with active inflammatory bowel 
disease were malnourished. A tendency towards more severe malnutrition was seen in can-
cer patients. Malnourished patients also differed from well-nourished patients in duration 
of hospital stay, number of different drugs used, and functional capacity (Table 3). 
No complications occurred in 74 of the 155 patients; 32 patients suffered 3 or more 
complications (Figure 3). Two patients died during hospital stay. Figure 4 shows the mean 
number of complications per patient for the various groups of complications for well nou-
rished and malnourished patients. A significantly higher number of complications was 
seen in malnourished than in well-nourished patients. The patients with cancer were more 
at risk of developing complications than non-cancer patients (Figure 5). Significant diffe-
rences were observed in the total number of complications and in non-severe non-infec-
tious complications between patients with cancer and without cancer (p < 0.05, for both). 
Figure 6 shows the mean number of complications for the two indices that yielded a gra-
ding in severity of malnutrition. Is was not possible to compare the separate groups becau-
se some of the group sizes were too small, but the Spearman correlation coefficient was sig-
nificantly different from 0 both for the Subjective Global Assessment and the Nutritional 
Risk Index (R=0.30 and R=0.24, respectively). The Kruskal-Wallis test yielded similar 
results. 
Table 4 shows the crude Odds Ratio's for the association between malnutrition and 
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Severe Severe Non-severe Non-severe 
infectious non-infectious infectious non-infeclious 
2 50 
0.00 
Cancer No Cancer 
Figure 5 - Mean number of complications occurring per patient during hospital stay, as a func-
tion of the presence or absence of cancer (error bars indicate one SEM) 
the occurrence of complications. The risk of complications was increased in malnourished 
patients in all methods of assessment of the nutritional status. 
A number of variables could confound this relation by causing both malnutrition 
prior to admission and complications later on during hospital stay. The major potential 
confounder is the severity of disease. We entered the presence of cancer and of non-malig-
nant diseases, divided into gastrointestinal and non-gastrointestinal, as independent varia-
bles in a multivariate analysis, and added 'number of drugs used', 'duration of hospital stay' 
and 'functional capacity' as proxies for the severity of the disease. Adjustment for these 
potential confounding factors lowered the Odds Ratios for the risk of complications in 
malnourished patients (Table 5). However, all Odds Ratio's remained elevated, and that for 
the Maastricht Index remained significantly higher than 1 for 'All Complications'. 
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DISCUSSION 
Prevalence of malnutrition 
We found that at least 40 % of the patients in a ward for non-surgical patients were 
malnourished at admission, and that the risk of subsequent complications was higher in 
malnourished patients. The frequency of malnutrition was as high as or higher than that 
reported in surgical patients (1-10). This figure of at least 40% malnutrition can be an 
underestimation because patients were excluded if nutritional status could not be assessed 
within 24 hours after admission. This mostly involved admissions during the weekend of 
patients with acute conditions, who probably had a more severe illness. The validity of the 
indices used was confirmed in a study of the prevalence of apparent malnutrition in heal­
thy volunteers (22). That study was performed in parallel with the present study, and it 
demonstrated 1.9 % apparent malnutrition in healthy volunteers according to the 
Nutritional Risk Index , and 3.8% according to the Maastricht Index. However, the 
Subjective Global Assessment Nutritional Risk Index 
CZI 777Δ 
Moderale 
(η - 83) (η - 36) (η - 22) 
Seventy of malnutrition 
( η - 9 ) • 65) (η - 9) (η - 56) 
Severity of malnutrition 
Figure 6 - Mean number of complications during hospital stay, as a function of the grade of 
malnutrition at admission. The left section presents malnutrition assessed by the Subjective glo­
bal assessment. The right section shows the results of the Nutritional Risk Index. The Maastricht 
Index does not subdivide the malnourished patients in severity of malnourishment, and is not 
depicted. Error bars indicate one SEM. 
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Maastricht Index overestimated the prevalence of malnutrition in elderly volunteers (22). 
This probably had only a limited influence on the results of the present study, because only 
16% of the patients were aged over 70 years. 
One could argue that the group of patients was very heterogeneous and that it might 
have been preferable to study one disease in detail. We deliberately studied this heteroge-
neous population because our aim was to study the relation between nutritional status and 
complications in patients at a non-surgical ward. If a correlation could be demonstrated in 
this heterogeneous population, this would strengthen the need for active treatment of mal-
nutrition. 
The high prevalence of malnutrition in cancer patients, especially according to the 
Subjective Global Assessment, may suggest that the presence of cancer weighed heavily in 
the diagnosis of malnutrition made by a subjective method, even though cancer is not by 
itself diagnostic of malnutrition. However the physician assessing nutritional status had no 
Table 4 
Crude Odds Ratio's (with 95% confidence intervals) for risk of complications during hospital 
stay, in patients malnourished at entry compared with well-nourished patients on a non-sur-
gical ward. 
Type of 
complication 
(number of 
occurrences) ' 
Severe 
(73) 
Non-severe 
(122) 
Infectious 
(32) 
Non-infectious 
(163) 
All complications 
(195) 
Risk in malnourished patients, by method of assessment 
Subjective 
Global 
Assessment 
2.5 
(1.2-5.2) 
2.7 
(1.4-5.3) 
3.1 
(1.2-8.2) 
2.7 
(1.4-5.2) 
2.7 
(1.4-5.3) 
Nutritional 
Index 
Index 
2.7 
(1.2-5.9) 
2.5 
(1.3-4.9) 
3.8 
(1.2-11.0) 
2.6 
(1.3-4.0) 
2.8 
(1.5-5.5) 
Maastricht 
Index 
2.4 
(1.0-5.4) 
2.6 
(1.3-5.5 
1.9 
(0.6-5.6) 
2.9 
(1.4-6.1) 
3.1 
(1.5-6.4) 
COMBI 
Index 
3.5 
(1.4-8.5) 
2.9 
(1.4-6.2) 
4.3 
(1.2-15.7) 
3.2 
(1.5- 6.6) 
3.3 
(1.6-7.1) 
' The 155 patients developed 195 complications; one patient could suffer more than one complication. 
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knowledge of the medical history or the diagnosis. 
Malnutrition and complications 
Nutritional status, the occurrence of complications, and the underlying diseases con­
stitute a triangle in which it is unclear what causes what (Figure 1). One could argue that 
malnutrition is not the cause of complications but that both malnutrition and complica­
tions are the result of the underlying disease or of other factors. The Nutritional Risk Index 
and the Maastricht Index use serum concentrations of proteins which are influenced by the 
nutritional status but also by inflammatory stress due to a disease. This is why we also used 
the Subjective Global Assessment, which is not influenced by these serum proteins. 
Patients who were malnourished at admission developed more complications during 
hospital stay. Patients who were more severely malnourished were more at risk than to less 
malnourished patients. The crude Odds Ratio's for the risk of complications in malnou-
Table 5 
Multivariate Odds Ratio's (with 95% confidence intervals) for occurrence of complications in 
malnourished patients compared with well-nourished patients after adjustment for confoun­
ding variables *. 
Type of 
complication 
(number of 
occurrences) 
Severe 
(73) 
Non-severe 
(122) 
Infectious 
(32) 
Non-infectious 
(163) 
All complications 
(195) 
Risk in malnourished patients, by method of assessment 
Subjective 
Global 
Assessment 
1 2 . . b . c 
(0.4-3.3) 
1.9 a " 
(0.9-4.0) 
1.5" 
(0.5-4.8) 
j 7a.Ce 
(0.Θ-3.6) 
1.7"° 
(0.8-3.6) 
Nutritional 
Index 
Index 
-ι na.b.c 
(0.4-3.2) 
1.6м 
(0.8-3.5) 
1.0" 
(0.3-4.1) 
1.4"'" 
(0.6-2.0) 
1.6"·" 
(0.7-3.3) 
Maastricht 
Index 
1.5" 
(0.6-3.9) 
2.2C 
(1.0-4.8) 
1 i 4 r t d 
(0.3-6.9) 
ρ pa.c.d 
(1.0-5.0) 
2.4" , a 
(1.1-5.4) 
COMBI 
Index 
1.3ab 
(0.4-3.6) 
2.3C 
(1.0-5.0) 
1.4" 
(0.3-7.5) 
1.5"'" 
(0.6-3.6) 
-1 ya,c,d 
(0.7-4.0) 
* Adjusted for ' functional capacity, b number of drugs used,c duration of hospital stay, d disease category, and * surgery within 3 
months before admission. 
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rished versus well-nourished patients varied between 1.9 and 4.3. Larsson (9) reported 
crude Odds Ratio's of 1.9 and Robinson (13) of 2.6. The increased risk of complications 
in malnourished patients could be due to confounders such as age, underlying disease, or 
severity of the disease. Therefore we adjusted the crude Odds Ratio's for these variables. 
Because a general index for the severity of diseases does not exist we used proxy variables 
such as 'number of drugs used', 'duration of hospital stay' and 'functional capacity'. Such 
adjustment decreased the Odds Ratio's to values between 1.0 and 2.4. Presence of cancer 
was an especially important confounder. However, Odds Ratio's for the risk of complica-
tions in malnourished versus well-nourished patients still remained elevated after multiva-
riate adjustment, and the Maastricht Index was still significantly higher than 1. One might 
argue that these values are inflated because of residual confounding; this is a well-known 
problem when confounding variables are measured with insufficient precision, as was pro-
bably the case here. On the other hand, one may also argue that we overadjusted the crude 
Odds Ratios by including confounders such as functional capacity which may itself have 
been an end result of malnutrition. If this is the case then the adjusted Odds Ratio's unde-
restimate the independent impact of malnutrition. 
Although the disease category strongly predicted the occurrence of complications, tre-
atment of the disease is not always possible or successful, and nutritional intervention 
would still be valuable if it reduced the occurrence of complications. Therefore the effect 
of nutritional intervention on the rate of disease-specific complications in non-surgical 
patients merits study. 
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APPENDIX 
Subjective Global Assessment 
Questionnaire 
What was your usual weight 6 months ago ? 
Did you lose weight dunng the past year ? 
Did you lose appetite ? 
Did you use food supplements ? 
Are there complaints of 
nausea 
vomiting 
diarrhoea 
dizziness when rism 
swollen feet 
swollen abdomen 
loss of physical capacity 
Physical examination 
Extent of loss of subcutaneous fat upon physical examination 
Extent of loss of muscular mass upon physical examination 
Presence and extent of ascites 
Presence and extent of oedema 
Presence and extent of dehydration 
Correction of weight for ascites, oedema and dehydration 
Conclusion regarding nutritional status not, mild, moderately or severely malnounshed. 
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ABSTRACT 
Protein-energy malnutrition is thought to be widespread in hospitalized patients. However, 
the specificity of indices used to assess malnutrition is uncertain. We therefore assessed the 
rate of false-positive diagnoses of malnutrition when biochemical-anthropometrical indi­
ces were applied to healthy subjects. Nutritional status was assessed in 175 healthy blood 
donors (aged 44.2 ± 13.4 years) and 34 highly fit elderly volunteers in the Nijmegen Four 
Days Walking March (aged 74.7 ± 3.6 years). We investigated both the Nutritional Risk 
Index (1.5 χ albumin + 42 χ present/usual weight) and the Maastricht Index (21 - 0.24 χ 
albumin - 19 χ transthyretin (pre-albumin) - 1.9 χ lymphocytes - 0.04 χ ideal weight). 
Earlier we found 52% - 64% of non-surgical hospital patients to be malnourished accor­
ding to these indices. Apparent malnutrition was present in 1.9 % of the 209 volunteers 
according to the Nutrition Risk Index, and in 3.8 % according to the Maastricht Index. 
The prevalence of apparent malnutrition in the elderly volunteers was 5.9% and 20.6%, 
respectively. The rate of false-positive diagnoses was acceptably low below the age of 70 
years for both the Nutritional Risk Index and the Maastricht Index, and will not cause a 
clinically significant bias in the assessment of the prevalence of malnutrition in hospitals. 
The high percentage of spurious malnutrition in elderly limits the use of the Maastricht 
Index to subject under the age of 70 years. 
INTRODUCTION 
Various methods have been developed to assess protein-energy malnutrition in hos­
pital patients. In 20 published studies the observed frequency of malnutrition varied from 
23 to 62%, with an overall mean of 38% (Table 1). In a previous study (1) in non-surgi­
cal hospital patients we found a prevalence of malnutrition of 52% using the Nutritional 
Risk Index and 64% using the Nutrition Index or Maastricht Index. The Nutrition Index 
was developed by workers in Maastricht (3); to avoid confusion with similarly named other 
indices we will designate it the Maastricht Index in this paper. In malnourished surgical 
patients as assessed by these indices, nutritional intervention has proven to reduce the 
number of post-operative complications (2-4). If the prevalence of malnutrition is truly 
high in non-surgical patients, a considerable percentage of these patients might also bene­
fit from nutritional support. However, the specificity of current instruments for assessing 
malnutrition has not been properly assessed. The Nutritional Risk Index was developed by 
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Table 1 
Published figures for the prevalence of malnutrition in random samples of hospitalized 
patients. 
Patients 
Surgical 
Geriatric 
General Medicine 
Reference 
Postma(15) 
Hall (16) 
Pettigrew (17) 
McWhirter(18) 
Bistrian (19) 
Detsky (20) 
Reilly (21) 
Buzby (22) 
Mean 
Larsson (23) 
Füllöp (24) 
Constane (25) 
Sullivan (26) 
Mean 
Larsson * (27) 
Willard * (28) 
Coats (29) 
McWhirter(18) 
Weinsier (30) 
Robinson (31) 
Reilly (21) 
Bistrian (32) 
Mean 
N 
422 
367 
198 
200 
131 
202 
406 
100 
500 
552 
324 
110 
382 
200 
228 
300 
134 
100 
365 
251 
Prevalence 
23% 
29% 
32% 
33% 
40% 
44% 
48% 
62% 
4 1 % 
29% 
34% 
37% 
38% 
33% 
29% 
32% 
38% 
45% 
48% 
56% ' 
59% 
44% 
44% 
* = part of these samples were surgical patients. 
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calculating the association of various nutritional parameters with post-operative complica-
tions (5,6), and it has not been checked in healthy subjects. The Maastricht Index (7) has 
been developed by comparing Objective nutritional parameters' in 50 patients selected for 
parenteral nutrition with the same parameters in 38 patients selected for elective minor 
surgical procedures. Neither of these indices have been validated in healthy subjects. We 
were concerned whether the high prevalence of protein-energy malnutrition that we obser-
ved in non-surgical hospitalized patients could originate from false-positive misclassifica-
tion. We therefore investigated the prevalence of apparent malnutrition in a healthy po-
pulation, in which the prevalence of true malnutrition should be low. 
METHODS 
Volunteers 
The study was performed after permission had been obtained from the local ethical 
committee. We selected 175 blood donors, and 34 healthy elderly people. In the 
Netherlands blood donors give blood at least once or twice a year as an act of charity wit-
hout financial compensation. All donors are registered and receive medical and laboratory 
check-ups at regular intervals. Only volunteers who were completely healthy, according to 
the most recent medical and laboratory check-up and who were free from active or chro-
nic diseases, were selected for this study. Their mean age was 44.2 (SD 13.4) years and their 
body mass index 25.6 (SD 4.1) kg/m2. 
In the Netherlands persons aged 70 years or over are excluded from blood donors-
hip. We therefore approached elderly people who had completed the 1993 Nijmegen Four 
Days Long Distance March, a sports event in which volunteers walk 30 km (19 miles) each 
day during four days (table 2). We excluded elderly persons suffering from a chronic dise-
ase, thereby reducing the risk of including malnourished persons. The remaining 34 elder-
ly had a mean age of 74.7 (SD 3.6) years and a body mass index of 24.1 (SD 2.3) kg/m2. 
The age distribution of subjects was similar to that of the hospitalized patients which we 
studied previously (1) (Table 2). 
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Table 2 
Characteristics of 209 healthy Dutch volunteers investigated for the presence of apparent 
malnutrition 
Age range Women (n) 
Weight (kg) 
(Years) 
21 - 29 18 
3 0 - 3 9 17 
40-49 17 
50-59 19 
60-69 16 
>69 11 
Total 9Θ 
Assessment of nutritional status 
We used two methods to determine nutritional status (Table 3). The Nutritional Risk 
Index (5,6) is based on serum albumin and current versus usual weight; a value of 100 or 
less indicates malnutrition. The Maastricht Index (3) uses serum albumin, serum pre-albu-
min, blood lymphocyte count and percentage of ideal weight; a positive value indicates 
malnutrition. For the ideal weight the tables of the Metropolitan Life Insurance Company 
were used (8). 
Current weight was determined using a Krupps or a Seca balance, and height using a 
Seca or Stanley 04-116 microtoise. The usual weight for blood donors was the weight 
registered by the blood bank 6 months prior to the assessment of the nutritional status; the 
usual weight was also ascertained in all subjects by means of a questionnaire. The weight 
reported by the blood donors and the weight recorded by the blood bank 6 month prior 
to assessment were highly similar (75.0 ± 12.2 and 75.4 ± 12.8 kg respectively). 
Men (n) Height (cm) 
(SD) 
176 
(8.5) 
173 
(9.6) 
172 
(8.4) 
169 
(8.1) 
169 
(9.3) 
168 
(8.2) 
171.2 
(8.7) 
(SD) 
74.7 
(12.2) 
73.1 
(12.3) 
77.0 
(15) 
79.2 
(11.8) 
74.3 
(11.4) 
69.1 
(10.4) 
74.6 
(12.2) 
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Table 3 
Indices used to determine the nutritional status in 209 healthy volunteers 
Nutritional Risk Index (5,6) = 1.489 χ serum albumin (g/L) + 41.7 χ 
(present weight/ usual weight) 
Nutritional Risk Index > 100: not malnourished; 
100 > Nutritional Risk Index > 97.5: mild malnourishment; 
97.5 > Nutntional Risk Index > 83.5: moderate malnourishment; 
Nutritional Risk Index < 83.5: severe malnourishment. 
Maastricht Index (7) = 20.68 - 0.24 χ serum albumin (g/L) - 19.21 χ serum 
transthyretin (pre-albumin, g/L) -1.86 χ lymphocytes (106/L) - 4 χ present weight/ideal weight* 
Maastricht Index < 0: not malnourished; 
Maastricht Index > 0: malnourished. 
* For the ideal weight the tables of the Metropolitan Life Insurance Company were used (8) 
Laboratory methods 
Blood levels of albumin and other analyses are influenced by body posture (9). 
Therefore blood sampling was performed with subjects in a semi-recumbent position iden­
tical to that used in patients in our clinical study and in most hospitals (4). In the elderly 
people blood was drawn before or at least 2 weeks after the four-days march. Training was 
performed about 5 hours per week. To exclude influences of the training on the blood 
levels of albumin and other analyses, the elderly volunteers were not to performing any 
training at least 2 days before the blood sampling. 
Serum albumin concentrations were determined by spectrophotometry with bromcresol 
green on a BM/Hitachi 747 (Hitachi, Tokyo, Japan), transthyretin (pre-albumin) by 
immunonephelometry on a Cobas Fara II (Hoffmann-La Roche, Basel, Switzerland) using 
a rabbit anti-human pre-albumin anti-serum (DAKO, Copenhagen, Denmark). 
Transthyretin (pre-albumin) was calibrated against the CRM-470 international reference 
serum of the International Federation of Clinical Chemistry. Total number of blood 
lymphocytes was determined by an automatic cell counter (Sysmex NE 8000, TOA Med. 
Electron., Kobe, Japan). 
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Statùtics 
We made the assumption that in a healthy population the true prevalence of mal-
nutrition is zero percent. The observed percentage of malnourished persons in our sample 
therefore equals the percentage that is misclassified. The upper limit of the 95% confi-
dence interval for the proportion malnourished was calculated as 
ρ + Ζ
α
 χ SD(p), with SD(p)= V[p(l-p)/n] 
in which ρ is the observed proportion malnourished, η is the sample size, and Z
a
 is 1.96. 
For the subgroup of elderly subjects 95% confidence intervals were calculated according to 
tables for small samples (10). 
All calculations were done with the statistical program SAS (11). 
RESULTS 
The mean value of the Nutritional Risk Index for the total sample was 111.1 (SD 
4.9). Four out of the 209 volunteers were classified as mildly malnourished 
(97.5<NRI<100) according to the Nutritional Risk Index (Figure la). Two were men and 
two women, and three of the four were over 50. The apparent percentage of malnutrition 
was thus 1.9% (upper 95% confidence limit 3.8%). Figure lb shows the mean value of the 
Nutritional Risk Index by age. Three of the subjects were classified as malnourished becau­
se of a minor decrease of serum albumin. However, the weight of these 3 persons was above 
100% of their usual weight. The mean present weight was 171.2 (SD 8.7, table 2) kg; in 
52% of subjects it was lower and in 48 % higher than their usual weight. One male weigh­
ted 87% of his usual weight and was classified as malnourished by the Nutritional Risk 
Index; nevertheless his actual weight was higher than his ideal weight according to the 
Metropolitan Life Insurance Company (8). This person was the fourth one categorized as 
malnourished according to the Nutritional Risk Index. The outcome for the age categories 
of 60-69 and above 69 years was significantly lower than that for ages 21-29, indicating an 
increased apparent risk at a higher age. The mean prevalence of apparent malnutrition in 
the blood donors aged 21-69 years was 1.1 % (95% upper confidence limit 2.7%), as 
opposed to 6% (95% upper confidence limit 20%) in the elderly hikers who were aged 
over 69. No differences were observed between sexes. 
The mean value of the Maastricht Index for the total sample was -3.63 (SD 2.25). 
Nine subjects, or 4.3% (upper 95% confidence limit: 7.0 % ) , were classified as malnou-
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rished according to the Maastricht Index; these seven were males, and all nine were over 
60 years of age (Figure 2a). The reasons for apparent malnutrition according to the 
Maastricht Index were a combination of factors in all cases. A significantly higher -1 e. 
poorer- score for this index, was seen in the age categories 60-69 and above 69 years com-
pared with the reference age category of 21-29 years, again indicating a higher probability 
of spurious malnutrition at a higher age (Figure 2b). The mean prevalence in the blood 
donors was 1 1 % (95% upper confidence limit 1.2%), and in the elderly marching com-
petitors 20 6% (95% upper confidence 38%). No differences were seen between sexes. 
NUTRITIONAL RISK INDEX NUTRITIONAL RISK INDEX 
MALNOUfllSHMENT 
1 29 30 39 40 49 SO S9 60 69 >6S 
AGE IN YEARS 
figure 1 - Figure la the left figure thows the individual value of the Nutritional Risk Index 
by age in 209 apparently healthy subjects Figure lb the right figure shows the mean 
Nutritional Risk Index and the standard deviation by age category in 209 apparently healthy 
subjects, * P<0 05 compared with age category 21-29 
DISCUSSION 
We applied two biochemical-anthropometnc indices for assessment of clinical mal-
nutrition to two groups of healthy subjects, and found that the rate of apparent malnutri-
tion was low and of no clinical significance in the group of subjects aged less than 70 years; 
however, 6 to 2 1 % of our group of highly fit, active elderly subjects were classified as mal-
nourished. 
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We assumed that the volunteers were not malnourished. This is made plausible by 
process of the selection of these volunteers: a medical and laboratory examination brought 
out no abnormalities, and volunteers with chronic diseases were excluded. In the 
Netherlands blood donors are unpaid, and donorship is seen as an act of charity. The vo­
lunteers were socially well adjusted, with a regular income, and they were of normal body 
weight according to the Body Mass. In our group of elderly volunteers the BMI was not 
different from that in younger volunteers. It is well known that unselected elderly subjects 
can be malnourished concerning protein (12) and micronutrients. In most previous stu­
dies concerning malnutrition in elderly persons, subjects with (chronic) diseases were not 
excluded. If they were excluded the proportion of malnourished elderly persons was less 
than 10% (13). The group of elderly volunteers included in our study were physically acti­
ve and their average nutrient intake was close to the Dutch recommendations (14). 
However, we can not exclude that a small percentage of the elderly persons was malnou­
rished. 
One could argue that some of the variables used in these indices are derived from 
laboratory methods which have been calibrated to yield normal values in a normal healthy 
population, so that the outcome is biased to normal values. However, the coefficients and 
constants that are used to calculate the value of each index are fixed and not calibrated per 
MAASTRICHT INDEX MAASTRICHT INDEX 
20 30 40 50 60 70 90 21-29 30-39 40-49 50-59 βΟ-βΟ >69 
HALNOURISHMENT MALNOURISHHENT
 A Q E I N YEARS 
Figure 2 - Figure 2a: the left figure shows the individual value of the Maastricht Index by age in 
209 apparently healthy subjects. Figure 2b: the right figure shows the mean value of the 
Maastricht Index and the standard deviation by age category in 209 apparently healthy subjects, 
* : P<0.05 compared with the first age category. 
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laboratory. The published reference ranges could be inapplicable, and outcome of the 
index could be erroneous if the coefficients and constants used are inappropriate for the 
population studied. Therefore, apparent prevalence of malnutrition in healthy volunteers 
could be considerable. This is illustrated by the discrepancy in frequency between the two 
indices. The less favourable values seen in otherwise highly fit elderly subjects could point 
to cases of malnutrition that were included in our sample in spite of our various precau-
tions. However, it could also suggest that the risk of a misdiagnosis of malnutrition is 
appreciable in elderly patients. Using the Nutritional Risk Index, the percentage of appa-
rent malnutrition in our highly fit elderly subjects aged >70 was 6% with an upper limit 
of the 95% confidence interval of 20%; using the Maastricht Index it was 2 1 % with an 
upper confidence level of 38%. These figures put into question the clinical significance of 
nutritional indices applied to elderly subjects. A false diagnosis of malnutrition could cause 
a patient to receive unnecessary enteral or parenteral nutrition. This would be expensive 
and could induce complications. 
The two elderly volunteers categorized as malnourished in the Nutritional Risk index were 
both classified as mildly malnourished. Obviously the risk of a false-positive diagnosis is 
highest in those subjects classified as mildly malnourished. The Veterans Affairs Total 
Parenteral Nutrition Group study (2) has demonstrated that perioperative parenteral nu-
trition was ineffective in such mildly malnourished patients, and was effective only in more 
severely malnourished patients. Therefore the consequence of misclassification in elderly 
patients using this index is limited. The Maastricht Index does not include grades of mal-
nutrition. Application of this index in elderly patients results in 2 1 % or more of the elder-
ly patients being treated mistakenly as malnourished. However, the number of elderly sub-
jects in our study precludes definitive conclusions. 
Our results indicate that the high proportion of hospitalized patients diagnosed as 
malnourished is not the result of positive misclassification, except possibly when elderly 
patients are involved. 
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ABSTRACT 
The serum zinc concentration is frequently applied for the assessment of zinc deficiency, 
but this concentration is also influenced by other factors. The aim of this study was to 
compare various methods of assessing the zinc status in patients with Crohn's disease. 
Serum zinc, serum alkaline phosphatase activity, and zinc in various types of cells were rela-
ted to factors potentially inducing zinc deficiency: the number of liquid stools, weight loss, 
bowel resection and the extent and severity of inflammation. Thirty-one patients with 
more or less active Crohn's disease were included. In 68 % of these patients the serum zinc 
concentration was below the reference level, and it was correlated with the extent of bowel 
resection and the van Hees Index, but not with the Crohn's Disease Activity Index. Serum 
alkaline phosphatase activity was correlated with bowel resection. Zinc in blood cells was 
poorly correlated with factors inducing zinc deficiency. 
A decrease of serum zinc concentration is frequently seen in active Crohn's disease. This 
study suggests that the determination of zinc in blood cells is not superior to the determi-
nation of the serum zinc concentration and serum alkaline phosphatase activity. 
INTRODUCTION 
Zinc is one of the most prominent trace elements in humans. It has been known to 
be essential for mammals since 1934 (1). Its deficiency causes a variety of symptoms (2). 
In patients with Crohn's disease, symptoms of zinc deficiency are observed occasionally (3, 
4, 5). Cachectic patients with Crohn's disease are particularly at risk of clinical manifesta-
tions of zinc deficiency in the post-operative anabolic period, because in this period there 
is a great need for zinc and the quantity available in the zinc depots is limited. We call the 
zinc status in patients with symptoms of zinc deficiency in the post-operative period and 
without clinical symptoms of zinc deficiency in the pre-operative period subclinical zinc 
deficiency 
In most studies concerning the zinc status in patients with Crohn's disease, only 
serum or plasma zinc is studied to determine the zinc status (table 1). Serum zinc is fre-
quently decreased in patients with Crohn's disease, but this does not always indicate zinc 
deficiency. Serum zinc is also decreased in case of inflammatory stress (6) as a result of a 
decrease of serum albumin (the most important zinc transporting protein in blood) and 
redistribution of zinc into the liver. As an alternative to serum zinc, serum alkaline phos-
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phatase activity has been suggested as a parameter of zinc deficiency because alkaline 
phosphatase activity is influenced by the zinc status (7). In some studies the detetmination 
of the zinc concentration in blood cells is used for the assessment of the zinc status, as an 
alternative to scrum zinc. The zinc concentration in blood cells of patients with Crohn's 
disease was compared to the zinc concentration in blood cells of healthy volunteers. In 
most of the studies no differences were observed. In none of these studies this method was 
disputed as an insufficient method (table 1). Although the results of these studies are dis-
appointing, determination of zinc in blood cells is still applied in clinical studies (8). 
The question arises if the method in which patients with active Crohn's disease are 
compared to healthy volunteers is adequate. As in patients with subclinical zinc deficiency 
the serum zinc concentration is nearly normal, it is difficult to demonstrate a significant 
difference between patients with Crohn's disease and healthy volunteers. 
We hypothesized that serum zinc, serum alkaline phosphatase and the zinc concen-
trations in blood cells are correlated with factors that are potentially related to zinc defi-
ciency: the activity of Crohn's disease, weight loss, the extent of the inflammation, the 
extent of the resection or the number of liquid stools. We have chosen for these factors, 
potentially causing zinc deficiency, because no gold standard for the zinc status, applicable 
in clinical practice, is available. The activity of Crohn's disease has been suggested as a cause 
of zinc deficiency (9, 10, 11). Weight loss can be a result of malnutrition, which may also 
result in a decrease of zinc status. Valberg et al. (12) observed a decrease of zinc absorption 
in undernourished patients with moderate or severe disease activity. Diarrhoea results in an 
increase of zinc loss. Therefore, we selected the extent of inflammation, the extent of the 
resection and the number of liquid stools as potential causes of a decrease of zinc status. 
We postulate that the parameters for the zinc status, most frequently correlated with 
potential causes of zinc deficiency, are of the greatest value for the determination of the 
zinc status. 
METHODS 
Patients 
This study was approved by the Committee for Ethics and Research in Humans of 
the University Hospital Nijmegen, in accordance with the Declaration of Helsinki. 
The activity of Crohn's disease was determined using the CDAI (normal value < 150 
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Table 1 
Zinc deficiency in Crohn's disease, a literature survey 
Author t 
(reference) F 
Bra (21) 
Nakamura (25) 
Ainley (26) 
Hinks (27) 
Sjogren (28) 
Valberg (12) 
Deflandre (29) 
Kruis (30) 
Schoelmerich 
(9) 
Hessov (31) 
Brignola (32) 
Ringstad (33) 
Terwolbeck 
(36) 
Ainley (35) 
Goode (36) 
Fernandez-
Banarez(11) 
Sturniolo (37) 
Fleming (38) 
McClain (3) 
Mills (39) 
Jr. of 
>atients 
10 
10 
31 
20 
30 
17 
29 
50 
54 
87 
27 
47 
26 
32 
34 
14 
33 
63 
52 
20 
Plasma or 
serum Zn* 
(μπιοΙ/L, 
patients/ 
controls) 
J-(11.6/14.9) 
4-(8.7/14.5) 
1(13.5/15.4) 
N (12.7/12.7) 
1(12.2/14.0) 
N (14.0/14.0) 
1(13.4/16.8) 
1(12.7) 
1(11.9/14.5) 
1(11.0) 
1 
Erythro 
cytes 
N 
1 
1 
N(o":14.4/12.7). 
( 9 :13.5/12.9) 
1(11.3/13.1) 
1(13.5/15.4) 
1(11.3/12.7) 
1(14.4/15.6) 
1(14.9/20.8) 
1(16.0/16.6) 
1 
N(13.7/15.6) 
N 
Leuco 
cytes 
N 
N 
Zinc in blood cells ** 
Lympho MNC Mono PMNC 
cytes 
N 
Ν N 
1 
N N . N 
N I N 
Alkaline 
Phos­
phatase 
Activity 
N 
N 
* Mean plasma or serum zinc concentration in patients with Crohn's disease and in a control population · · Cell type accor­
ding to the authors. N = normal compared to a control population, I = decreased compared to a control population,. = not 
determined 
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(13)) and the van Hees Index (normal value <100 (14)). Only patients with a serum albu-
min less than 37 g/L at the last visit to the out-patient clinic were included to ensure that 
a significant part of the patients had active Crohn's disease on the day of investigation. The 
site of the inflammation was determined by X-ray and/or endoscopy. Medical treatment 
was recorded. Blood was taken in a fasting state for the determination of serum zinc, serum 
alkaline phosphatase activity and the zinc concentration in erythrocytes, MNC and 
PMNC. Blood was drawn using stainless steel needles and plastic syringes with 10 /¿L of 
preservative-free heparin ( 50 IU ). 
Procedures 
Separation of blood cells performed by a modified discontinuous Percoli gradient. 
The method of determination of the cellular zinc concentration was adapted from 
Milne (15), but partly modified (16). Blood was diluted 1:3 with GPB (13.5 mmol/L 
Na2HPCv 3.3 mmol/L KH,P0 4 , 5.4 mmol/L KCl, 133 mmol/L NaCl and 5 mmol/L 
glucose in ion-free water and, if necessary, adjusted to pH 7.4 with HC0 3 - ) . Three solu-
tions of Percoli of different densities (1.060, 1.075 and 1.095 kg/L respectively) were pre-
pared by dilution with Hanks' balanced salts solution (without Ca and Mg) and were kept 
at 4°C to prevent clumping and zinc exchange by the cells (17). Six mL of a heavier solu-
tion was layered in a 50 mL tube underneath the lighter solution using a stainless steel 
needle of 15 cm and a plastic syringe. Subsequently the tube was centrifuged for 20 min., 
at 500 χ g at 4°C in a swing-out rotor without brake (Heraeus Crist Minifuge GL, 
Osterode am Harz, Germany). This resulted in separated layers of platelets, MNC, PMNC 
and erythrocytes. The MNC, PMNC and erythrocytes were harvested using a pipet and 
resuspended in 5 mL GPB in a 15 mL tube. Erythrocyte contamination of the M N C and 
PMNC fractions was removed by resuspending the cells twice for 10 min. at 4°C in 5 mL 
of erythrocyte lysing buffer (155 mmol/L NH4C1 and 10 mmol/L K H C 0 3 in ion-free 
water, pH adjusted to 7.4 with H CO,-) and subsequent washing steps with 5 mL of GPB. 
After these steps the tube was centrifuged for 10 min., 200 χ g, 4°C with brake. Cells were 
resuspended in 1 mL of GPB for cell counting and zinc determination. Cytospin prepara­
tions (Shandon; Astmoor, UK) were made at random to check purity of the cell suspen­
sions. The cell suspensions contained less than 10% contamination by other cells. The cell 
suspensions were centrifuged, supernatants were aspirated and the cells were digested by 
the use of undiluted nitric acid. Erythrocytes were destroyed by lysis with de-ionized water. 
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Finally zinc content was determined in the samples. Albumin and alkaline phosphatase 
activity were measured using standard clinical procedures. The normal values for serum 
alkaline phosphatase activity, albumin, and zinc were determined using blood of 200 heal­
thy blood donors (Serum albumin: 37-50 g/L; serum alkaline phosphatase activity: 25-120 
U/L; serum zinc: 10-17 ^mol/L). Alkaline phosphatase activity (Boehringer, Mannheim, 
Germany) was determination according to IFCC recommendations (18). Serum albumin 
was determined using a chemical method (19). 
Determination of zinc 
Zinc was determined by atomic absorption spectrophotometry (AAS)(Perkin Elmer 
5000; Norwalk, Connecticut, USA). The lower limit of detection was 0.28 ^mol/L and 
the response was linear to at least 15 ^mol/L. The normal range of serum zinc in healthy 
volunteers was 10-17 /<mol/L. Standard reference solution (ZnCl2, Titrisol, Merck, 
Darmstadt, Germany) was used in the concentrations expected to be found in the samp­
les. Cells were counted by a Coulter counter Model ZM (Luton, Bedfordshire, England), 
adjusted to the size of the cells to prevent counting of cell fragments. 
No detectable zinc concentrations could be determined in the solutions and in ion-
free water put into tubes and bottles apart from a low zinc concentration in diluted Percoli 
(2,56/ffliol/L). 
MateriaL· 
Stainless steel needles and plastic syringes (Monoject, Sherwood, USA) were used. All 
solutions were prepared with de-ionized distilled water (resistance > 15 Μ Ω ), processed 
through a Millipore system (Bedford, Massachusetts, USA). All materials were acid was­
hed. 
Only polypropylene pipet tips, plastic tubes (15 mL polystyrene, Greiner, Solingen, 
Germany and 50 mL polypropylene, Falcon, Becton Dickinson and Company, Lincoln 
Park, New Jersey, USA) and bottles (0.8 L, N U N C , Roskilde, Denmark) were used. All 
chemicals were of analytical grade (Merck, Darmstadt, Germany). Percoli was supplied by 
Pharmacia (Uppsala, Sweden). Hanks' balanced salts solution (without Ca and Mg) was 
obtained from Flow Laboratories (Rickmansworth, Herts, U.K.). 
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Statistics 
Spearman correlation coefficients between the parameters were determined by regres­
sion analysis and the null hypothesis, that correlation was zero, was examined. The num­
ber of significant p-values was an indication of the relation between a parameter for the 
zinc status and the various factors potentially inducing zinc deficiency. The significance of 
the difference in serum zinc concentration in patients with various localisations of Crohn's 
disease, and in patients with various medical treatments was calculated using an ANOVA 
analysis. 
Table 2 
Correlations between suggested factors inducing zinc deficiency and parameters to determi­
ne the zincstatus in patients with more or less active Crohn's disease (R, p). 
CDAI 
van Hees Index 
Extent of inflammation 
Extent of resection 
Changes in body weight 
Number of liquid stools 
Serum 
Zinc 
Concentration 
-0.2 
0.2B 
-0.5 
0.01 
-0.29 
0.16 
-0.5 
0.01 
0.3 
0.11 
-0.1 
0.6 
Serum 
Alkaline 
Phosphatase 
Activity 
-0.14 
0.43 
+0.5 
0.01 
-0.33 
0.04 
-0.39 
0.01 
0.14 
0.41 
-0.1 
0.56 
Zinc in 
Erythro 
cytes 
0.2 
0.29 
-0.14 
0.3Θ 
-0.1 
0.55 
0.05 
0.85 
-0.28 
0.09 
-0.1 
0.54 
blood cells 
MNC 
-0.35 
0.08 
0.14 
0.48 
0.05 
0.84 
0.1 
0.74 
0.32 
0.55 
-0.3 
0.06 
PMNC 
-0.3 
0.15 
-0.05 
0.95 
-0.3 
0.14 
0.02 
0.96 
0.4 
0.03 
-0.4 
0.03 
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RESULTS 
Popidation characteristics 
Thirteen males and 18 females were studied, with a mean age of 37 years (22 - 62 
years). The CDAI ranged from 49 to 298 with a mean of 157, and the van Hees Index 
from 104 to 310 with a mean of 177. The extent of the inflammation ranged from 2 to 
180 cm (mean 58 cm). In 16 patients small bowel resection had been performed pre­
viously, ranging from 5 to 300 cm (mean 94 cm). 
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Figure 1 - Correlation of the serum zinc concentration and inflammatory activity of Crohn's disease 
a. Left figure: serum zinc concentration and van Hees Index, R = -0.5, p = 0.01 
b. Right figure: serum zinc concentration and the extent of bowel resection. R = -0.5, ρ = 0.01 
CorreUtion between the parameters to determine the zinc status and probable factors 
inducing zinc deficiency 
The correlations between parameters for the zinc status and factors potentially indu­
cing a negative zinc balance are given in table 2. 
In 68% of the patients with more or less active Crohn's disease, serum zinc was below 
the normal range ( 10-17 /<mol/L). A distinct correlation was found between the serum zinc 
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concentration and both the van Hees Index (Figure la, P=0.01) and the extent of resec-
tion (Figure lb, p=0.01). No correlation was found between the serum zinc concentration 
and the CDAI, the extent of inflammation, weight loss or number of liquid stools. A near-
ly significant difference (p=0.06) in serum zinc concentration was seen in patients with 
active Crohn's disease in both the small bowel and colon compared to inflammation in 
only the colon or small bowel (Figure 2a). There were no significant differences in serum 
zinc concentrations between the various medical treatments (Figure 2b). 
The serum alkaline phosphatase activity was positively correlated with the van Hees 
index (Figure 3a, p=0.01) and negatively with the extent of resection (Figure 3b, p=0.01). 
Zinc concentrations in erythrocytes, MNC and PMNC were not correlated with the 
Crohn's activity indices, the extent of inflammation or resection. The changes in body 
weight (Figure 4) showed a negative tendency towards a correlation with zinc in erythro-
cytes (p=0.09), but they showed a positive correlation with zinc in PMNC (p=0.03). The 
number of liquid stools showed a nearly significant negative correlation with the zinc con-
tent in MNC (p=0.06) and reached significance with zinc in PMNC (p=0.03) (Figure 5). 
SMALL BOWEL COLON BOTH 
LOCATION OF DISEASE ACTIVITY 
SASP S-ASA PRED COMB 
MEDICATION 
Figure 2 - CorreUnon of the serum zinc concentration and clinical variables 
a. Left figure: serum zinc and location of disease activity. A lower zinc concentration was obser-
ved in patients with active Crohn's disease in small and large bowel compared to inflamma-
tion in only the colon or small bowel, which was nearly significant (p = 0.06) 
b. Right figure: serum zinc and medical treatment. No significant differences were observed 
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InterreUtions between the parameters to determine zinc deficiency and interrelations 
between factors геШеа to zinc deficiency: 
The interrelations between parameters for the zinc status are shown in Table 3. The 
serum zinc concentration was correlated with serum albumin (R=0.56, P=0.003). Zinc in 
M N C was correlated with serum alkaline phosphatase activity (p=0.03). Zinc in PMNC 
was correlated with both zinc in erythrocytes (p=0.03) and zinc in M N C (p=0.007). The 
zinc concentration in blood cells showed no correlation with the serum zinc concentration. 
The serum alkaline phosphatase activity was not significantly correlated with the serum 
zinc concentration (p=0.1). 
The van Hees Index was correlated with the extent of inflammation (p=0.04). The 
van Hees Index and the CDAI were not significantly correlated. 
DISCUSSION 
The relative value of various methods to determine the zinc status in patients was stu­
died by systematically investigating the relation with factors potentially inducing a decre­
ti 25 SO 75 100 125 150 
SERUM ALKALINE PHOSPHATASE U/L 
0 25 50 75 100 125 150 
SERUM ALKALINE PHOSPHATASE U/L 
Figure 3 - CorreUtion of serum alkaline phosphatase activity and factors suggested to induce 
zinc deficiency 
a. Left figure: serum alkaline phosphatase activity and the van Hees Index. R = + 0.5, p = 0.01 
b. Right figure: alkaline phosphatase activity and the extent of resection. R = - 0.39, ρ = 0.01 
83 
ase of zinc status. This study design was used because a gold standard for the assessment of 
the zinc status, which can be applied in clinical practice, is not available. 
Serum zinc concentration 
In 68% of the patients with more or less active Crohn's disease we demonstrated a 
serum zinc concentration below the reference level. The serum zinc concentration was cor-
related with serum albumin concentration, bowel resection and the van Hees Index. In 
most studies a low serum zinc concentration was frequently seen in patients with active 
Crohn's disease (Table 1). 
This decrease may be caused by a real zinc deficiency, but it can also be an apparent 
zinc deficiency owing to the inflammation: inflammation causes a decrease of serum albu-
min and because zinc is transported in part by albumin this decrease of serum albumin will 
result in a decrease of serum zinc. In addition, during inflammation zinc is redistributed 
from the serum into the liver. We call a decrease of serum zinc resulting from inflamma-
tion, apparent zinc deficiency, because no symptoms of zinc deficiency occur during in-
flammatory stress. The high prevalence of a decreased serum zinc level could partly be 
explained by a decrease of serum albumin, because the serum zinc concentration was cor-
related with serum albumin. In some of these patients with a low scrum zinc concentra-
tion there will be a real decrease of zinc status, but their number is unknown. Therefore, 
we also correlated the serum zinc concentration with factors potentially inducing zinc defi-
ciency. Serum zinc was correlated with the extent of bowel resection. Because the extent of 
bowel resection was not correlated with the severity of inflammation, this correlation can-
not be explained by apparent zinc deficiency due to inflammation. This may indicate that 
in some of these patients with Crohn's disease with extensive bowel resection the zinc sta-
tus was really decreased. 
A correlation was seen with the van Hees Index, but albumin is one of the nine para-
meters in the van Hees Index, so the serum zinc concentration and the van Hees Index are 
not completely independent variables. No significant correlation was demonstrated with 
the CDAI. The studies of Schoelmerich (9) and Piroli (10) showed a correlation between 
serum zinc and the CDAI, but this could not be confirmed by McLain (3). Fernandez-
Banarez (11) also demonstrated a correlation between the serum zinc concentration and 
the van Hees Index, but did not mention the partial relationship of the van Hees Index 
and serum zinc. 
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Figure 4 - Correlation of the zinc concentration in blood celL· and changes in body weight 
a. Left figure: zinc in erythrocytes and changes in body weight. R = - 0.28, p = 0.09 
b. Right figure: zinc in PMNC and changes in body weight. R = + 0.40, ρ = 0.03 
The serum zinc concentration was lower in patients with Crohn's disease located both 
in the colon and small bowel. In the study by Schoelmerich (9) no difference in serum zinc 
concentration was seen between groups of patients with different localizations of disease. 
Serum alkaline phosphatase activity 
The alkaline phosphatase activity is correlated with the extent of resection, the van 
Hees Index and the extent of inflammation. 
Serum alkaline phosphatase activity has been suggested as a parameter of zinc defi­
ciency because enzyme activity is influenced by the zinc status. Zinc is a component of 
more than 200 enzymes (20). Alkaline phosphatase is one of these zinc-dependent metal-
lo-enzymes. In case of zinc deficiency, zinc-containing metallo-enzymes are not functio­
ning optimally. Alkaline phosphatase activity is not only influenced by the serum zinc con­
centration, but also by other factors like bone turn-over and liver function. These factors 
induce variations in the serum concentration of the enzyme. 
The negative correlation between serum alkaline phosphatase activity and the extent 
of bowel resection can be explained by a lower serum zinc concentration in these patients. 
As alkaline phosphatase activity is not directly related with one of the parameters of 
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Figure 5 - Correhtion of the zinc concentration in blood cells and frequency of liquid stools 
a. Left figure: zinc in MNC and numbers of liquid stooh. R = - 0.30, ρ = 0.06 
b. Right figure: zinc in PMNC and numbers of liquid stooh. R = - 0.40, ρ = 0.03 
the van Hees Index, the correlation we demonstrated between alkaline phosphatase activi­
ty and disease activity could be of clinical significance for the determination of the zinc sta­
tus. However, an increase of Crohn's activity was correlated with an increase of alkaline 
phosphatase activity. One would expect that in case of an increase of disease activity, serum 
zinc and subsequently serum alkaline phosphatase activity would decrease. The positive 
correlation between alkaline phosphatase activity and the van Hees Index probably does 
not indicate a correlation with the zinc status. In the studies by both Bro et al. (21) and 
Fernandez-Banarez et al. (11) the serum alkaline phosphatase activity in patients with 
Crohn's disease was increased compared to healthy volunteers, and this difference reached 
statistical significance in the study by Fernandez-Banarez for patients with active colitis 
(p=0.02). Scrum alkaline phosphatase activity is influenced not only by the serum zinc 
concentration, but by other factors as well, like liver function disorders, especially in more 
active Crohn's disease. This may be the explanation why an increase of serum alkaline 
phosphatase activity was positively correlated with an increase of activity of Crohn's disease. 
Zinc concentrations in blood cells 
The small number of significant correlations (2 of the 18 tested) between the zinc 
concentrations in the various blood cells and factors potentially inducing zinc deficiency, 
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Table 3 
Mutual correlation between parameters for the zinc status (Я, p) 
Serum Alkaline 
Phosphatase Activity 
Zinc in blood cells 
Erythrocytes 
MNC 
PMNC 
Serum 
Zinc 
Concentration 
_ _ _ 
0.33 
0.08 
0.2 
0.34 
0.16 
0.52 
0.26 
0.26 
Serum 
Alkaline 
Phosphatase 
Activity 
0.17 
0.32 
0.49 
0.03 
0.25 
0.73 
Zinc in blood cells 
Erythro MNC PMNC 
cytes 
0.2 
0.3 
0.48 0.57 
0.03 0.007 
was unexpected. Besides the number of significant correlations, the mean p-value of a spe­
cific parameter also provides an indication of the significance of this specific method for 
the determination of the zinc status. The mean p-values were higher for blood cells (ery­
throcytes 0.45, M N C 0.46, PMNC 0.37) compared to the mean p-value for serum zinc 
(0.2) and serum alkaline phosphatase activity (0.25). Probably only the zinc concentration 
in PMNC was of clinical importance because of a significant positive correlation with 
body weight loss and a negative correlation with the number of liquid stools. Wolman et 
al. (22) demonstrated zinc loss to be correlated with the weight of the stools per day. 
Zinc in blood cells has frequently been used to determine the zinc status, as an alter­
native to serum zinc, although the data to validate this method are conflicting. 
Controversy exists about the question whether zinc deficiency leads to an increase (12) or 
a decrease (23) in intracellular zinc concentrations. After zinc supplementation even a 
decrease of granulocyte zinc was observed (11). In most of the studies in which the zinc 
concentrations in blood cells of patients with active Crohn's disease were compared to 
those of healthy volunteers, no differences were observed (Table 1). But the conclusion was 
not drawn that this method has only limited value for the assessment of the zinc status. 
The reasons for the observed low correlation between zinc concentrations in blood 
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cells and factors potentially inducing zinc deficiency (2 out of the 18 correlations), and also 
the frequent reports in the literature of normal zinc concentrations in blood cells of 
patients with Crohn's disease, could be explained by one of the following three hypotheses. 
Firstly: the zinc status is not influenced by the factors that have been proposed as possible 
causes of zinc deficiency. This is not likely since zinc deficiency does occur in patients with 
Crohn's disease, and there are strong indications of subclinical zinc deficiency in patients 
with active Crohn's disease, because in these patients clinical symptoms of zinc deficiency 
emerge in the post-operative anabolic period. The correlation we demonstrated in this 
study between the serum zinc concentration and the serum alkaline phosphatase activity 
on the one hand and the extent of bowel resection on the other, supports the hypothesis 
that in these patients with Crohn's disease the zinc status is decreased. 
Secondly: the risk of zinc contamination of the cell suspension is high, which makes the 
determination of zinc in blood cells difficult (24). In our experiments we could not 
demonstrate zinc contamination (see Methods). Because there is a correlation between zinc 
in PMNC and zinc in MNC as well as in erythrocytes, it is also unlikely that zinc conta-
mination is the cause of this low correlation. 
Thirdly: the zinc concentration in blood cells is very low and the exchangeable zinc pool 
in these cells is even smaller. Using 10 mL of blood and with a cell recovery of 50%, the 
final zinc concentration of the cell suspension is about 1.0 /«nol/L when resuspended in 
0.5 mL GPB, which is near the lower limit of detection of an AAS determination. In a pre-
vious study we demonstrated that the exchangeable zinc pool was 3% in erythrocytes, 24% 
in MNC and 26% in PMNC (17). This indicates that determination of the zinc concen-
tration in blood cells is unsuitable for this purpose because of the low zinc concentrations 
in the final cell suspensions and the small exchangeable zinc pool of these cells. 
In addition to the present study we performed animal experiments in which rats were 
made zinc-deficient. Hair loss was observed in the zinc-deficient rats. After four weeks the 
serum zinc concentration in zinc-deficient rats was 40% ofthat in control animals. No dif-
ferences were observed between zinc concentrations in erythrocytes, MNC and PMNC 
taken from individual zinc-deficient rats and control rats. The zinc levels of the final cell 
suspensions were low in these samples and therefore an identical experiment was perfor-
med in which the blood samples of the various rats were pooled. No differences in zinc 
concentrations between blood cells of zinc-deficient rats and those of control rats were 
observed in this experiment either. Milne et al. (24) studied the zinc content of lymph 
nodes and spleen of zinc-deficient rats. Because of the larger number of cells the zinc con-
centration of the concentrated cell suspension taken from lymph nodes and spleen was 
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even higher than in our experiments. Milne's animal experiments revealed no differences 
either. These observations support the third hypothesis mentioned. 
In conclusion: determination of zinc in blood cells is no better method than deter-
mination of serum zinc and serum alkaline phosphatase activity for the assessment of the 
zinc status in patients with active Crohn's disease. This is probable due to the low zinc con-
centrations in the cell suspensions and the small exchangeable zinc pool of these cells. 
Since in the present study a clear correlation was shown between the extent of bowel 
resection on the one hand, and both serum zinc concentration and serum alkaline phos-
phatase activity on the other, a decrease of zinc status was likely in the patients with 
Crohn's disease as a group. However, it is not possible to determine the zinc status in indi-
vidual patients with active Crohn's disease by these methods because of the interference of 
other factors that influence the serum zinc concentration and serum alkaline phosphatase 
activity. Better methods are needed. They should be applicable in clinical practice, and 
they should be able to detect subclinical zinc deficiency and distinguish real zinc deficien-
cy from a decrease of serum zinc resulting from other factors. 
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ABSTRACT 
During zinc deficiency and inflammation serum zinc concentrations are decreased. 
However, during inflammation no symptoms of zinc deficiency are present. This limits the 
use of serum zinc as an indicator of zinc deficiency, for instance in malnourished patients 
with an inflammation. There is a need for a method that can differentiate between both 
conditions. The physiologic changes in zinc metabolism during zinc deficiency and inf-
lammatory stress were investigated and related to zinc exchange by blood cells. 
In rats zinc deficiency was induced by a deficient diet and inflammation by turpentine 
injection. To study the in-vivo uptake and exchange of zinc by tissues and blood cells, ' Zn 
was injected intraperitoneally. 
Both in zinc-deficient rats and in rats with inflammatory stress serum zinc concentrations 
were decreased. In contrast the uptake in Zn by erythrocytes, mononuclear cells, liver and 
bone marrow was increased in zinc-deficient rats, but not in rats with inflammatory stress. 
The uptake of Zn by bone cortex was very slow in the zinc deficient rats and only half of 
that in control rats. In rats with stress the activity of ' Zn was increased in liver and bone 
marrow, and to a lesser degree in muscle and skin. The observed differences in Zn upta-
ke by blood cells in Zn deficiency and inflammatory stress, make it possible to distinguish 
real zinc deficiency from a decrease of serum zinc caused by an inflammation. These dif-
ferences provide a physiologic basis for new methods to determine zinc status. 
INTRODUCTION 
Zinc (Zn) is one of the major trace elements. It is part of many metallo-enzymes, cell 
structures and zinc fingers, which are components of the cell nucleus. Zn deficiency results 
in a variety of symptoms (1). Although various methods have been proposed to determine 
Zn deficiency, no single method can be used to determine Zn deficiency and most 
methods fail to reveal an apparent Zn deficiency. A status of apparent zinc deficiency may 
occur due to inflammation resulting in redistribution of Zn from serum to the liver and 
to a decrease of serum albumin (2), the most important Zn-transporting protein in blood. 
Apparent Zn deficiency can be observed in patients with inflammatory stress, for instance 
patients with active Crohn's disease. In these patients the serum Zn concentration may be 
decreased. The methods currently available to determine Zn deficiency, cannot distinguish 
between real and apparent Zn deficiency. 
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The aim of the present study was to investigate the physiologic reaction of Zn exchan-
ge by tissues and blood cells (as a kind of tissue) aftet induction of Zn deficiency and inf-
lammatory stress. Special attention was given to the behaviour of injected Zn as a tracer 
for the distribution and redistribution of Zn during a Zn-deficient state and during in-
flammatory stress. Animal models were used to induce a Zn-deficient state and an inflam-
matory stress state to differentiate between real and apparent Zn deficiency. Animals were 
used because it is almost impossible to find groups of patients with pure inflammatory 
stress or zinc deficiency in whom Zn might be determined in a variety of tissues. 
METHODS 
Animab 
Male Wistar rats weighing 200 g on arrival (raised at the central animal laboratory, 
WU strain), were housed separately in stainless steel metabolic cages. The day-night 
rhythm was 12-12 hours and the temperature was 20"C. The humidity of the animal labo-
ratory was 60%. The diet on which the rats were raised (SMRA) contained a variable and 
often excessive amount of Zn. The rats had free access to tap water ad libitum. To adapt 
the animals to the diet and the cages (separate metal metabolic cages for each animal with 
wire mesh bases to reduce coprophagy) and to reduce the excess of Zn in their depots, a 
diet (IRI-OB) (table 1 (3)) containing 12 mg/kg Zn was given to the rats for a period of 
2 weeks before the start of the experiment. This Zn concentration is considered sufficient 
to maintain a normal Zn status (4). During this period demineralized water was provided 
to the rats. The guidelines for the care and use of laboratory animals in the Netherlands 
were followed. The experiments were approved by the animal welfare officer of the 
University of Nijmegen, and they were performed by specialized personnel. 
Diets 
The diet (IRI-OB) was produced by Hope Farms (Woerden, the Netherlands) using 
components low in Zn (table 1,(3)) resulting in a Zn concentration of less than 2 mg/kg. 
In the Zn-sufficient food Zn was added as sulphate to a final Zn concentration of 12 
mg/kg. Sufficient quantities of other trace elements were added. The copper (Cu) concen-
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tration in both versions of the diet was 9 mg/kg. The commercial diet SMRA (Hope 
Farms, Woerden, the Netherlands) contained 92 mg/kg Zn and 25 mg/kg Cu. 
MateriaL· 
Solutions 
Glucose Phosphate Buffer (GPB): 
13.5 mmol/L N a 2 H P 0 4 , 3.3 mmol/L K H 2 P 0 4 , 5.4 mmol/L KCl, 133 mmol/L NaCl and 
5 mmol/L glucose in ion-free water and, if necessary, adjusted to pH 7.4 with HCO,~. 
Erythrocyte Lysing Buffer: 
155 mmol/L NH 4C1 and 10 mmol/L K H C O , in ion-free water, pH adjusted to 7-4 with 
HCO,'. 
Discontinuous Gradient of Percoli 
Three solutions of Percoli of different density (1.060, 1.075 and 1.095 kg/L respec­
tively) (5) were prepared by dilution with Hanks' balanced salts solution without Ca and Mg. 
All solutions were prepared with deionized distilled water (resistance > 15 Μ Ω ), pro­
cessed through a Millipore system (Bedford, Massachusetts, USA). Only polypropylene 
pipet tips, plastic tubes (15 ml, polystyrene, Greiner, Solingen, Germany and 50 mL poly­
propylene, Falcon, Becton Dickinson and Company, Lincoln Park, New Jersey, USA) and 
bottles (0.8 L, N U N C , Roskilde, Denmark) were used. All chemicals were of analytical 
grade (Merck, Darmstadt, Germany). Percoli was supplied by Pharmacia (Uppsala, 
Sweden). Hepes was obtained from Sigma (St Louis, MO, USA), albumin from Behring 
(Marburg, Germany), Hanks' balanced salts without Ca and Mg from Flow Laboratories 
(Rickmansworth, Herts, U.K.) and the radiotracer Zn from Amersham International 
(Amersham, Buckinghamshire, U.K., code ZAS 2 , 3.7-37 GBq per mg of Zn as chloride 
in 0.1 mol/L HCl). There was no detectable Zn in solutions or in ion-free water put into 
tubes and bottles apart from a low Zn concentration in diluted Percoli (2,56 ^mol/L). 
Stainless steel needles and plastic syringes (Monoject, Sherwood, USA) with 10 μ\, of pre­
servative-free heparin ( 50 IU ) were used. 
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Table 1 
Composition of the IRI-OB diet 
Ingredients 
Glucose 
Corn starch 
Ovalbumin 
Sun flower seed oil 
Fibre (cellulose) 
Choline chloride 
Mineral mix 
Sodium diphosphate 
Potassium chloride 
Calcium carbonate 
Magnesium sulphate 
Sodium meta-silicate 
Trace element salt mix 
Vitamin mix in glucose 
Trace element salt mix 
Mn 
Fe 
Zn 
Cu 
Ni 
Cr 
Mo 
Se 
As 
Co 
Concent 
50.65 
15.0 
20.0 
4.0 
5.0 
0.3 
0.1 
1.0 
Concenti 
ration (g/100g) 
1.5 
0.7 
1.0 
0.5 
0.25 
ration (mg/kg) 
55 
66 
various cone. 
9.3 
2.4 
1.8 
0.2 
0.36 
0.13 
0.2 
Analytical Procedures 
Zinc determination 
Zn was determined by atomic absorption spectrophotometry (AAS)(Perkin Elmer 
5000; Norwalk, Connecticut, USA). The lower limit of detection was 0.28 ^mol/L and 
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the response was linear to at least 15 /«nol/L. Standard reference containing ZnCl 2 
(Titrisol, Merck, Darmstadt, Germany) was used in the concentrations expected to be 
found in the samples. 
Zinc was determination in tissues in duplicate. A sample of the tissue (of about 50 
mg) was weighed precisely. Tissue was destroyed in borosilicate tubes, washed in 8M 
H N O , (Suprapure, Merck, Darmstadt, Germany). Destruction was performed in three 
steps: with 1 mL and twice with 0.1 mL of H N 0 3 , with drying procedures at 95°C in 
between. The final residue was dissolved in 1 mL 0.5 M H N O , and the Zn concentration 
was determined. A standard reference of Bovine Liver SRM 1577a, processed in the same 
way, was used as control. For the determination of zinc in tissues, bone, muscle and liver 
are especially important, because these organs contain most of the total body zinc content (5). 
Isolation procedure of the blood celh 
Blood was drawn from anaesthetized rats by heart puncture using stainless steel need­
les and plastic syringes with 10 fih of preservative-free heparin (50 IU). Cell separation was 
performed using a discontinuous Percoli gradient (6). All solutions were kept at 4°C to pre­
vent clumping and Zn exchange by the cells. Blood was diluted with GPB 1:3. Six mL of 
a heavier solution was layered in a 50 mL tube underneath the lighter solution using a 
stainless steel needle of 15 cm and a plastic syringe. Subsequently the tube was centrifuged 
for 20 min., at 500 x g at 4"C in a swing-out rotor without brake (Heraeus Crist Minifuge 
GL, Osterode am Harz, Germany). This resulted in separated layers of platelets, mononu­
clear cells (MNC), polymorphonuclear cells (PMNC) and erythrocytes. The MNC, 
PMNC and erythrocytes were harvested using a pipet and resuspended in 5 mL GPB in a 
15 mL tube. Erythrocyte contamination of the M N C and PMNC fractions was removed 
by resuspending the cells twice for 10 min. at 4°C in 5 mL of erythrocyte lysing buffer and 
subsequent washing steps with 5 mL of GPB. After lysing and washing steps the tube was 
centrifuged for 10 min., 200 χ g, 4°C with brake. Cells were resuspended in 1 mL of GPB 
for cell counting. The erythrocytes were washed with GPB twice and centrifuged for 10 
min., 200 χ g, 4°C with brake. Random Cytospin preparations (Shandon; Astmoor, UK) 
were made to check purity of the cell suspensions. The cell suspensions contained less than 
10% contamination with other cells. The volume was determined from the weight diffe­
rence of the tube. Numbers of cells and radioactivity were counted. The whole procedure 
was performed in one day. 
Cells were counted using a Coulter counter Model ZM (Luton, Beds., England), 
adjusted to the size of the cells to prevent counting of cell fragments. 
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Radioactivity 
' Zn was measured by means of a Nal crystal with an automatic sample changer 
(LKB, Wallac 1282 Compugamma; Turku, Finland). The counting time was adjusted to 
ensure a statistical error of < 0.3 %. A tube with medium but without blood cells, incu­
bated and washed according to the procedure of the cell-containing tubes, served as a 
blank. 
Total body radioactivity of the rats was counted with a shadow shield counter con­
sisting of two Tl-activated Nal crystals (4 χ 6"), both at a distance of 45 cm from the rat, 
connected to a Nuclear Data multi-channel analyzer N.D. 60 A (Nuclear Data; 
Schaumburg, Illinois, USA). In the zinc-deficiency experiment the first determination of 
the Zn whole-body retention was performed four hours after the intraperitoneal admini­
stration of ' Zn. This first determination was taken as 100%. In the inflammatory stress 
experiment the results of the Zn whole-body retention on the successive days were 
expressed as % of the activity of t = -6, one day after the ' Zn injection. 
Outline of the two experiments 
Experiment 1 : zinc-deficiency experiment. 
At the end of the adaptation period (day -7) the rats were divided into two groups of 
twelve rats each in such a way that the body weight distributions of the animals were simi­
lar. One group remained on the control diet and the other group was switched to the Zn-
deficient diet containing < 2mg Zn/kg. The control group received pair-feeding throug­
hout the rest of the experiment. At day 0, when the rats who had been given a diet low in 
Zn were in a mild Zn-deficient state, 6 /<Ci Zn was injected intraperitoneally. After 3 
hours and on days 1, 3, 7, 14, and 24, three to five mL blood were taken under inhalation 
of ether anaesthesia by heart puncture in 2 of the rats in each group. The serum was ana­
lyzed for albumin and Zn by AAS. The various blood cells were isolated. The rats were sac­
rificed after blood sampling and liver, muscle from the front legs, bone and bone marrow 
been taken out after determination of total body retention of ' Zn. Whole-body coun­
ting was performed after 4 hours and on days 1, 3, 7, 14 and 24. Whole-body counting 
was performed on the sacrificed animals of that sample day (before removal of the organs 
and tissues), as well as on all of the animals still alive on that day. Bone marrow was sepa­
rated from the bone cortex using of a plastic syringe filled with air to blow the marrow out 
of the bone. During the experiment most of the zinc-deficient animals showed loss of hair. 
had 
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Experiment 2: inflammatory stress experiment. 
Fourteen days prior to induction of inflammatory stress 64 rats were switched from 
the commercial diet to the purified diet (IRI-OB) and put into the metabolic cages to 
adapt the animals (see Animals and experiment 1). Throughout the experiment the rats 
received the IRI-OB food containing 12 ppm of Zn. On day -7 3 μ€λ ' Zn was injected 
intraperitoneally. On day 0 the rats were divided into two groups of 32 rats in such a way 
that the body weight distributions of the rats were similar. Thirty-two rats were injected 
intramuscularly in the hind legs with 0.5 mL turpentine. Immediately before turpentine 
injection (t=0), after 4 hours, and on days 1, 2, 3, 4, 7, and 14, three to five mL blood was 
withdrawn from four rats of each group for blood cells. Serum was used to measure Zn 
and Cu concentrations. Rats were sacrificed under anaesthesia by breaking the neck. Total 
body ' Zn retention was determined and liver, muscle, skin, bone and bone marrow were 
taken for determination of radioactivity. As ' Zn was given 7 days prior to the induction 
of inflammatory stress, the fast changes in Zn seen immediately after Zn injection did 
not interfere with the changes in zinc concentrations seen directly after turpentine injec­
tion, as demonstrated in the control group of the zinc-deficiency experiment and by the 
study of Weigant and Kirchgessner (7). This injection of radioactive zinc seven days prior 
to the induction of inflammation resulted in an approximation of an equilibrium of Zn 
with cold Zn. 
Zinc-deficiency experiment 
ι 1 m—ι 1 1 1 
-21 -7 0 24 
animals sacrificed after various intervals 
65~ Zn injection 
randomisation: < 2 ppm or 12 ppm food 
12 ppm food 
Inflammatory stress experiment 
ι 1 m—ι 1 1 1 
-14 -7 0 14 
animals sacrificed after various intervals 
randomisation: turpentine injection or control 
65-7 · • 
Zn injection 
12 ppm food 
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Figure 1: zinc deficiency experiment 
Zinc concentration in serum (a, left figure) and whole-body retention of Zn (b, right figure) 
in zinc-deficient (closed dots) and control rats (open dots). At the start of the curve the rats on 
a diet low in zinc were already mildly zinc-deficient. During zinc deficiency serum zinc is 
decreased. The whole-body retention of Zn indicated that zinc-deficien t rats retained more 
' Zn than control rats. The error bars indicate standard deviations (*p=<0.05; **ƒ>=< 0.01; 
*** p=<0.001). 
Caku^ions 
Statistics: 
A Wilcoxon Rank Sum test was performed to compare the data of the two groups 
throughout the total experiment. The Student t-tcst was performed for individual sample 
points, if enough samples were available. Differences between two groups were considered 
significant if ρ < 0.05 (two tails). 
Biological half-life: 
When plotting the natural logarithm of the whole-body data versus time, a linear 
relation was found from day 7 onwards. From the slope (γ) of this line the biological half-
life of the Zn was calculated using T 1 / 2 = In 2 / γ, expressed as % of the activity at t = 3h. 
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Figure 2: zinc deficiency experiment 
2a: Left figure: zinc concentration of bone cortex (dots) and bone marrow (triangles) in zinc-
deficient (closed dots , closed triangles respectively) and control rats (open dots, open triangles 
respectively). During zinc deficiency the concentration of zinc is severely decreased in bone cor­
tex, but not in bone marrow. 
2b: Right figure: zinc concentration of liver (dots) and muscle (triangles) in zinc-deficient (clo­
sed dots, closed triangles respectively) and control rats (open dots, open triangles respectively). 
This figure indicates that using a Wilcoxon Rank Sum test there is a very small but statistical­
ly significant decrease of zinc concentration in the liver, but not in muscle. 
RESULTS 
Zinc deficiency experiment 
Serum Zn concentrations were significantly decreased after 7 days on the Zn deficient 
diet (day 0 in Figure la, 3 hours after the Zn injection 15.15 versus 26.85 /<mol/L) and 
after that, for a period of 30 days (day 24 in Figure la, 9.5 versus 28.5 /<mol/L, Wilcoxon 
rank sum test ρ = 0.0025). In rats on the Zn-deficient diet Zn concentrations in bone cor­
tex and liver were significantly decreased (p < 0.01 and <0.05 respectively), but not those 
in bone marrow and muscle (p = 0.25 and 0.9 respectively, Figure 2). 
Radiotracer study: Zn-deficient rats retained more of the administered Zn than con­
trol rats: the biological half-life was significantly increased (41 versus 154 days, ρ < 0.001, 
Figure lb) compared to rats fed with adequate amounts of Zn. In Zn-deficient rats the 
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Figure 3: zinc deficiency experiment 
За: Lefi figure: the ' Zn uptake and exchange of bone cortex (dots) and of bone marrow (triang­
les) in zinc-deficient rats (closed dots, closed triangles respectively) and control rats (open dots, 
open triangles respectively). During zinc deficiency the uptake of zinc by bone marrow is incre­
ased, but the uptake by bone cortex decreased compared to control rats. 
3b: Right figure: the ' Zn uptake and exchange of liver (dots) and of muscle (triangles) in zinc-
deficient rats (closed dots, closed triangles respectively) and control rats (open dots, open triang-
Us respectively). During zinc deficiency the uptake of zinc by liver and muscle is significantly 
increased compared to control rats. 
accumulation of Zn was higher in liver and bone marrow (p = 0.0025, both), and a hig­
her retention was observed. This was also observed in muscle, but less pronounced 
(p=0.005). In contrast, in zinc-deficient rats the ' Zn accumulation was reduced in bone 
cortex (Figure 3). Erythrocytes and M N C of Zn deficient rats accumulated and retained 
more Zn (p = 0.01 and 0.05 respectively, Figures 4a and 4b), and the same picture -
although less clear - was observed for PMNC for which the difference did not reach signi­
ficance (p = 0.2, Figure 4c). All cell types showed a maximum value 3-5 days after Zn 
administration, and they also showed an obviously slower release. 
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Figure 4: zinc deficiency experiment 
4a: Upper left figure: the ' Zn uptake and exchange of erythrocytes in zinc-deficient (closed dots) 
and control rats (open dots). During zinc deficiency the uptake of zinc by erythrocytes is signi­
ficantly increased compared to control rats. 
4b: Upper right figure: the Zn uptake and exchange of MNC in zinc-deficient (closed dots) 
and control rats (open dots). During zinc deficiency the uptake of zinc by MNC is significant­
ly increased compared to control rats. 
4c: Bottom figure: the Zn uptake and exchange of PMNC in zinc-deficient (closed dots) and 
control rats (open dots). During zinc deficiency the uptake of zinc by PMNC shows a tenden­
cy towards an increase compared to control rats. 
105 
Inflammatory stress experiment 
In the animals with induced inflammatory stress, serum Zn concentrations decreased 
dramatically after the first day (Figure 5a), and a (significant although) less pronounced 
difference still existed later on. In the animals with induced inflammatory stress, the serum 
Cu concentrations increased significantly during the first few days reaching a maximum 7 
days after administration of turpentine, which persisted throughout the experiment 
(Figure 5b). 
No (significant) difference in whole-body retention of Zn between the two groups 
(Figure 5c) was seen at any individual point or for the total period. The serum Zn con-
centration decreased during the experiment after turpentine injection. 
In contrast, Zn content was significantly increased in the liver until day 3 after tur-
pentine injection, after which it decreased again (Figure 6a). In other compartments, like 
muscle and bone marrow (Figure 6b, 7b respectively), higher Zn contents persisted lon-
ger, although in skin they did not remain so high for so long in skin (Figure 6c). On day 
1 and day 7 the content of bone cortex was lower than in control rats (Figure 7a). No clear 
differences were observed for erythrocytes and MNC (Figures 8a and 8b), and in PMNC 
a tendency towards a lower content of ' Zn was seen in the first four days after turpentine 
injection (Figure 8c). 
DISCUSSION 
Design of the experiments 
The present experiments were designed to investigate the influence of Zn deficiency 
and inflammatory stress on the Zn exchange among various tissues and blood cells, by 
means of administration of a radioactive tracer: Zn. 
In experiment 1 a status of Zn deficiency could be induced by giving diets low in Zn 
(3). The zinc-deficient rats showed loss of hair. In experiment 2 a status of a decrease of 
serum zinc concentration not accompanied by symptoms of zinc deficiency was induced 
by administration of turpentine. By using the radio-active tracer Zn we intended to 
measure the exchange of Zn in the various tissues and blood cells. We expected rapid chan-
ges of Zn in scrum, and probably also of Zn in blood cells and other tissues, after the 
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Figure 5: inflammatory stress experiment 
5a : Upper Ufi figure: serum zinc in rats with inflammation (closed dots) and control rats (open 
dots). The error bars indicate standard deviations (*p=<0.05;**p=< 0.01; ***p=<0.001). 
During inflammatory stress serum zinc is severely decreased after the first day. Later on this dif­
ference is less pronounced. 
5b : Upper right figure: serum Cu in rats with inflammation (closed dots) and control rats (open 
dots). The error bars indicate standard deviations (*p=<0.05; ***p=<0.001). Serum copper 
is increased during inflammatory stress. 
5c : Bottom figure: whole-body retention of Zn in rats with inflammation (closed dots) and 
control rats (open dots). The error bars indicate standard deviations. No significant difference 
in whole-body retention is observed during inflammatory stress. 
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induction of inflammatory stress in contrast to slower shifts after induction of dietary Zn 
deficiency. The differences in physiologic response were demonstrated by the change in 
serum Zn concentration: in the Zn deficiency experiment serum Zn reached the lowest 
level after 33 days: 9.5 ftmo\/L. After turpentine injection the lowest Zn level was reached 
after only one day: 10.3 pmol/L. The intention was to provide ' Zn when the serum zinc 
concentration was decreased. Therefore we used different time schedules of radiotracer 
administration in the Zn deficiency and the inflammatory stress experiments. In the Zn 
deficiency experiment Zn was injected 7 days after induction of a deficient state. In the 
inflammatory stress experiment the injections of ' Zn and turpentine could not be given 
simultaneously. The first days after an injection of Zn rapid changes in Zn content of 
the various body compartments were observed. We chose to administer ' Zn prior to the 
induction of inflammatory stress. 
By using this design the goals of this study could be attained as closely as possible. 
Zinc uptake and retention in blood celL· 
The main objective of this study was to validate the observations made in vitro: the 
uptake of Zn by blood cells drawn from zinc-deficient rats is increased, contrary to blood 
cells drawn from rats with inflammatory stress. In the present study the in-vivo uptake of 
Zn by blood cells in rats with Zn deficiency and in rats with inflammatory stress was 
measured. The uptake and retention of Zn by erythrocytes and MNC were increased in 
case of real Zn deficiency compared to control rats. No such difference could be demon-
strated in case of inflammatory stress. The pattern of uptake of ' Zn by blood cells of zinc-
deficient rats suggested that a maximum is reached later than in control rats. This can be 
explained by the simultaneous rapid and enormous uptake of ' Zn by liver and bone mar-
row. Following the time-course of the inflammatory experiment, in which serum Zn was 
severely depressed, no differences were observed between erythrocytes and MNC of rats 
with inflammatory stress and those of control rats. Even less Zn was retained in PMNC 
isolated from rats with inflammatory stress. As far as we know, this is the first report of fin-
dings concerning the in-vivo exchange of ' Zn by blood cells. 
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Figure 6: inflammatory stress experiment 
6a: Upper left figure: the ' Zn activity of liver in rats with inflammation (closed dots) and con­
trol rats (open dots). The error bars indicate standarddeviations (**p=< 0.01; ***p=<0.001). 
During the first days of inflammatory stress the Zn content of the liver is significantly incre­
ased. 
6b: Upper right figure: the Zn activity of muscle in rats with inflammation (closed dots) and 
control rats (open dots). The error bars indicate standard deviations (*p=<0.05;**p=< 0.01). 
In muscle the Zn content is significantly increased during inflammatory stress. 
6c: Bottom figure: the Zn activity of skin in rats with inflammation (closed dots) and control 
rats (open dots). The error bars indicate standard deviations (*p=<0.05; ***p=<0.001). After 
the first days of inflammatory stress the ' Zn content of the skin is significantly increased. 
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Figure 7: inflammatory stress experiment 
7a: Left figure: the Zn activity of bone cortex in rats with inflammation (closed dots) and con­
trol rats (open dots). The error bars indicate standard deviations (*p=<0.05; ***p=<0.001). 
On day 1 and day 7 the Zn content of bone cortex is decreased. 
7b: Right figure: the Zn activity of bone marrow in rats with inflammation (closed dots) and 
control rats (open dots). The error bars indicate standard deviations (* p=<0.05). In bone mar­
row the Zn content is significantly increased after three days. 
Whole-body zinc retention 
The higher ' Zn retention in Zn-deficient rats indicated that the rats were Zn deficient. 
These rats showed loss of hair, one of the classic symptoms of Zn deficiency (1). In the 
induced inflammatory stress experiment, no difference in Zn retention was seen between 
rats with stress and control rats. In these stressed rats no signs of Zn deficiency were obser­
ved, although the serum Zn concentration was severely depressed. The absence of diffe­
rence in total body Zn retention and of classic signs of Zn deficiency in the rats with 
inflammatory stress both indicated that in these rats only apparent Zn deficiency was present. 
Serum copper concentration 
In rats with induced inflammatory stress serum Cu concentrations were elevated. 
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This phenomenon, which is known to be caused by an increase of the Cu-containing pro-
tein ceruloplasmin, has been reported before (8). The long-persisting increase of serum Cu 
validated our inflammatory stress model, and it did indeed indicated that the experimen-
tal model resulted in a long-lasting inflammation, although after 3 days the serum Zn con-
centration partially recovered. 
Zinc uptake and exchange by tissues 
Concentration of zinc in bone, muscle and liver are the main parameters, because 
these organs account for the greater part of the total body zinc content (9). Bone marrow, 
liver and muscle retained more Zn, unlike bone cortex in which less Zn was retained in 
Zn-deficient rats. We could demonstrate that bone cortex and bone marrow should be 
separated before Zn determination in Zn deficiency experiments because of their different 
behaviour during Zn deficiency. This was also demonstrated after measurement of total Zn 
concentrations in tissues. During Zn deficiency, the Zn concentrations in bone cortex 
decreased, although no clear changes were observed in bone marrow, muscle or liver, indi-
cating that especially bone marrow - and also muscle - are spared the effect of Zn deficiency 
for a long period. Bone cortex is the principal source of Zn in case of zinc deficiency. 
Changes in concentrations of total Zn in various tissues during Zn deficiency are descri-
bed in some studies (9,10,11,12), but in all of these studies only once and on a fixed day 
(9,11,12) ot in a special situation (signs of severe zinc deficiency (10)) tissue samples were 
collected. Prospective studies in which consecutive tissue samples are collected, have not 
been performed. In all studies the concentrations are decreased in serum (plasma) and in 
bone, but not in other tissues. For example: O'Dell et al (10) found no decrease of Zn in 
muscle, liver, skin and brain; Giugliano et al (11) reported unchanged zinc concentrations 
in muscle, spleen and thymus and lowered zinc concentrations in liver, kidney, testis, in-
testine and especially plasma and bone; Roth and Kirchgessner (12) reported a decrease of 
72% in serum, 65% in femur, 34% in pancreas, 23% in muscle, 11% in testis and 7% in 
brain. Van de Wouwe et al (9) determined the zinc content of tissues after 21 days and 
showed a decrease in pancreas, tibia and muscle, and an increase in spleen but no changes 
in liver, kidney, cerebrum and cerebellum. Gupta et al (13) demonstrated a decrease of Zn 
in liver, testis and kidney. Van de Wouwe et al (14) demonstrated a decrease of Zn only 
in liver and bone, but the control rats were injected with saline which will also induce a 
stress reaction. 
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Figure 8: inflammatory stress experiment 
8a: Upper left figure: the Zn activity of erythrocytes in rats with inflammation (closed dots) 
and control rats (open dots). The error bars indicate standard deviations (** p=<0.01). Only 
on day 14 a higher Zn content was observed in erythrocytes of rats with inflammatory stress, 
but the Wikoxon Rank Sum test did not demonstrate a différence for the total period. 
8b: Upper right figure: the Zn activity of MNC in rats with inflammation (closed dots) and 
control rats (open dots). The error bars indicate standard deviations. No differences in Zn con-
tent were observed. 
8c: Bottom figure: the Zn activity of PMNC in rats with inflammation (cbseddots) and con-
trol rats (open dots). The error bars indicate standard deviations (*p=<0.05; **p=<0.01). In 
PMNC the Zn content was decreased in rats with inflammatory stress on days 2, 3, 4, and 14. 
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In contrast to the situation of zinc deficiency, ' Zn was given 7 days prior to the 
induction of stress, in other words Zn was assumed to be more or less in equilibrium with 
total (cold) Zn. Therefore, changes in Zn activity in tissues represent redistribution of 
Zn. During inflammatory stress we measured a redistribution of Zn activity to the liver. 
Later on during the experiment a tendency toward increase of Zn retention in muscle, 
bone marrow and skin was observed. No such increase was found in bone cortex. It might 
be hypothesized that during inflammatory stress a partial recovery of the serum Zn con-
centration is due to (a combined action of) an initial but brief redistribution of zinc to the 
liver and a persistent decrease of serum albumin, the main zinc-transporting protein (16). 
This hypothesis is supported by the present experiment in which the decrease of serum 
zinc occurred simultaneously with the decrease of the activity of Zn in the liver. Later on 
higher Zn activity was measured in muscle and skin. Therefore, the smaller decrease after 
day 3 was probably due to a combination of a decrease of serum albumin and redistribu-
tion to other tissues like muscle and skin. A limited number of studies have been perfor-
med during inflammatory stress and most of these were limited to short-term effects 
(14,15). Tufft and Nockels (16) and Klasing (17) demonstrated an increase of weight and 
Zn concentration of the liver and spleen during a longer-lasting bacterial infection. In an 
acute inflammatory model Pakarek et al (15) demonstrated an increase of zinc content in 
liver and a decrease in kidney after intraperitoneal injection of leucocytic endogenous 
mediator (LEM). No significant changes were observed in the GI tract, pancreas, heart, 
lungs or spleen. Van de Wouwe (14) demonstrated only marginal differences after endo-
toxin exposure, but the control rats were also injected - with saline -, which will induce an 
acute stress reaction. 
Conclusions 
The present in-vivo studies demonstrate that the zinc metabolism of the tissues is dif-
ferent during inflammation and during zinc deficiency, probably to adapt to the different 
needs of these tissues in both situations. This is also demonstrated by the increase of zinc 
uptake by blood cells during zinc deficiency, which was not demonstrated during inflam-
mation. By using blood cells, it is possible to distinguish between situations with real and 
with apparent Zn deficiency. 
We also demonstrated that during inflammation the serum Cu concentration was 
increased. In theory the distinction between real and apparent Zn deficiency can also be 
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made by the combined determination of serum Zn and Cu: in real Zn deficiency serum 
Zn concentrations are decreased and serum Cu is normal; in inflammatory stress serum Zn 
concentrations are decreased, and serum Cu concentrations increased. In clinical practice 
a combination of both conditions is frequently present: for instance in patients with acti-
ve Crohn's disease the decrease of serum Zn is partly explained by an increase of zinc loss, 
but also partly by a decrease due to inflammatory stress. In case serum Cu is increased and 
serum Zn decreased, this indicates that the decrease of serum Zn is pardy caused by inf-
lammatory stress. But these results do not provide an answer to the question whether a real 
Zn deficiency partly causes the decrease of serum zinc. 
Therefore, it is necessary to find a method that demonstrates real zinc deficiency. The 
present experiments support and provide a physiologic basis for earlier studies. If in expe-
riments could be demonstrated that the in vitro Zn uptake by blood cells of Zn-deficient 
rats is also increased and not in rats with an inflammation, this would be of value to deter-
mine real zinc deficiency. 
114 
REFERENCES 
1 Ulmer D D Current concepts, trace elements N Engl J Med 1977, 297 318-321 
2 Falchuk KH Effect of acute disease and ACTH on serum zinc proteins N Engl J Med 1977, 296 1129-
1134 
3 Van Barneveld AA, Morse Η A new diet for trace element research with rats and mice Ζ Versuchstierk 1982, 
24 24 
4 Johnson PE, Hunt JR, Ralston NVC The effect of past and current dietary Zn intake on Zn absorption and 
endogenous excretion in the rats J Nutr 1988, 118 1205-1209 
5 Jackson ML, Jones DA, Edwards R H T Tissue zinc levels as an index of body zinc status Clin Phys 1982, 
2 333-343 
6 Milne DB, Ralston NVC, Wallwork JC Zinc content of cellular components of blood methods for cell 
separation and analysis evaluated Clin Chem 1985, 31 65-69 
7 Weigand E, Kirchgessner M txcretion and distribution of injected radio7inc in rats as influenced by the type 
of carbohydrate J Trace Hem Hectrolytes Health Dis 1992, 6 33 37 
8 DiSilvestro RA Influence of dietary copper, copper injections and inflammation on rat serum ceruloplasmin 
activity levels Nutrition Research 1990, 10 355 358 
9 Van Wouwe JP, Hoogenkamp S, Van den Hamer CJA Histidine supplement and / n status in Swiss random 
mice Biol Trace Flement Research 1989, 22 35 43 
10 O'Dell BI, Becker JK, Browing JD Production and reversal of the neuromuscular pathology and related 
signs of zinc deficiency in guinea pigs J Nutr 1989, 119 196 201 
11 Giugliano R, Millward DJ Growth and zinc homeostasis in severely Zn deficient rats Br J Nutr 1984, 52 
546 560 
12 Roth HP, Kirchgessner M Calmodulin, zim. and calcium concentration in tissues of zinc and calcium-defi­
cient tats J Itace Hem blectrolytes Health Dis 1988, 2 73 78 
13 Gupta RP, Verma PC, Sadana JR, Gupta VK Effect of experimental zinc deficiency and repletion on sodi­
um, potassium and iron concentrations in guinea pigs J Nutr 1989 62 407 414 
14 Wouwe JP Veldhuizen M, Van den Hamer CJA, De GoeyJJM Discrimination between low dietary zinc and 
endotoxin exposure a model study on weaning rats Pediatr Res 1990, 28 332 335 
15 Pekarek RS, Wanncmachre RW, Beisel WR The effect of leucocytic endogenous mediator (LEM) on the tis­
sue distribution of zinc and iron Proc Soc Exp Biol 1972, 140 685 688 
16 TufTt LS, Nockels CF The effects of stress, Escherichia coli, dietary ethylenediaminetetra-acetic acid, and 
theit interaction on tissue trace elements in chicks Poult Sci 1991, 70 2439 2449 
17 Klasing КС The effect of inflammatory agents and intcrlcukin 1 on ion and zinc metabolism Am J 
Physiology 1984, 247 R901-904 
115 

CHAPTER 7 
IN VITRO ZINC UPTAKE BY BLOOD CELLS IN RATS 
WITH ZINC DEFICIENCY 
Ton H.J. Naber1, 
Cornells J.A. van den Hamer , 
Wim J.M. van den Broek 
Jan H.M. van Tongeren , 
Faculty of Medical Sciences, Department of Gastroenterology, 
Department of Nuclear Medicine, University Hospital Nijmegen, Nijmegen, 
and Department of Radiochemistry, Interfaculty Reactor Institute, 
Technical University, Delft, the Netherlands 
Biological Trace Element Research 1992; 35: 137-152. 

ABSTRACT 
Several methods are used to determine the zinc status; all these methods have their limita-
tions. The serum zinc concentration is influenced by the zinc status, but also by the serum 
albumin concentration and inflammatory stress. The results of studies on the zinc con-
centration of blood cells in zinc deficiency are conflicting, probably in part because of tech-
nical and analytical problems. 
The aim of this study was to investigate, under standard conditions, the uptake of ' Zn-
labeled zinc by blood cells, taken from rats with alimentary zinc deficiency and, as a pilot 
experiment, from rats in which an inflammation is induced. In both conditions the serum 
zinc concentration is reduced. In clinical practice this makes it difficult to determine 
whether the decrease of serum zinc is the result of a real or an apparent zinc deficiency. In 
stress, like in inflammatory disease, the decrease of zinc reflects an apparent zinc deficien-
cy resulting from redistribution of serum zinc into the liver and because of decrease of 
serum albumin concentration. Over 70% of the serum zinc is bound to albumin. Blood 
cells from zinc-deficient and control rats were isolated using a discontinuous Percoli gra-
dient and incubated under nearly physiologic conditions in a ' Zn containing medium. A 
significant increase of the in vitro uptake of Zn labeled zinc by the blood cells of zinc-
deficient rats was seen: erythrocytes 1.3, mononuclear cells 2.0 and polymorphonuclear 
cells 2.6 times the control values. After induction of inflammation blood was drawn only 
after 2 days as a pilot experiment. No change in ' Zn labeled zinc uptake by erythrocytes 
and mononuclear cells was demonstrated , although the serum zinc and albumin concen-
trations were decreased but a small but significant increase of zinc uptake by polymorpho-
nuclear cells was observed. This study of ' Zn uptake in vitro under standard conditions 
may prove of value for distinguishing in patients real zinc deficiency from apparent zinc 
deficiency owing to, e.g., stress, although additional experiments should be performed. 
INTRODUCTION 
Zinc is one of the most prominent trace elements in humans. It is known to be essen-
tial for mammals since 1934 (1). Its deficiency causes hair loss, acrodermatitis enteropat-
hica and other skin lesions (2), delayed wound healing (3), dysfunction of the immune sys-
tem (4,5) and growth retardation (6). Zinc deficiency is a complication in many patholo-
gical conditions. However, no good method is available for detection of real zinc deficien-
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су. One of the best parameters is the zinc concentration in various tissues, but this method 
is not suitable in medical practice. Neither is whole-body retention of Zn as a function 
of time. Blood cells are a kind of tissue and are easy to obtain. Attempts have been made 
to determine the zinc concentration in blood cells, but much blood is needed to be able to 
determine the zinc concentration and the risk of zinc contamination is great. Therefore, it 
is not surprising that the results are conflicting. Controversy exists about the question of 
whether zinc deficiency leads to an the increase (7) or decrease (8) in intracellular zinc con­
centrations. A decrease of granulocyte zinc has been observed after zinc supplementation (9). 
The aim of this study was to investigate the in vitro uptake of ' Zn labeled zinc by 
various blood cells in physiological conditions in rats. This method was applied to cells 
(obtained by discontinuous Percoli gradient) of zinc-deficient rats in comparison to those 
of control rats. The induction of dietary zinc deficiency in the rats was monitored by the 
whole-body retention of Zn and by serum zinc concentration. In various forms of stress, 
serum zinc concentration is low as a result of redistribution of zinc from serum to the liver 
rather than of deficiency. In separate experiments, we therefore studied the zinc uptake of 
blood cells taken from rats in which an inflammation in the hind legs was induced and 
compared the results with those found in real zinc deficiency. 
The method of measurement of the in vitro uptake of zinc by blood cells is a combi­
nation of a modified cell separation method described by Milne et al (10) and a modifica­
tion of methods to determine the in vitro uptake of Zn by erythrocytes or whole blood 
(11,12,13,14). 
M E T H O D S 
AnimaL· 
Male Wistar rats of 200 g were housed separately in stainless-steel metabolic cages. 
The diet on which the rats were raised (SMRA) contains a variable and sometimes an 
excessive amount of zinc. Therefore, in experiments 1, 2 and 3 a diet (IRI-OB) (table 1 
(15)), containing 12 mg/kg zinc was given to the rats during the 2 wk before the experi­
ment to adapt the animals to this diet and to reduce the excess of zinc in their depots. This 
zinc concentration is considered sufficient to maintain a normal zinc status (16). The gui­
delines for the care and use of laboratory animals in the Netherlands were followed. 
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Table 1 
Composition of the IRI-OB diet 
Ingredients 
Glucose 
Corn starch 
Ovalbumin 
Sun flower seed oil 
Fibre (cellulose) 
Choline chloride 
Mineral mix 
Sodium diphosphate 
Potassium chloride 
Calcium carbonate 
Magnesium sulphate 
Sodium meta-sihcate 
Trace element salt mix 
Vitamin mix in glucose 
Trace element salt mix 
Mn 
Fe 
Zn 
Cu 
Ni 
Cr 
Mo 
Se 
As 
Co 
Concent 
50.65 
15.0 
20.0 
4.0 
5.0 
0.3 
0.1 
1.0 
Concent 
ration (g/100g) 
1.5 
0.7 
1.0 
0.5 
0.25 
ration (mg/kg) 
55 
66 
various cone. 
9.3 
2.4 
1.8 
0.2 
0.36 
0.13 
0.2 
Materials 
The diet (IRI-OB) was produced by Hope Farms (Woerden, the Netherlands) using 
components low in zinc (table 1,(15)). In the zinc-sufficient food zinc was added as sulp-
hate to a final zinc concentration of 12 mg/kg. A sufficient quantity of other trace elements 
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was added. The Cu concentration in both versions of the diet was 9 mg/kg. The commer-
cial diet SMRA (Hope Farms, Woerden, the Netherlands) contained 92 mg/kg Zn and 25 
mg/kg Cu. 
Stainless-steel needles and plastic syringes (Monoject, Sherwood, USA) with 10 ¡L· of pre-
servative-free heparin ( 50 IU ) were used. All solutions were prepared with deionized dis-
tilled water (resistance > 15 ΜΩ), processed through a Millipore system (Bedford, 
Massachusetts, USA). 
Only polypropylene pipet tips, plastic tubes (15 mL polystyrene, Greiner, Solingen, 
Germany), 50 mL polypropylene (Falcon, Becton Dickinson and Company, Lincoln Park, 
New Jersey, USA) and bottles (0.8 L, NUNC, Roskilde, Denmark) were used. All chemi­
cals were of analytical grade (Merck, Darmstadt, Germany). Percoli was supplied by 
Pharmacia (Uppsala, Sweden). Hepes was obtained from Sigma (St Louis, MO, USA), 
albumin from Behring (Marburg, Germany), Hanks' balanced salts without Ca and Mg 
from Flow Laboratories (Rickmansworth, Herts, U.K.) and the radiotracer Zn from 
Amersham International (Amersham, Buckinghamshire, U.K., code ZAS 2 , 3.7-37 GBq 
mg of Zn as chloride in 0.1 mol/L HCl). No detectable zinc could be determined in solu­
tions and in ion-free water put into tubes and bottles apart from a low zinc concentration 
in diluted Percoli (2.56 /¿mol/L). 
Zinc was determined by atomic absorption spectrophotometry (AAS, Perkin Elmer 
5000; Norwalk, Connecticut, USA). The lower limit of detection was 0.28 /miol/L, and 
the response was linear to at least 15 /tfnol/L. Standard reference containing ZnCl2 
(Tritisol, Merck, Darmstadt, Germany) 
was used in the concentrations expected to be found in the samples. Cells were counted by 
a Coulter counter Model ZM (Luton, Beds., UK), adjusted to the size of the cells to pre-
vent counting of cell fragments. Zn was measured with an Nal crystal with an automa-
tic sample changer (LKB, Wallac 1282 Compugamma; Turku, Finland). The counting 
time was adjusted to assure a statistical error of less than 0.3%. A tube with medium but 
without blood cells, incubated and washed according the procedure of the cell containing 
tubes, served as a blank. 
Total body radioactivity of the rats was counted with a shadow shield counter con-
sisting of two Tl-activated Nal crystals ( 4 x 6 inch), both at a distance of 45 cm from the 
rat, connected to a Nuclear Data multichannel analyzer N.D. 60 A (Nuclear Data; 
Schaumburg, Illinois, USA). The first determination of the Zn whole-body retention was 
performed 4 h after the ip injection of Zn, and the second after 24 h. The results of the 
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Zn whole-body retention at the successive days were expressed as percent of the activity 
after 24 h rather than after 4 h because the losses during the first 24 h were rather erratic. 
Solutions 
Glucose Phosphate Buffer (GPB): 
13.5 mmol/L Na2HP04 , 3-3 mmol/L KH2P04 , 5.4 mmol/L KCl, 133 mmol/L NaCl and 
5 mmol/L glucose in ion-free water and if necessary adjusted to pH 7.4 with HCO,~. 
Erythrocyte lysing buffer: 
155 mmol/L NH4C1 and 10 mmol/L KHCO, in ion-free water, pH adjusted to 7.4 with 
H C O / . 
Incubation Medium: 
145 mmol/L NaCl, 6 mmol/L KCl, 2 mmol/L MgCl2, 2.4 mmol/L CaCl2, 7.6 /miol/L 
ZnCl2, 5.6 mmol/L glucose, 10 mmol/L Hepes and albumin 40 g/1 in ion-free water trace-
red with Zn and adjusted to pH 7.4 with C 0 2 . 
Procedures 
Discontinuous Gradient of Percoli 
Three solutions of Percoli of different density (1.060, 1.075, and 1.095 kg/L, respec-
tively) (10) were prepared by dilution with Hanks' balanced salts solution without Ca and 
Mg. Six millilitres of a heavier solution were layered in a 50-mL tube underneath the ligh-
ter solution using a stainless-steel needle of 15 cm and a plastic syringe. 
Isolation procedure of the blood cells 
Cell separation was performed using a discontinuous Percoli gradient. All solutions 
were kept at 4°C to prevent clumping and zinc exchange by the cells. The method descri-
bed by Milne et all (10) was modified, because blood cells of rats clot easily. Blood was 
drawn from anaesthetized rats by heart puncture using stainless-steel needles and plastic 
syringes with 10 ^ L of preservative-free heparin (50 IU). Blood was diluted 1:3 with GPB. 
The Percoli solutions of different densities were layered underneath the diluted blood. 
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Subsequently, the tube was centrifuged for 20 min, at 500 χ g at 4°C in a swing-out rotor 
without brake (Heraeus Crist Minifuge GL, Osterode am Harz, West Germany). This 
resulted in separated layers of platelets, mononuclear cells (MNC), polymorphonuclear 
cells (PMNC) and erythrocytes. The MNC, PMNC and erythrocytes were harvested using 
a pipet and resuspended in 5 mL GPB in a 15 mL tube. Erythrocyte contamination of the 
M N C and PMNC fractions was removed by twice resuspending the cells for 10 min. at 
4°C in 5 mL of erythrocyte lysing buffer and subsequent washing steps with 5 mL of GPB 
After lysing and washing steps the tube was centrifuged for 10 min., 200 χ g, 4°C with 
brake. Cells were resuspended in 1 mL of GPB for cell counting. The erythrocytes were 
washed twice and centrifuged for 10 min, 200 χ g, 4°C with brake. At random, Cytospin 
preparations (Shandon, Astmoor, UK) were made to check purity of the cell suspensions. 
The cell suspensions contained less than 10% contamination of other cells. 
Incubation procedure of the blood celL· 
The incubation was performed in physiologic conditions. Volumes corresponding to 
3.75 χ 10 M N C and 1.25 χ 10' PMNC (the mean concentration of blood cells in 1 mL 
of blood in rat) were taken and centrifuged. Supernatant was discarded and 1 mL of incu­
bation medium added. In case of erythrocytes, 0.4 mL of the concentrated suspension was 
added to 0.6 mL of the incubation medium. Incubation was carried out in a shaking bath 
for 1 h at 37°C and was stopped by adding 5 mL of cold (4°C) NaCl 0.9%. The cells were 
centrifuged and resuspended four times using cold NaCl 0.9%. The last time the cells were 
resuspended in 1 mL of GPB The volume was determined from the weight difference of 
the tube. Number of cells and radioactivity were counted. The whole procedure was per­
formed in 1 d. 
Calculations and statistics 
Calculation of the uptake of zinc: 
Since the zinc concentration (Zn
m
 : 7.6 μΜ) and the radioactivity (R,J of the incu­
bation medium per millilitre are known, and the number of cells (N
c
) and the radioactivi­
ty (R,.) of a cell sample are measured, the zinc uptake of the cells (ZnJ can be calculated 
using the expression: 
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R. IO6 or IO9 
χ 7.6 χ = Zn
c
 in nmol Zn/ 10 or 10 cells 
Statistics: 
The Student's t-test was performed; differences between two groups were considered 
significant if ρ < 0.05 (two tails). 
Calculation of the biological half-life: 
When plotting the natural logarithm of the whole-body data versus time, a linear 
relation was found from day 7 on. From the slope (γ) of this line the biological half-life of 
the ' Zn was calculated using T 1 / 2 = In 2 / γ. 
Design of the experiments 
Experiment 1 : Zn whole-body retention in zinc deficiency. 
After adaptation (see Animals), 16 rats were injected ip with 74 kBq (2 /<Ci) Zn 
(day 0). Eight rats received the Zn-adequate food (IRI-OB; 12 mg/kg Zn), and eight 
others Zn-deficient food (<2 mg/kg Zn). The control group received pair feeding throug­
hout the experiment. 
Whole-body counting was performed on days 0, 1,2, 5, 9, 14, 21 and 28. Three mL of 
blood were taken under anaesthesia by heart puncture on day 0, 7, 14, 21, and 28. The 
serum was analyzed for albumin and Zn by AAS. 
Experiment 2: ' Zn uptake by MNC, PMNC and erythrocytes in zinc deficiency. 
After adaptation (see Animals), four rats were fed the IRI-OB food, whereas four 
others received the Zn deficient variant of this food. Blood samples were taken as above on 
days 0, 10, and 31, and used for isolation of blood cells that were used for incubation. 
Experiment 3: Zn uptake by erythrocytes in zinc deficiency. 
After adaptation (see Animals), eight rats were fed the IRI-OB food, and eight others 
the Zn-deficient variant. Blood samples, now 1.5 mL, were taken as above on days 0, 6, 
13, 20, and 27, and used for isolation of erythrocytes only. These cells were also used for 
incubation with Zn. 
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Figure 1 : Whole-body retention of Zn in zinc-deficient (diet < 2 mg/kg; closed dots) and con­
trol rats (12 mg/kg; open dots). The whole-body retention of Zn 1 d after ip injection was 
taken as 100%. The error bars indicate SD (*p=<0.05; **/>=< 0.01; ***p=<0.001). 
Experiment 4: Zn uptake by blood cells in stress. 
Eight rats (not adapted to the IRI-OB food) received the commercial diet during the 
experiment. On day 0, four rats were injected im in the hind legs with 0.5 mL turpenti­
ne. Four rats served as controls. On day 2, 3 mL of blood were withdrawn for blood cells 
and in vitro Zn uptake. Serum was used to measure zinc and albumin concentrations. 
This experiment was performed twice. 
RESULTS 
The whole-body retention of Zn is normally calculated as a percentage of injected 
dose immediately after injection. Because two rats lost a significantly greater quantity of 
' Zn (52% and 36%) compared to the other rats (5.55% sd 4.42%) in faeces and urine 
(not separately collected) during the first 24 hours, the whole-body retention at day one is 
taken as 100%. Probably part of the Zn was injected in the gut. In experiment 1 zinc-
deficient rats retained more Zn compared to control rats (Figure 1, T 1 / 2 = 176 d versus 
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Тш
 = 51 d). The Zn whole-body retention confirmed the difference in zinc status 
between the rats. Serum zinc decreased gradually (Figure 2). On day 28 the serum zinc 
concentration was 40% ofthat of control rats. No change was seen in the serum albumin 
concentration in the zinc-deficient rats. 
The results of experiment 2 and 3 are presented in Figures 3, 4, and 5. In all types of 
blood cells of zinc-deficient rats the in vitro zinc uptake was increased. In erythrocytes and 
PMNC, significant differences were seen after 13 and 10 d respectively. The zinc uptake 
by erythrocytes in experiment 3 confirmed the results of experiment 2 (results not shown). 
In MNC, differences were seen at 31 d. After 4 wk the increase of the zinc uptake by 
PMNC, MNC, and erythrocytes reached peaks of 2.6, 2.0, and 1.3 times the control 
respectively. 
Subsequently the influence of stress was tested (experiment 4). Serum zinc was redu­
ced by 47% and serum albumin by 18% (Figure 6). The uptake of zinc by erythrocytes 
and M N C did not show any difference (Figure 7), but a significant difference was seen in 
the uptake of zinc by PMNC: in the case of inflammation 14.8 ± 2.0 pmol/10' cells and 
in control rats 8.8 ±1.9 pmol/10' cells. These results were confirmed in a second experi­
ment. 
serum Zinc umol/l 
Figure 2 : Serum zinc in zinc-deficient (diet < 2 mg/kg; closed dots) and control rats (12 mglkg; 
open dots). In zinc-deficient rats serum zinc declined; a significant difference was reached after 
14d. The error bars indicate SD (***p=<0.001). 
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Figure 3 : Zinc uptake by erythrocytes of zinc-deficient (diet < 2 mglkg; closed dots) and con­
trol rats (12 mglkg; open dots). In vitro the erythrocytes drawn from zinc-deficient rats take up 
more zinc after 14 d. Approximately 0.08pmolZn/10 celh was taken up by erythrocytes. The 
error bars indicate SD (*p=<0.05; ***p=<0.001). 
DISCUSSION 
The zinc concentrations in blood cells in cases of zinc deficiency have been determi­
ned, but the results are conflicting. Some authors describe a decrease (7) and others an 
increase (8) in the intracellular zinc concentration. Also, a decrease of the intracellular zinc 
concentration after zinc supplementation has been described (9). One of the reasons for 
these conflicting results is that it is not clear if these persons were really zinc deficient. 
Another explanation is that zinc concentrations in M N C and PMNC suspensions are low. 
Using 3 mL of blood and with a cell recovery of 50%, the final zinc concentration of the 
cell suspension is about 0.3 //mol/L when resuspended in 0.5 mL GPB, which is near the 
lower limit of detection of an AAS determination. Also the risk of zinc contamination of 
the suspension must be considered. Therefore, determination of zinc in blood cells is dif­
ficult (17). To our knowledge, a decrease of the concentration of zinc in blood cells in zinc-
deficient animals has never been demonstrated. We therefore studied the in vitro uptake 
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of Zn-labeled zinc by blood cells taken from zinc-deficient rats and rats with an inflam­
mation to determine the need for zinc. 
The reason why we studied both zinc-deficient rats and rats with an inflammation is 
that, in both conditions, the serum zinc concentration is decreased. This makes it difficult 
to determine whether the decrease of serum zinc concentration is the result of a real or an 
apparent zinc deficiency. In stress, like in inflammatory disease, the decrease of serum zinc 
(18,19) reflects an apparent zinc deficiency, because zinc is redistributed from the serum 
to the liver and because the serum albumin concentration decreases. Over 70% of serum 
zinc is bound to albumin (20), and therefore, a decrease of the serum albumin concentra­
tion will result in a decrease of the serum zinc concentration. 
In our experiments, whole-body retention of Zn as a function of time served as an 
indicator of the zinc status. A significant difference in whole-body Zn retention was seen 
between the rats on a diet with less than 2 mg/kg zinc and rats consuming food containing 
pmol/10 cells 
20 
15 
10 
• < 2 ppm 
о 12 ppm 
1Д 21 28 days 
* p=<005 
* * * p=<0001 
Figure 4 : Zinc uptake by polymorphonuclear cells of zinc-deficient (diet < 2 mg/kg; closed dots) 
and control rats (12 mg/kg; open dots). At day 31 the PMN cells drawn from zinc-deficient rats 
took up 260% of the zinc taken up by celh drawn from rats in the control group. Approximately 
10 pmol Zn/10 cells is taken up by PMN celL The error bars indicate SD (*p=<0.05; 
***p=<0.001). 
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12 mg/kg zinc, showing that, indeed, the experimental animals had become zinc deficient 
(Figure 1). Significant differences between the two groups of rats were also found in serum 
zinc (Figure 2) and in the in vitro uptake of zinc in the three cell types tested (Figure 3, 4, 
and 5), but particularly in the PMN cells. 
The uptake of Zn labelled zinc by blood cells has been studied before (11, 12, 13, 
21, 22), and the partly preliminary results of these studies point in the same direction as 
our study. However, the in vitro uptake of zinc by the three blood cell types in a standard 
medium as in our experiment has never been studied. Two of the studies are only publis­
hed in abstract without necessary details (13,22). Moreover, In one of these studies only 
the in vivo uptake was studied, and in the other only the results of the uptake of zinc by 
erythrocytes was described. The in vitro uptake of ' Zn by whole blood has been exami­
ned by Berry et al. (11) and Chester and Will (21). The zinc uptake by blood cells of zinc-
deficient rats was higher than in zinc-sufficient rats, but the increase of Zn uptake may 
have been owing in part to a decrease of serum zinc concentration: a higher specific acti-
pmol ZN/10ecells 
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Figure 5 : Zinc uptake by mononuclear cells of zinc-deficient and control rats. Approximately 
8 pmol Zn/10' cells were taken up by MNC. Closed dots represent rats with <2 mglkg in the 
diet and the open dots represent the zinc-sufficient group (diet with 12 mglkg). The error bars 
indicate SD (*p=<0.05). 
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Figure 6 : Serum albumin and serum zinc in turpentine induced stress after 2 d. The serum 
albumin and zinc concentration was decreased by 18% respectively 47% 2 d after inducing the 
inflammation. The error bars indicate SD. The closed bars indicate control group and the stri-
ped bars the stress group. The error bars indicate SD (*p=<0.05; ***p=<0.001). 
vity of Zn would cause an increased ' Zn uptake, even when the uptake of total zinc is 
the same. The Zn uptake should therefore be performed in a standard medium with fixed 
conditions, as in the present paper. 
There is an apparent contradiction between our results indicating a higher uptake of 
Zn by blood cells in zinc deficiency and the finding that, in experimental zinc deficien-
cy in animals no significant decrease of zinc concentration in leucocytes can be demon-
strated (17). The explanation is that changes in the intracellular zinc concentrations are to 
small to be determined by the AAS method. Theoretically there is also a second mecha-
nism. Cells formed during a period of zinc deficiency may have (as a compensatory mecha-
nism) more transport carriers for zinc on their membrane (23), causing a faster zinc trans-
port across the membrane. When the efflux would increase of the same amount as the inf-
lux, the zinc concentration would not be influenced. A third explanation would be that, 
by zinc deficiency the in- and outflow of zinc are increased because the integrity of the cell 
membrane is decreased. 
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Figure 7 : Zinc uptake by blood celh of rats in stress (striped bars) and control rats (closed bars) 
after 2 d. No significant differences were seen in zinc uptake by erythrocytes andMNC. A small 
but significant increase of zinc uptake was demonstrated in PMN celh. The error bars indica-
te SD (* p=<0.05). 
The relatively high zinc concentration of the Percoli gradient didn't have a significant 
effect on the in vitro uptake of zinc. By performing the isolation procedure at 4°C, zinc 
exchange was largely prevented (own experience). 
In general, a decrease of serum zinc concentration caused by stress is not regarded as 
zinc deficiency. In stress zinc is redistributed from several tissues into the liver. Also, the 
serum albumin concentration is decreased and because 70% of the serum zinc is transpor-
ted by albumin a decrease of serum albumin will result in a decrease of serum zinc con-
centration. 
In our stress experiments no difference was seen in the in vitro uptake of zinc by 
erythrocytes and MNC after 2 days although serum zinc and serum albumin were redu-
ced in these animals (Figure 6). Part of the decrease of scrum zinc concentration is the 
result of the decrease of serum albumin. A small but significant increase of uptake of zinc 
was demonstrated by PMNC. 
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Chester and Will (21) found a higher uptake of Zn by whole blood of animals that 
had received an ip endotoxin injection (short term experiment). However, by addition of 
Zn to whole blood the incubation is performed in a medium with a variable albumin and 
trace element concentration. The in vitro uptake of Zn by blood cells is inversely related 
to the albumin concentration in the medium (14) and consequently, the uptake of Zn by 
blood cells, drawn from animals in stress, is higher if it is performed in its own serum, as 
was mentioned before. Therefore the increase of zinc uptake by blood cells in stress as 
described by Chester and Will can be the result of the decrease of scrum albumin concen-
tration. Also, the higher specific activity of Zn would cause an increased Zn uptake like 
mentioned before. 
In the experiment described by Sasser et al (12) stress was induced by a skin injury 
from ß radiation. The long term effects of zinc deficiency and stress were studied (10 mo). 
Both in zinc deficiency and in stress they found an increase of zinc uptake by blood cells 
in vitro. For a considerable part the increase of zinc uptake in stress was the result of chan-
ges in the plasma protein composition, but there were some intrinsic changes. However, 
these changes could be the result of a true zinc deficiency, ß radiation resulted in a com-
plete epilation and accumulation of plasma exudate over 12% of the body surface. Large 
quantities of zinc can be lost by skin lesions (24). Also no pair feeding was used. The absen-
ce of the results of a zinc balance study or the results of a ' Zn total body counting in their 
long-term experiment makes the interpretation of this experiment difficult. Also in these 
long term experiments the higher specific activity of ' Zn owing to a decrease of serum zinc 
can account for the increase of Zn uptake. 
In our study the cells that showed the greatest increase of zinc uptake in zinc defi-
ciency (PMNC) were the only cells that showed a small, but significant increase of zinc 
uptake in case of inflammation. This can be the result of the higher sensitivity of these cells 
for low serum zinc concentrations or the shorter half-life of the PMN cells compared to 
the other blood cells, if the change resulting from zinc deficiency is built in during the 
formation of the cells. A longer exposure to zinc deficiency or a shorter half-life of the cells 
would result in more affected cells. A long-term stress experiment would probably give 
more insight in this problem. 
Several methods are used to determine the zinc status, e.g., serum zinc (25), alkaline 
phosphatase activity levels (26), and zinc concentrations in urine (27) and hair (28). All 
these methods have their limitations. Serum zinc is influenced by the zinc status, but also 
by the serum albumin concentration and stress (18). The zinc concentration in urine 
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shows no correlation with the degree of zinc deficiency (29). The concentration of zinc in 
hair is decreased in the early phase of zinc deficiency, but because zinc deficiency can slow 
down the hair growth, the zinc concentration may return to normal (30). The whole-body 
retention of a dose of Zn as a function of time seems to reflects the zinc status (16). It 
may be a suitable tool for research, but not for daily practice (31). The activity of zinc 
depended enzymes, e.g., serum alkaline phosphatase is influenced by many other factors 
such as liver function and bone turnover. Determination of tissue zinc concentrations are 
probably a more appropriate method to determine the zinc status, but tissue specimens are 
generally difficult to obtain. Blood cells are a kind of tissue and are more easily obtained. 
However, as previously explained, determination of zinc in blood cells is difficult (17) and 
validity of this method has never been demonstrated in animals. In our opinion, it is essen-
tial to validate a method to determine zinc deficiency in an animal experiment, because it 
is very difficult to perform an experiment in humans with proven zinc deficiency or stress 
as the only factors. 
The results of this study point to a possible application of measuring Zn uptake by 
blood cells as an indicator of the zinc status. The determination of ' Zn activity in blood 
cells is not as difficult as the determination of a low-zinc concentration. This is the reason 
why we have studied the in vitro uptake of zinc by blood cells. Our experiments demon-
strate that, in the case of a low serum zinc concentration, the in vitro uptake of zinc by 
MNC and erythrocytes can discriminate between true zinc deficiency and the effect of a 
stress factor after 2 d. This opens the possibility of distinguishing between true and appa-
rent zinc deficiency. The results of our experiments should be confirmed in humans. 
Additional experiments concerning the effect of variables influencing the incubation, e.g., 
incubation time, incubation temperature, the effect of various diets, and the effect of long-
term inflammation are needed. 
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ABSTRACTS 
Serum zinc (Zn) is generally used to detect zinc deficiency, but it is influenced by several 
factors, e g , inflammation In clinical practice this makes it difficult to determine whether 
the decrease of serum zinc is the result of a real or an apparent zinc deficiency Other 
methods to determine the zinc status have been tested but have disadvantages In previous 
studies we have demonstrated that the in vitro uptake of zinc by blood cells, under stan-
dard conditions, is increased in zinc-deficient rats The uptake of zinc by blood cells has 
been studied before, but because we used a new method, the results of the present study 
differ from others The aim of the present study was to investigate the in vitro uptake of 
zinc during inflammatory stress 
After the first day of inflammation, when a major decrease of serum zinc concentration was 
observed, a smaller difference persisted until the end of the experiment from one day after 
turpentine injection a decrease of serum albumin concentration was observed in the rats 
with an inflammation When the serum zinc concentration was corrected for the decrease 
of serum albumin a small, mostly non-significant decrease of serum zinc was observed in 
the stress group after the first few days This suggests that after the fourth day the decrea-
se of serum zinc was mainly due to a decrease of serum albumin No increase of the in vitro 
zinc uptake by blood cells, especially erythrocytes, was observed in case of inflammation, 
this in contrast to the findings in case of real zinc deficiency In mononuclear cells (MNC) 
and polymorphonuclear cells (PMNC) a small increase of zinc uptake was observed only 
during the first three days Because after the fourth day the decrease of serum zinc was 
mainly the result of a decrease of serum albumin, these results indicate that the uptake of 
zinc by MNC and PMNC was not influenced by an apparent zinc deficiency due to a 
decrease of serum albumin Consequently this method can probably differentiate between 
an apparent zinc deficiency resulting from inflammatory stress and a real zinc deficiency 
Additional experiments to validate this method should be performed 
INTRODUCTION 
Zinc deficiency is a complication of many pathologic conditions and manifests itself 
in many symptoms, such as growth retardation (1), lack of appetite, skin lesions and loss 
of hair (2), impaired wound healing (3), dysfunction of the immune system (4,5), decre-
ased protein synthesis and through a decrease of retinol binding protein, night blindness 
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However, no adequate method is available for detection of real zinc deficiency. 
Generally the serum zinc concentration is used for this purpose, but serum zinc is influ-
enced by several other factors apart from zinc deficiency, e.g., hydration, albumin concen-
tration influenced by inflammatory diseases, drugs like steroids, etc. We have demonstra-
ted that the in vitro uptake of ' Zn labelled zinc by various blood cells, drawn from zinc-
deficient rats, was increased (6). In the present study the same method was applied to rats 
in which inflammatory stress was induced by an intramuscular injection of turpentine. 
The aim of the present study was to investigate a) the physiologic process of the in 
vitro uptake of zinc by the various blood cells during long term inflammatory stress; b) the 
zinc status during inflammation and c) the suitability of this method to differentiate 
between a real and an apparent zinc deficiency. 
METHODS 
General remarks concerning the design of the study 
Turpentine (0.25 mL) was injected intramuscularly, to induce a long-standing in-
flammation causing stress. An identical group of rats served as controls. At variable times 
blood was taken by heart puncture from 4 rats of the stress group and 4 rats of the control 
group for determination of the in vitro uptake of zinc by blood cells. The serum zinc and 
serum albumin concentrations were evaluated as well. 
The various types of blood cells were separated and incubated as described before (6). 
The total body retention of intraperitoneally injected Zn served as a control to determi-
ne if zinc deficiency occurred. This was studied in a separate experiment, because the Zn 
was given in vivo. The uptake of Zn by the cells in vivo would influence the measure-
ments of the uptake of ' Zn by the blood cells in vitro. Wherever the word 'stress' is used 
in this study, it refers to 'inflammatory stress induced by an inflammation caused by a tur-
pentine injection'. 
Animab 
Male Wistar rats of 200 g were housed separately in stainless steel metabolic cages 
from 7 days before the start of the experiment to adapt the animals to these cages. The rats 
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were raised on a commercial diet (SMRA)(6). The guidelines for the care and use of labo­
ratory animals in the Netherlands were followed. 
Materiab 
Details concerning materials and procedures were published previously (6). Only a 
summary of the procedures and the information relevant to this study are given. 
Zinc was determined by atomic absorption spectrophotometry (Perkin Elmer 5000; 
Norwalk, Connecticut, USA). Cells were counted by a Coulter counter Model Z M 
(Luton, Beds., UK). 
Zn was measured with a Nal crystal with an automatic sample changer (LKB, Wallac 
1282 Compugamma; Turku, Finland). Total body radioactivity of the rats was counted 
with a shadow shield counter consisting of two Tl-activated Nal crystals (4 χ 6") connec­
ted to a Nuclear Data multi-channel analyzer N.D. 60 A (Nuclear Data; Schaumburg, 
Illinois, USA). 
Procedures 
Isolation of the blood ceUs 
Blood was drawn from anaesthetized rats by heart puncture. Cell separation was per­
formed using a discontinuous Percoli gradient using three solutions of Percoli of different 
densities (1.060, 1.075 and 1.095 kg/L respectively) (7). All solutions were kept at 4°C to 
prevent clumping and zinc exchange by the cells. The method described by Milne (7) was 
modified because blood cells of rats clot easily. Blood was diluted 1:3 with glucose-phos­
phate buffer. The Percoli solutions of different densities were layered underneath the dilu­
ted blood. Subsequently the tube was centrifuged. This resulted in separate layers of plate­
lets, mononuclear cells (MNC), polymorphonuclear cells (PMNC) and erythrocytes. The 
MNC, PMNC and erythrocytes were harvested. Erythrocyte contamination of the M N C 
and PMNC fractions was removed by using an erythrocyte-lysing buffer containing 
NH4C1. Cells were resuspended in a glucose phosphate buffer for cell counting. Cytospin 
preparations (Shandon; Astmoor, UK) were made at random to check the purity of the cell 
suspensions. The cell suspensions contained less than 10% contamination of other cells. 
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Incubation procedure of the blood cells 
The incubation was performed under nearly physiological conditions (6). Volumes 
corresponding to 3.75x10' M N C and 1.25x10' PMNC (the mean number of blood cells 
in 1 mL of blood in rat) were taken and the cells incubated in an incubation medium con­
taining albumin. Incubation was carried out in a shaking bath for 1 hour at 37°C and was 
stopped by adding 5 mL of cold (4"C) NaCl 0,9%. The cells were washed and the num­
bers of cells and radioactivity of the cells were determined. 
Calculions 
Biological half-life 
The biological half-life was calculation of from the total body retention, measured as 
a function of time as follows: 
When plotting the natural logarithm of the whole-body data versus time, a linear relation 
was found from day 7 on. From the slope (γ) of this line the biological half-life (T,/2) of 
the Zn was calculated using T 1 / 2 = In 2 / γ. 
Cakulation of the uptake of zinc 
Since the zinc concentration (Zn
m
: 11.6/<M) and the radioactivity (R
m
) of the incu­
bation medium per mL are known and the number of cells (N t) and the radioactivity (RJ 
of a cell sample are measured, the zinc uptake of the cells (ZnJ can be calculated using the 
equation: 
R
c
 106 or 10' 
χ Zn
m
 χ = Zn
c
 in nmol Zn per 10 or 10 cells 
Estimation of the corrected serum zinc concentration in rats with stress: 
Serum zinc is mainly transported by albumin (alb) and alpha- 1-macroglobulin (non 
alb). Alpha-1-macroglobulin is not an acute phase protein. In case of inflammation the 
serum zinc concentration is decreased because of redistribution of serum zinc into the liver 
and because of a decrease of serum albumin concentration. Because in normal situations 
about 75% of the serum zinc is transported by serum albumin (8) an estimation of the 
serum zinc concentration of the inflammation group can be made. 
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The total serum zinc concentration in the control rats is divided into two parts. 
Zn tot = Zn non alb + Zn alb 
or 
Zn tot (control) = 0.25 χ Zn tot (control) + 0.75 χ Zn tot (control) 
We hypothesize that the binding of zinc to the binding proteins (the number of zinc 
molecules transported by one protein molecule), in the normal situation and in case of an 
inflammation will be similar. The factor 0.25 represents the fraction of the serum zinc con­
centration not bound to albumin in the control rats. This fraction is mainly bound to 
alpha-1-macroglobulin. The concentration of this protein is not significantly changed in 
stress, so the number of zinc molecules transported by alpha-1-macroglobulin in the inf­
lammation group will be equal to that of the control group. 
In the rats with an inflammation the fraction of serum zinc transported by albumin 
is decreased resulting from the decrease of serum albumin. If the serum level of albumin 
in the inflammation group will be increased to the level of the control group, the correc­
ted serum zinc concentration can be calculated by the equation: 
Alb control 
Corr Zn tot (inflam) = 0.25 χ Zn tot (control) + χ ((Zn tot (inflam)) - (0.25 
χ Zn tot (control))) Alb inflam 
Zn tot (control): total serum zinc concentration of the control group 
Corr Zn tot (inflam): corrected serum zinc concentration of the inflammation group 
Alb control: serum albumin of the control group 
Alb inflam: serum albumin of the inflammation group 
Zn tot (inflam): total serum zinc concentration of the inflammation group 
If the decrease of serum albumin is the main cause of the decrease of serum zinc, the 
corrected serum zinc concentration of the inflammatory group should be identical to the 
serum zinc concentration of the control group. If a difference is still observed between the 
corrected serum zinc concentration and the serum zinc concentration of the control group, 
this difference will be the result of other causes, e.g., redistribution. 
This equation is only used to explain in part the observed decrease and subsequent 
increase of serum zinc concentration during the experiments; it should not be used in cli-
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nical practice to correct the scrum zinc concentration for the decrease of serum albumin, 
because we made the assumption that the binding of zinc to the binding proteins will not 
change in case of stress, and because the concentration of alpha-1-macroglobulin is not 
measured. 
Statistics: 
A Wilcoxon rank sum test was performed for comparison of the independent results 
of both groups of rats on all the data collected during the experiment or during a period 
of the experiment. 
The Student t-test was performed on the data collected at one moment; differences 
between two groups were considered significant if ρ < 0.05 (two tails). In case of repeated 
measurements and only one significant difference between the two groups the Bonferonni 
correction was applied. 
Design of the experiments 
Experiment 1: in vitro uptake of Zn by MNC, PMNC and erythrocytes during long 
term inflammation. 
After an adaptation period of 7 days in which 64 rats were housed separately in stain­
less steel metabolic cages, the rats were divided into two groups of equal mean weight and 
numbers: 32 rats in the inflammation and in a control group. Before turpentine was injec­
ted in the rats of the inflammation group, blood was collected from 4 rats of the inflam­
mation group and 4 rats of the control group. Turpentine was injected intramuscularly in 
a dose of 0.25 mL into both hind legs. Four hours, 1 day, 2, 3, 4, 7 and 14 days after the 
turpentine injection 3 ML blood was withdrawn under anaesthesia by heart puncture from 
4 rats of the inflammation group and 4 rats of the control group, for collection of blood 
cells. Also, 2 mL was drawn for determination of the serum zinc and albumin concentra­
tions. The control group was pair fed throughout the experiment. 
Experiment 2: ' Zn whole-body retention in zinc deficiency. 
The design of the experiment was the same as in experiment one. All the rats were 
injected intraperitoneally with 74 kBq (2 ^Ci) ' Zn seven days before the turpentine injec­
tion. The whole-body activity at the time of the turpentine injection was taken as 100%. 
During the first 7 days after the Zn injection the stress group was of course identical with 
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the control group. Whole-body counting was performed after 4 hours and on days 1, 2, 3, 
4, 7, and 14. The serum was analyzed for albumin and zinc concentrations. 
RESULTS 
During experiment two the whole-body retention of Zn (Figure 1) showed no dif­
ference between the groups, indicating absence of zinc deficiency (inflammation group 
Ti/2=34 days, control group 31.5 days). The serum zinc and serum album concentrations 
were comparable to the concentrations found in experiment one. 
In experiment one the serum albumin concentration decreased during the first day 
(Figure 2). Thereafter a constant difference persisted (about 7 g/L). Using a Wilcoxon rank 
sum test a highly significant difference was calculated if all the data of both groups were 
compared (p<0.0001). 
During the first day a considerable decrease of serum zinc concentration was seen in 
the rats with stress (day one: inflammation group 12.5 /<mol/L and control group 20.4 
^mol/L, p=0.002) (Figure 3). After that a smaller difference persisted (of about 4 fimol/L). 
A Wilcoxon rank sum test was performed for comparison of the independent results of 
both groups of rats on all the data collected during the experiment. A highly significant 
Total body retention 
% 
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Figure 1: Total body retention of ' Zn in rats with an inflammation (closed dots) and control 
rats (open dots) during the experiment 
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Figure 2 : Serum albumin concentration in rats with an inflammation (closed dots) and con­
trol rats (open dots) during the experiment (**p<0.01; ***p<0.001). 
difference was calculated (p<0.0001). 
When the serum zinc concentration of the rats with an inflammation was corrected 
for the decrease of serum albumin using the equation described in Methods, the differen­
ces between the groups were smaller, especially after the third day. 
No difference in the in vitro uptake of zinc by erythrocytes was present except for a 
decrease of uptake by the erythrocytes of the inflammation group on day 7 (p<0.04) 
(Figure 4a). Because repeated measurements were performed on independent variables a 
Bonferroni correction for repeated measurements was applied. After the Bonferroni cor­
rection no significant increase of uptake of zinc by the erythrocytes of the rats of the in­
flammation group was observed. Using the Wilcoxon rank sum test no difference obser­
ved either during the first three days (p=0.39), or when the data of the total experimental 
period were compared (p=0.42). On day two the PMNC showed an increase of uptake of 
zinc compared with the control group (5.5 versus 3.9 pmol/L, p=0.02) (Figure 4b). When 
all the data of the first days of both groups were compared, no significant difference was 
observed (p=0.08). The same was seen when all the data of the total experimental period 
were compared (p=0.87). In M N C an increase of uptake of zinc was seen during the first 
three days (day one 6.1 versus 4.5 pmol/L/10' cells, p<0.001; Wilcoxon test during the 
first three days: p=0.0007) (Figure 4c). When all the data were compared a significant dif­
ference was calculated (p=0.02), but after the third day no difference was observed between 
the groups (p=0.78). 
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DISCUSSION 
The serum zinc concentration is often used to determine the zinc status (9) but it is 
influenced by several factors such as time elapsed after the meal, the serum albumin and 
stress. This makes it difficult to determine whether a decrease of serum zinc concentration 
is the result of a real or an apparent zinc deficiency. In stress, like in inflammatory disease, 
the decrease of serum zinc (10,11) is due to an apparent zinc deficiency caused by a redis-
tribution of zinc from the serum to the liver and by a decreased serum albumin concen-
tration, but the total body zinc content is believed to remain unchanged. 
Several other methods have been used to determine the zinc status, e.g., alkaline 
phosphatase activity (12), zinc concentration in urine (13) and zinc concentration in hair 
(14), but all these methods have limitations. The zinc concentration in urine shows no cor-
relation with the degree of zinc deficiency (15). The concentration of zinc in hair is decre-
ased in the early phase of zinc deficiency but because zinc deficiency can slow down hair 
growth, it may return to normal (16). The whole-body retention of a dose of Zn as a 
function of time reflects the zinc status (17). It may be a suitable tool for research but not 
for daily practice (18). The activity of zinc-dependent enzymes, e.g., serum alkaline phosp-
hatase, is influenced by many other factors such as liver function and bone turnover. One 
of the best parameters for determination of the zinc status is the zinc concentration in body 
tissues, but this method is not suitable for medical practice either. Blood cells are a kind of 
tissue and easy to obtain. Attempts have been made to determine the zinc concentration 
in blood cells but this requires much blood and the results are conflicting: controversy 
exists about the question whether zinc deficiency leads to an the increase (19) or decrease 
(20) in intracellular zinc concentrations. A decrease of the zinc concentration of granulo-
cytes has even been observed after zinc supplementation (21). One explanation of these 
conflicting results is that it is not always clear if the subjects were really zinc deficient. 
Another is that the concentration of zinc in MNC and PMNC suspensions is small (6), 
increasing the risk of contaminating the suspension with extraneous zinc. Determination 
of zinc in blood cells is therefore difficult. To our knowledge a decrease in the concentra-
tion of zinc in blood cells in zinc-deficient animals has never been demonstrated although 
attempts have been made (22). Inducing a zinc deficiency in an animal model, is impor-
tant to validate a method because it is very difficult to perform an experiment in humans 
with proven zinc deficiency or stress as the only factor. 
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Previously we studied the in vitro uptake of Zn labelled zinc by blood cells, taken 
from zinc-deficient rats, to see whether this uptake is an indicator of the zinc status. The 
uptake of zinc by all cells investigated was increased: after four weeks in PMNC the upta­
ke 2.6, in MNC 2.0 and in erythrocytes 1.3 times the uptake of the control group (6). 
In the present study we examined the uptake of zinc, labelled with ' Zn, by blood 
cells in case of inflammatory stress (Figure 1). The whole-body retention of Zn as a func­
tion of time served as an indication for the zinc status. 
No difference in zinc retention was observed indicating that in case of long term inflam­
mation no true zinc deficiency was present despite a marked decrease of serum zinc (Figure 
3). The in vitro uptake of zinc by erythrocytes was not influenced by inflammatory stress 
(Figure 4a). The in vitro uptake of zinc by M N C and PMNC (Figure 4b and 4c) was incre­
ased in case of severe inflammation. After the first days after the turpentine injection the 
zinc uptake of these cells is normal, although the serum zinc is still decreased, resulting 
from the decreased albumin. Thus after the first days the apparent zinc deficiency did not 
have an influence on the uptake in zinc by PMNC and MNC. These results conform those 
of an earlier performed pilot experiment (6) in which inflammation was also induced by 
Serum Zn and corrected serum Zn 
μπιοΙ/Ι. 
Figure 3 : Serum zinc concentration in rats with an inflammation (closed dots), control rats 
(open dots) and serum zinc concentration corrected for the decrease of serum albumin (closed 
triangle) during the experiment. The error bars indicate SD (* p<0.05; ** p<0.01; *** 
ρ<0.001 for serum zinc in rats with an inflammation compared with control rats. + p<0.05; 
++ ρ <0.01 for corrected serum zinc in rats with an inflammation compared with control rats) 
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turpentine. Only the uptake of zinc by blood cells after 2 days was studied. No difference 
was seen in the in vitro uptake of zinc by erythrocytes after 2 days although serum zinc and 
serum albumin were reduced in these animals. In MNC a small, non-significant increase 
was demonstrated. A significant increase of in vitro uptake of zinc in case of inflammation 
was observed in PMNC. The results of the present study confirm these results. 
The uptake of Zn labelled zinc by erythrocytes or total blood cells during zinc defi-
ciency or stress has been studied before (23,24,25,26). The in vitro uptake of zinc by the 
three separate types of blood cell in a standard medium as in our experiment has never 
been reported before. The partly preliminary results of these studies concerning the zinc 
uptake by blood cells during inflammation do not point in the same direction as our study. 
However, these studies had certain shortcomings. Two of the studies were only published 
in abstract form, lacking necessary details (25, 27). Moreover, in one of these only the in 
vivo uptake was studied and in the other only the results of the uptake of zinc by erythro-
cytes was described. It is only in two paper that the results in case of stress are presented. 
Contrary to our results Chester and Will (26) found a higher uptake of ' Zn by whole 
blood of animals which had received an intraperitoneal endotoxin injection (short term 
experiment). However, by addition of ' Zn to whole blood the incubation takes place in a 
environment with a variable albumin and trace element concentrations. The in vitro upta-
ke of ' Zn by erythrocytes is inversely related to the albumin concentration in the medi-
um (28) and consequently the uptake of Zn by blood cells drawn from animals in stress 
is higher when it is tested in the animals own serum. Therefore the increase of zinc upta-
ke by blood cells in stress as described by Chester and Will (26) may be the result of the 
decrease of serum albumin concentration. Also, the higher specific activity of Zn will 
cause an increased Zn uptake, even when the uptake of total zinc (cold zinc and tracer 
Zn) is the same. In the experiment described by Sasser et al (24) stress was induced by a 
skin injury from beta radiation. The long term effects of zinc deficiency and stress were 
studied (10 months). Both in zinc deficiency and in stress they found an increase of zinc 
uptake by blood cells in vitro. For a considerable part the increase of zinc uptake in stress 
was the result of "changes in the plasma protein composition, but there were some intrin-
sic changes". However, these changes could be due to a true zinc deficiency. Beta radiation 
resulted in a complete epilation and accumulation of plasma exudate over 12% of the body 
surface. Large quantities of zinc can be lost via skin lesions (29). No pair feeding was used. 
The absence of a zinc balance study and the absence of a Zn total body counting in their 
long term experiment make the interpretation of this experiment difficult. Furthermore in 
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Figure 4 : In vitro uptake of une by bhod cells in rats with an inflammation (closed dots) and con­
trol rats (open dots) during the experiment. Figure 4a (upper figure): uptake by erythrocytes; figure 
4b (middle figure): uptake of zinc by polymorphonuclear celb; figure 4c (bottom figure): uptake of 
zinc by mononuclear celh. The error bars indicate SD (*p<0.05; **p<0.01; ***p<0.001; (*) not 
significant if a Bonferroni correction of the t-testfor repeated measurements was used). 
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the long term experiments performed by Sasser et al. the higher specific activity of Zn 
resulting from a decrease of serum zinc can account for the increase of Zn uptake. The 
uptake of zinc by blood cells should therefore be studied in a standard medium under fixed 
conditions, as in the present paper. 
During the first few days of the present experiment the serum zinc concentration was 
markedly reduced. The serum zinc concentration of the rats with stress was hardly redu-
ced, compared to the concentration in the control group, after correction of the serum zinc 
concentration of the stress group for the reduction in serum albumin concentration after 
the third day. This indicates that after the third day the decrease of serum zinc was main-
ly due to a decrease of serum albumin. During the first few days, together with a decrease 
of serum albumin, serum zinc was also reduced because of an increase of zinc uptake by 
the liver, probably the result of an increase of metallothionin in the liver. After stabilisation 
of metallothionin in the liver this redistribution process gradually ceases and the serum 
zinc is from then on mainly influenced by the serum albumin concentration. 
The equation that is used to explain the observed decrease and subsequent increase of 
serum zinc concentration during the experiments, can be used in clinical practice to cor-
rect the serum zinc concentration for the decrease of serum albumin if all the hypothesis 
are true. The assumption that the binding of zinc to the binding proteins will not change 
in case of stress, should be confirmed. The concentrations of serum albumin and alpha-2-
macroglobulin in (human) subjects with stress should be measured and the concentrations 
of albumin and alpha-2-macroglobulin in subjects without stress should be known. 
Evaluating the aims of this study we may conclude that the results of these experi-
ments indicate that the reduction in serum zinc concentration is probably the result of the 
physiologic process of reduction in serum albumin concentration and, during the first few 
days, a short term increase of zinc uptake by the liver (redistribution process). These expe-
riments stress the fact that the total body retention of Zn is a reference for the zinc sta-
tus. Probably the in vitro uptake of zinc by erythrocytes can differentiate between an appa-
rent zinc deficiency due to an inflammatory stress and a true zinc deficiency. The results 
of this study point to a possible application of measuring Zn uptake by blood cells as 
indicator of the zinc status. 
The results of our experiments should be confirmed in humans. Additional experiments 
concerning the effect of variables influencing the incubation, such as incubation time, 
incubation temperature and the effect of various diets are needed. 
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ABSTRACT 
Determination of zinc concentrations in white blood cells has been used to establish zinc 
deficiency. During pathological conditions changes in zinc concentrations in these blood 
cells were observed. However, these investigations were hampered by the low amount of 
zinc in this form per mL blood. Earlier we demonstrated that, in the case of zinc deficien-
cy, the uptake of zinc was increased, using the in vitro exchange of zinc by the various 
blood cells with extracellular zinc labeled with ' Zn in fairly physiologic conditions. In case 
of inflammation, no increase of zinc uptake by erythrocytes was seen, indicating that this 
method probably can be used to differentiate real from apparent zinc deficiency. Only 
during the first days of the inflammatory process, probably representing the redistribution 
phase during which zinc moves from the serum to the liver, a small increase of in vitro zinc 
uptake was seen in mononuclear cells (MNC) and polymorphonuclear cells (PMNC). 
Earlier papers raised some questions; e.g., is the uptake part of an exchange process and 
can the efflux of zinc by the cells be measured by the same method; what is the influence 
of time on the process of zinc uptake; what is the magnitude of the uptake of zinc by the 
cells compared to the zinc concentration in the cells; and, what is the influence of tempe-
rature on the uptake of zinc? 
In the present study, the influence of incubation time and temperature on the uptake of 
zinc by human and rat blood cells and on the release of zinc by rat blood cells was studied. 
By varying the incubation time, at least three phases of uptake of zinc in the various cells 
were found, a fast phase during the first half hour, probably caused by an aspecific binding 
of zinc on or in the cell membrane; a second fast uptake between 60 - 330 min, probably 
caused by an influx of zinc in the cell as part of the exchange process of zinc; and a slow 
third phase after 5-5 hours, in which probably the in- and efflux of the rapidly exchange-
able intracellular pool is more or less equilibrated). For mononuclear cells, polymorpho-
nuclear cells, and erythrocytes of rats the rapidly exchangeable intracellular pool is resp 
40%, 53% and 10%, respectively, of the total zinc content of the cells. This study is also 
performed in human cells; in human cells the exchangeable pool of mononuclear cells and 
erythrocytes is 17% and 3.5% of the total zinc content of the cells respectively. The efflux 
of zinc by blood cells can be measured by the same method. Both the uptake and the loss 
of zinc by blood cells of rats were compared and arc of the same magnitude, indicating that 
the in vitro uptake of zinc we described elsewhere, is part of an exchange process. 
Increasing temperature during incubation procedures results in an increase of zinc uptake 
by human blood cells, even at high temperatures of 4l°C although there are gradual diffe-
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rences between the various blood cells. Both the in- and efflux of zinc by blood cells are 
very small at 4°C. 
INTRODUCTION 
Zinc is one of the most prominent trace elements in humans. Zinc deficiency causes 
hair loss, skin lesions (1), delayed wound healing (2), and growth retardation (3). Although 
in one study an improved functioning of polymorphonuclear leucocytes in vitro is descri-
bed in case of zinc deficiency is described (4), other studies have found an impaired func-
tion of blood cells (5,6). The zinc content of blood cells has been proposed as a method 
for judging the zinc status although in animal experiments this method has never been vali-
dated to our knowledge. Measurement of the in vitro uptake of zinc by blood cells in near-
ly physiological standard conditions is probably a method to determine the zinc status (7, 
8). Earlier raised some questions; e.g., is the uptake part of an exchange process, and can 
the efflux of zinc by the cells be measured by the same method; what is the influence of 
time on the process of zinc uptake; what is the magnitude of the uptake of zinc by the cells 
compared to the zinc concentration in the cells; and what is the influence of temperature 
on the uptake of zinc? 
The aim of this study was to investigate the physiologic process of zinc uptake and 
efflux by the various blood cells by the measurement of the influence of incubation time 
and incubation temperature on the influx of zinc by blood cells. Also, the efflux of zinc by 
the cells was determined. 
MATERIALS AND METHODS 
Design of the experiments 
In both the first and fourth experiments we used rats so we would be in a the posi-
tion to compare the influx and efflux of zinc from the various types of blood cells. For the 
study of the efflux of zinc by blood cells, rats had to be injected with a considerable 
amount of Zn in order to incorporate enough Zn in the blood cells. This experiment 
was therefore not possible in humans. In the second experiment also we studied the influ-
ence of the incubation time on the uptake of zinc by blood cells, and employed human 
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cells taken from four volunteers. The third experiment, also performed with cells from 
human blood, was meant to determine the influence of temperature on the uptake of zinc. 
Experiment 1: Influence of incubation time on the influx of zinc by blood cells taken from 
rats. 
After an adaptation period of 2 weeks, in which all rats were fed the IRI-OB food 
containing 12 mg/kg of zinc (see Animals), 5 mL of blood were drawn by heart puncture 
under anaesthesia from each of four rats. The blood of the four rats was pooled, mixed, 
and blood cells were isolated. All procedures were performed at 4°C, except during the 
incubation period. MNC, PMNC, and erythrocytes were incubated at 37'C for 12, 30, 
60, 120, 330, 1020, and 1440 minutes in the incubation medium containing ' Zn. The 
cells were washed and the number of cells and their ' Zn content were determined. 
Experiment 2: Influence of incubation time on the influx of zinc by blood cells taken from 
human volunteers. 
Blood samples, now 20 mL, were taken from each of four fasting healthy volunteers. 
Because it was difficult to perform the cell isolation procedure on 20 mL of blood, the 
blood was separated into four portions and the isolation procedure was performed on each 
of the four portions. After the isolation procedure the various cell types of each volunteer 
were combined and the incubation procedure of the various cell types was performed as 
described in experiment 1. 
Experiment 3: Influence of incubation temperature on the influx of zinc. 
Twenty ml, of blood were taken by vena puncture from two healthy volunteers, as 
described in experiment 2. Blood was mixed and blood cells were isolated. The MNC, 
PMNC, and erythrocytes were incubated for 1 hour in ' Zn containing incubation medi­
um at 4°C, 20°C, 37°C, and 4l°C. The cells were washed according to the described pro­
cedures. Number of cells, volume, and radioactivity were determined. 
Experiment 4: Zinc efflux during isolation and incubation procedure. 
After adaptation (see Animals) four rats were injected ip with 740 kBq (20 μΟ) ' Zn 
on day 1 and 2. From each of these four rats 5 mL of blood were taken under anaesthesia 
by heart puncture on day 4. The blood of these four rats was mixed and the blood cells 
were isolated at 4°C and incubated at 37°C for 1 hour in the incubation medium accor­
ding to the procedures described. The incubation medium did not contain ' Zn. 
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Table 1 
Composition of the IRI-OB diet 
Ingredients 
Glucose 
Corn starch 
Ovalbumin 
Sun flower seed oil 
Fibre (cellulose) 
Choline chloride 
Mineral mix 
Sodium diphosphate 
Potassium chloride 
Calcium carbonate 
Magnesium sulphate 
Sodium meta-silicate 
Trace element salt mix 
Vitamin mix in glucose 
Trace element salt mix 
Mn 
Fe 
Zn 
Cu 
Ni 
Cr 
Mo 
Se 
As 
Co 
Concentration (g/100g) 
50.65 
15.0 
20.0 
4.0 
5.0 
0.3 
0.1 
1.0 
1.5 
0.7 
1.0 
0.5 
0.25 
Concentration (mg/kg) 
55 
66 
various cone. 
9.3 
2.4 
1.8 
0.2 
0.36 
0.13 
0.2 
Subsequent washing was performed at 4°C. After each consecutive step of the separation, 
lysation, washing, or incubation solutions were stored and the radioactivity, volume, and 
number of cells in each were determined. In order to avoid a rise in temperature caused by 
the manipulation of the suspension and therefore continuation of the exchange process, 
the radioactivity of the cell suspensions was determined at the beginning and at the end of 
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the separation and incubation procedure only, and not after each consecutive step. Using 
the radioactivity, the volume, and the number of cells of the last cell suspension and of the 
preserved solutions (all separation, lysation, washing, and incubation solutions used were 
stored), the efflux of zinc by the various blood cells could be calculated (see Calculations). 
Animah and human volunteers 
Male Wistar rats, 200 g, were housed separately in stainless steel metabolic cages. The 
commercial diet (SMRA) on which the rats were raised contains a considerable and varia­
ble amount of zinc (about 92 mg/kg) and copper (about 25 mg/kg). Therefore, in experi­
ments 1 and 4 a diet (IRI-OB; table 1 (9)), containing 12 mg/kg zinc and 9.3 mg/kg cop­
per, was given to the rats during the 2 weeks before the experiment, to adapt the animals 
to this diet and to reduce the excess of zinc in their bodies. This zinc concentration is con­
sidered sufficient to maintain normal zinc status (10). Blood was taken from healthy vol­
unteers (35-40 years in age). 
The guidelines for informed consent of the volunteers and for the care and use of labora­
tory animals in The Netherlands were followed. 
Materials and methods 
The diets (IRI-OB and SMRA; Table 1 (9)) were produced by Hope Farms 
(Woerden, the Netherlands), table 1 (9). Stainless steel needles and plastic syringes 
(Monoject, Sherwood, USA) with 10 fiL· of preservative-free heparin (50 IU) were used. 
All solutions were prepared with deionized distilled water, processed through a Millipore 
system (Bedford, Massachusetts, USA) (resistance >15 ΜΩ). Only polypropylene pipet 
tips, plastic tubes (15 mL polystyrene, Greiner, Solingen, Germany and 50 mL polypro­
pylene, Falcon, Becton Dickinson, Lincoln Park, New Jersey, USA) and bottles (0.8 L, 
NUNC, Roskilde, Denmark) were used. All chemicals were of analytical grade (Merck, 
Darmstadt, Germany). Percoli was supplied by Pharmacia (Uppsala, Sweden). Hepes was 
obtained from Sigma (St Louis, MO, USA), human albumin from Behring (Marburg, 
Germany), Hanks' balanced salts without Ca and Mg from Flow Laboratories 
(Rickmansworth, Herts, UK) and the radio tracer Zn from Amersham International 
(Amersham, Buckinghamshire, UK), code ZAS 2, 3.7-37 GBq/mg ZnCl 2 in 0.1 mol/L 
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HCl. The concentrations of zinc in the solutions and in ion- free water, after having been in 
contact with tubes and bottles, were below the lower limit of detection of the atomic absorp-
tion spectrophotometer, except for a low zinc concentration in diluted Percoli (2.56 /¿mol/L). 
Zinc was determined by atomic absorption spectrophotometry (Perkin Elmer 5000; 
Norwalk, Connecticut, USA). The lower limit of detection was 0.28 /<mol/L and the 
response was linear to at least 15 //mol/L. Standard reference containing ZnCl2 (Titrisol, 
Merck, Darmstadt, Germany) was used in the concentrations expected in the samples. 
Cells were counted by a Coulter counter Model ZM (Luton, Bedforshire, UK), adjusted 
to the size of the cells to prevent counting of cell fragments. ' Zn in the tubes was meas-
ured with a Nal crystal using an automatic sample changer (LKB, Wallac 1282 
Compugamma; Turku, Finland). The counting time was adjusted to assure a statistical 
error of <0.3%. A tube with medium but without blood cells, incubated and washed accor-
ding to the procedure of the cell containing tubes, served as a blank. 
Solutions 
Glucose Phosphate Buffer (GPB): 13.5 mmol/L Na,HP0 4 , 3.3 mmol/L KII2PO„ 5.4 
mmol/L KCl, 133 mmol/L NaCl, and 5 mmol/L glucose in ion-free water, pH adjusted to 
7.4 with H C O , . 
Erythrocyte Lysing Buffer: 155 mmol/L NH4C1 and 10 mmol/L KHCO, in ion-free 
water, pH adjusted to 7.4 with H C O , . 
Incubation Medium: 145 mmol/L NaCl, 6 mmol/L KCl, 2 mmol/L MgCL, 2.4 mmol/L 
CaCl2, 7.6/imol/L ZnCl2, 5.6 mmol/L glucose, 10 mmol/L Hepes and 40 g/L albumin in 
ion-free water tracered with about 10 MBq ' Zn/L and adjusted to pH 7.4 with C 0 2 . In 
experiment 4 no Zn was added. 
Methods 
Discontinuous Gradient of Percoli 
Three solutions of Percoli with different density (1.060, 1.075 and 1.095 kg/L 
respectively) (11) were prepared by dilution with Hanks' balanced salts solution without 
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Ca and Mg. Six mL of a heavier solution were layered in a 50 mL tube underneath the 
lighter solution by using a stainless steel needle of 15 cm and a plastic syringe. 
IsoUtion procedure of the blood ceUs 
Cell separation was performed using a discontinuous Percoli gradient. All cell sus­
pensions were kept at 4 'C to prevent clumping and zinc exchange by the cells. The method 
described by Milne (11) was modified because rat blood cells clot easily. Blood was drawn 
from anaesthetized rats by heart puncture using stainless steel needles and plastic syringes 
with 10 fL· of preservative-free heparin (50 IU). Blood was diluted with 2 volumes GPB. 
The Percoli solutions of different densities were layered underneath the diluted blood. 
Subsequently, the tube was centrifuged for 20 min., at 500 χ g at 4"C in a swing-out rotor 
without brake (Heraeus Crist Minifuge GL, Osterode am Harz, Germany). This resulted 
in separate layers of platelets, mononuclear cells (MNC), polymorphonuclear cells 
(PMNC), and erythrocytes. The MNC, PMNC and erythrocytes were harvested by using 
a pipet and resuspended in 5 mL GPB in a 15 mL tube. Erythrocyte contamination of the 
M N C and PMNC fractions was removed by twice resuspending the cells for 10 min at 
4"C in 5 mL of erythrocyte lysing buffer and subsequent washing steps with 5 mL of GPB. 
After the lysing and washing steps the tube was centrifuged for 10 min, 200 χ g, 4"C with 
brake. Cells were resuspended in 1 mL of GPB for cell counting. The erythrocytes were 
washed twice and centrifuged for 10 min., 200 χ g, 4"C with brake. At random Cytospin 
preparations (Shandon; Astmoor, UK) were performed to check the purity of the cell sus­
pensions. The cell suspensions contained less than 10% contamination of other cells. 
Incubation procedure of the blood celh 
The incubation was performed in physiologic conditions (e.g., albumin containing 
medium, incubation at 37"C, number of cells identical to the number in blood). Volumes 
corresponding to 3.75 χ 10' M N C and 1.25 χ 10 PMNC (the mean concentration of 
blood cells in 1 mL of blood in rat), or in the case of human cells, to 1.25 x 10 M N C and 
3.75 χ 10 PMNC (the mean concentration of blood cells in 1 mL of human blood) were 
taken and centrifuged. Supernatant was discarded and 1 mL of incubation medium added. 
In the case of erythrocytes 0.4 mL of the concentrated suspension was added to 0.6 mL of 
the incubation medium. Incubation was carried out in a shaking bath for 1 h at 37°C and 
was stopped by adding 5 mL of cold GPB. The cells were centrifuged and resuspended four 
times using cold GPB. The last time the cells were resuspended in 1 mL of GPB. The volu­
me was determined and number of cells and radioactivity were counted. 
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Calcidations and Statistics 
Calculation of the uptake of zinc by the use of ' Zn containing incubation medium: 
Since the zinc concentration (Znm : 7.6 /¿M) and the radioactivity (R,,,) of the incubation 
medium per mL are known and the number of cells (Nc) and the radioactivity (RJ of a 
cell sample are measured, the zinc uptake of the cells (Znc) can be calculated using the 
expression: 
D JQ6 
χ Z n
m
 χ = Z n
c
 in nmol Z n per 10 or 10 cells 
R
m
 N
c 
Mathematic formula fitting the curves of experiments 1 and 2: 
T h e curves expressing the results of experiments 1 and 2 showed three phases. T h e various 
parts of the curves were approximated by the expression: 
=а(1-е- а ' х )
 + Ь(1-е Ь ' ( х "")+сХ 
The slope of the curves is expressed by a' and b'. The intercept of the extrapolation of the 
curve between t = 5.5h and t = 24h to time 0 (the y-axis) has than the value a + b. In this 
formula it is assumed that X-d can only be equal or more than 0. 'd' is the lag-time of the 
second part of the curve. The rate of zinc uptake was calculated by the use of two points 
in the calculated period. 
Calculation of the efflux of zinc (experiment 4): 
Using the Zn content of the last cell suspension and the preserved solutions the Zn 
radioactivity of the intermediate cell suspensions, between the beginning and at the end of 
the separation and incubation procedure, was calculated. Because the activity of the last 
cell suspension was known, the activity of the preceding cell suspension can be calculated 
and subsequently the activity per 10 or 10 cells in these suspensions. 
A,., = \ + A^h and 
A, = R , x C 2 
A™!, = АкІЬ + Alym + Arfflu« 
in which 
Aj = total activity in cells of final suspension 
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Rj = activity per 10 or 10 cells in the final cell suspension 
С
г
 = total n u m b e r of cells in the final cell suspension divided by 10 or 10 
Aj_, = total activity in cells of the one-but final suspension 
Α,^ι, = total activity in cells in the wash of the one but final suspension 
A.-jis = total activity in cells loosed in the wash; the activity per cell is identical to Rz 
Atysjj = activity originating from damaged cells. T h e n u m b e r of cells involved is cal­
culated as the difference between the n u m b e r of cells in the final suspension 
and in the one but final suspension + the last wash. Knowing the Z n acti­
vity in these cells, the a m o u n t due to lysis can be calculated. 
\*Яш = activity released from the cells while washing the cells of the one but last 
suspension. 
The efflux can be calculated from the decrease of ' Zn content of the blood cells during 
the consecutive steps and by the A . ^ of the successive steps. For this calculation it is assu­
med that on day 4 of the experiment the specific activity of the Zn was constant throug­
hout the cells. 
Statistics 
The mean and the standard deviation were calculated if the same data of several sub­
jects were collected at the same moment (experiment 2). 
RESULTS 
In the first experiment the influence of incubation time on the uptake of zinc by 
blood cells, drawn from rats, was studied (Figure 1). During the first 5.5 hours a fast upta­
ke of zinc was seen (MNC 0.07 pmol Zn/106 cells.min, PMNC 0.077 pmol Zn/106 
cells.min, erythrocytes 0.003 pmol Zn/10 cells.min). In 5 out of 6 curves (experiments 1 
and 2) a shoulder can be observed from the period of 30 - 60 min.; so probably there are 
two rapid phases in the uptake of zinc by blood cells (0 - 30 min. and 60 - 330 min.). In 
the third period, 5.5 - 24 h, only a very small increase of zinc uptake was seen (MNC 
0.0025 pmol Zn/106 cells.min, PMNC 0.0032 pmol Zn/106 cells.min, erythrocytes 
0.00017 pmol Zn/106 cells.min). 
The point of intersection of the extrapolation of the curve of the third part of the 
curve with the Y-axis in the figures probably represents the amount of the maximum upta-
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Figure 1 - The influence of incubation time (X-axis) on the uptake of zinc by blood ceUs (Y-
axis), drawn from rats (experiment 1). The upper figure represents the uptake by MNC; the 
figure in the middle the uptake by PMNC and the bottom figure the uptake by erythrocytes. 
166 
ke of the cells and, in consequence, represents the exchangeable pool of zinc. The values in 
tables 2 and 3 represent the size of the exchangeable pool of the various cells and the total 
intracellular zinc content in rats and humans, respectively. 
Table 2 
Zinc uptake by blood cells of rats 
Type of cells 
MNC 
PMNC 
Erythrocytes 
estimation of the 
maximum zinc uptake 
by the cell membrane 
pmol Zn/106 cells 
4.9 (8%) 
7.1 (14%) 
0.17(1.5%) 
size of the 
exchangeable pool* 
pmolZn/106 
22 (36%) 
24 (53%) 
0.92 (10%) 
cells 
total cellular 
zinc content (13) 
pmol Zn/106 cells 
60 
51 
11 
* after 24 hours, including the membrane 
The figures of experiments 1 and 2 show a tendency toward a shoulder after 30 min. 
In experiment 2, standard deviations were calculated. In MNC of humans, this shoulder 
was significant if the curves of the shoulder were extrapolated for the period 60-330 min, 
and the standard deviations were taken in account. The differences in zinc uptake in the 
first 5.5 hours were not significant for PMNCs and erythrocytes, if the standard deviation 
was taken into account (Figure 2) although the similarity of the curves is striking (table 3). 
The point of intersection of the extrapolation of the shoulder of the curve with the Y-axis 
probably gives an indication of the maximum uptake of zinc by the cell surface. In rats the 
point of intersection was in MNC approximately 4.9 pmol Zn/10' cells, PMNC 7.1 
pmol/10' cells, and erythrocytes 0.17 pmol/10' cells. 
In experiment 2 the influence of incubation time on the uptake of zinc by blood cells 
from healthy volunteers was studied (Figure 2). In erythrocytes and MNC, the uptake of 
zinc resembles the same process as in the various cells taken from rats. During the first 5.5 
h, a fast uptake was observed especially in MNC and erythrocytes (0.075 pmol/10 
cells.min and 0.0019 pmol/10 cells.min respectively). After the first 5.5 hours the uptake 
of zinc decreased (0.027 pmol/10' cells.min and 0.00018 pmol/10' cells.min respective-
ly). The point of intersection of the extrapolation of third phases with the Y-axis was 19 
pmol/10 cells and 0.66 pmol/10' cells in MNC and erythrocytes respectively (table 3). In 
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Table 3 
Zinc uptake by blood cells of healthy volunteers 
Type of cells 
MNC 
PMNC 
Erythrocytes 
estimation of the 
maximum zinc uptake 
by the cell membrane 
pmolZn/10e cells 
3.26 (3.9%) 
-
0.022(0.13%) 
size of the 
exchangeable pool* 
pmol Zn/10e cells 
19(17%) 
-
0.61 (3.5%) 
total cellular 
zinc content (13) 
pmol Zn/106 cells 
113 
78 
17 
' after 24 hours, including the membrane 
PMNC the difference in zinc uptake between the first 5.5 h and the third part was small: 
0.024 pmol/10 cells.min and 0.02 pmol/10' cells.min indicating that the point of inter-
section of the second part can not to be calculated reliably. 
In human cells, especially in MNC and erythrocytes, a tendency towards a shoulder 
after 12 and 30 min respectively, can be observed. The point of intersection of the extra-
polation of the shoulder of the curve with the Y-axis was 3.3 pmol/10 cells and 0.022 
pmol/10 cells in MNC and erythrocytes respectively (table 3). 
The average percentage of the standard deviation (standard deviation compared to the 
value of the zinc uptake at that moment) was 26.1%, 24.2%, and 22.1% in MNC, PMNC 
and erythrocytes, respectively. This standard deviation is a combination of the inter-indi-
vidual and the intra-individual standard deviation) 
In experiment 3 the influence of the temperature during the incubation period on the 
influx of zinc was studied (Figure 3). With the rise of the incubation temperature more 
zinc is taken up by the blood cells. The uptake of zinc at 4°C is low (MNC 3.5 pmol 
Zn/106 cells, PMNC 0.2 pmol Zn/106 cells, erythrocytes 0.001 pmol Zn/106 cells 35%, 
11% and 12.5% of the uptake at 37°C respectively). A further increase of zinc uptake is 
seen if incubation temperature is increased from 37°C to 4l°C. These experiments have 
been performed with human blood cells. 
In experiment 4 the efflux of zinc from blood cells was determined (Figure 4). After 
an adaptation period of 2 weeks Zn was administered ip on two subsequent days. At the 
fourth day the Zn in MNC, PMNC, and erythrocytes had reached equilibration with the 
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Figure 2 - The influence of incubation time (X-axis) on the uptake of zinc by blood ceUs (Y-
axis), drawn from healthy volunteers (experiment 2). The upper figure represents the uptake by 
MNC; the figure in the middle the uptake by PMNC and the bottom figure the uptake by 
erythrocytes. The error bars indicate the standard deviation 
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intracellular zinc pools of the blood cells (unpublished data, own observation). This obser­
vation was supported by the results of the first experiment, which indicate that zinc in the 
blood cells in vitro reaches equilibration with their environment after 5.5 - 24 h (Figure 1) 
although in vitro the milieu for the cells is constant and in vivo the environment of the 
cells is in constant interaction with the tissues. Blood was drawn on day 4. 
The efflux can be calculated by the loss of activity in the cells of the cell suspensions 
( Ax see Design of the experiments). A considerable decrease of activity is observed after 
the first lysation procedure, especially in the PMNC cell suspension, compared to the loss 
of Zn during the rest of the whole procedure. This is because of loss of polluting cells like 
erythrocytes in the P M N C cell suspension and platelets in the M N C cell suspension, cells 
that are not counted in the Coulter counter but contain considerable amounts of ' Zn. 
The total loss during the rest of the procedure was 39%, 24% and 28% (MNC, PMNC, 
and erythrocytes, respectively) of the total Zn radioactivity in the cells calculated, after 
the separation and first lysation step. Also during the second lysation and washing steps 
polluting cells, not counted in the Coulter counter, are loosed. During all incubation and 
washing steps after the Percoli isolation of the various blood cells, MNC", PMNC and 
erythrocytes, lost 17 %, 19 %, and 20 % of their " Z n respectively; 75%, 76 % and 82%, 
respectively, of this efflux of ' Zn was lost during incubation and the first washing step 
after the incubation period. 
The efflux of 'Zn from the blood cells can be calculated not only from the loss of radio­
activity of the blood cells in the cell suspensions after each step (A,), but also from the 
Л.яіих> t n e activity released from the cells while washing the cells and determined in the 
various lysation, incubation, and washing solutions (see Design of the experiments). A 
slightly lower efflux is the result: 12%, 10%, and 19%. Probably the A
rfflux is less reliable 
because the А^д^ is calculated as the difference between the total loss of activity and the 
loss of activity owing to loss of cells. 
Figure 4 represents the total number of blood cells of the successive steps and conse­
quently the loss of cells during the whole procedure. Only the cells counted by the Coulter 
counter are represented, not the polluting cells like platelets or polluting erythrocytes in 
the M N C and PMNC suspensions. 
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DISCUSSION 
Determination of zinc concentrations in blood cells has been used for the determi­
nation of the zinc status. Changes in concentrations in blood cells have been demonstra­
ted in case of zinc deficiency (12). Determination of zinc in blood cells is difficult, howe­
ver (13), because the zinc concentrations in M N C and P M N C suspensions are low. Using 
3 mL of blood and assuming a cell recovery of 50% (see also the results of experiment 4) 
the final zinc concentration of the cell suspension is about 0.3 /rniol/L when resuspended 
in 0.5 mL СРВ, which is near the lower limit of detection of an AAS determination. There 
is also a risk of zinc contamination of the suspension. 
Using a medium containing ' Zn wc demonstrated that the in vitro uptake of zinc by 
blood cells is increased in the case of zinc deficiency (7). In inflammatory stress, in which 
a decrease of serum zinc concentration also can be demonstrated, no increase of zinc upta­
ke by erythrocytes was observed. In M N C and PMNC, a minor increase of zinc uptake 
was demonstrated only during the first days of inflammatory stress (8). Probably this 
method can differentiate between a real and an apparent zinc deficiency caused by inflam­
matory stress. The method is a combination of a modified blood cell separation procedu­
re (11) and the in vitro uptake of Zn by erythrocytes (14). In the present study, we inves­
tigated the influence of incubation time and incubation temperature on the in vitro upta­
ke of zinc by blood cells. Also, the in vitro efflux of zinc from blood cells during the in 
vitro isolation and incubation steps in nearly physiologic conditions was studied. 
In experiments 1 and 2, we studied the influence of incubation time on the uptake 
of zinc by three types of blood cells. All three types of cells showed more or less the same 
response. During the first 5.5 h zinc was taken up fast. After five and a half hours the Zn 
concentration increased only slowly. 
Five out of six curves (experiments 1 and 2 ) show a similar pattern that - idealized -
can be represented as shown in Figure 5. This curve can de regarded as the summation of 
three curves, e.g., 
1) A rapid section (within the first half hour), 
2) A second rapid phase (ending at about t = 5.5 h); and 
3) A slow, quasilinear process, visible after t = 5.5 h. 
These three phases can be explained as follows: during the first phase a rapid uptake in (or 
exchange on) the cell membrane takes place, a process that ends, c.q. reaches equilibrium, 
within the first half hour. During the second phase, a part of the intracellular zinc exchan­
ges with the ' Zn of the medium. This is also a rapid process that, however, does not start 
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Figure 3 - Influence of incubation temperature in °C (X-axis) on the uptake of zinc by human 
blood celh (Y-axis) (experiment 3). The upper figure represents the uptake by MNC; the figure 
in the middle the uptake by PMNC and the bottom figure the uptake by erythrocytes. The incu­
bation time was 1 h. 
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at time 0 but at about t = 0.5 h (Figure 5). This lag-time could be explained by assuming 
that the slope of the second curve is proportional to the y-value of the first curve. We belie-
ve however, that the reason why the two processes can be separated is the result of a spe-
cial circumstance: the cells were not immediately at the proper temperature, i.e., at 37°C, 
because the temperature used at the isolation procedure was 4°C. The lag-time could the-
refore be caused by the time required to warm up the cells. The first phase, a physical pro-
cess, would hardly be affected by the temperature difference and therefore shows no lag-
time. The third phase is probably an uptake in or exchange with a Zn compartment 
(either structural or chemical) that is much slower than the effect of the second phase. It 
therefore shows as a quasi linear phase (c.X in the expression in 'Calculations and 
Statistics'). The phenomenon of a shoulder, probably the result of the way the isolation and 
incubation is performed, provides the opportunity to study the successive phases in zinc 
uptake by blood cells. 
The first phase is not more than a shoulder. When taking in consideration the standard 
deviation of the points up to 5.5 h (only possible in experiment 2), the shoulder is only 
significant in MNC and not in PMNC and erythrocytes. However, taking into account 
the striking similarity between the curves, we believe this feature is real, especially since a 
plausible explanation can be given. Also Jones et al. (15) studied the uptake of zinc by 
blood cells during 45 minutes and found a rapid uptake during the first 15 min, a slower 
uptake between 1 5 - 3 0 minutes and a gradual increase in uptake after 30 min. These 
details were not discussed in their article. Because we cannot give exact numerical value for 
the shape of the curve (values a and d in the equation); we have to settle for the rough esti-
mates given in tables 2 and 3. 
The combination of the inter-individual and the intra-individual standard deviation 
was about 25% for all cells. It is noteworthy that the standard deviation increases with a 
longer incubation period and larger uptake of zinc by the cells, indicating that the increa-
se in standard deviation is mainly owing to the biological variation between the cells of the 
various persons (interindividual standard deviation), and, to a minor extent, owing to 
variations as a result of the method (intraindividual standard deviation). This was confir-
med by other experiments. In other experiments with human cells (to be published sepa-
rately) the intraindividual standard deviation in MNC, PMNC, and erythrocytes was 
11%, 15%, and 5%, respectively. 
The point of intersection of the extrapolation of the curve at the shoulder (t = 30 -
60 min) with the Y-axis probably gives an indication of the maximum uptake of zinc by 
the cell surface, although no complete equilibration has been reached. In experiment 1 the 
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Figure 4 - Quantity of the cellubr Zn concentration and the total number of blood celL· 
during washing and incubation procedures and consequently the loss of cells during the succes-
sive steps (experiment 4). MNC (upper figure), PMNC (figure in the middle) and erythrocytes 
(bottom figure). Along the X-axis the successive cell suspensions are indicated(GFB¡, LYS1, 
LYS2, INC+GFßl and so on, represents the successive steps during the isoUtion and incuba-
tion procedures; LYS represents the lysation and the consecutive washing step). The Y-axis shows 
the number of cells (left) and the counts/10 ' ceüs.min (right). 
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quantity of zinc that was taken up by the surface of the cells was in MNC, PMNC, and 
erythrocytes 8%, 14%, and 1.5%, respectively, of the total quantity of zinc in the cells. 
The point of intersection of the extrapolation of the curve after 330 min (the end part 
of the curve) with the Y-axis in the figures probably represents the maximum zinc uptake 
by the rapidly exchangeable zinc intracellular pools, both the membrane and the cytoplasm 
(a and b, respectively, in the section Calculations and Statistics). The values in table 2 
represent the size of the pool that is probably labeled by exchange with intracellular zinc 
not tightly bound to proteins, peptides, and amino acids. By comparison of the rapidly 
exchangeable pool as indicated in table 2 with the total cellular zinc content of the various 
blood cells (table 2 (13)), the size of the readily exchangeable pool is estimated to be 40%, 
53% and 10%, respectively, for MNC, PMNC, and erythrocytes, of the total cellular zinc 
content. There is probably a gradual difference between rapidly exchangeable and slowly 
exchangeable bound zinc (second category of zinc binders that do exchange with Zn in 
the medium at a slow rate or do not exchange at all), which probably explains the small 
slope after t = 5.5 h. In cells, zinc is tightly bound to metallothioneine, among others. 
The amount of the exchangeable pool can be calculated by comparison of the exchan-
geable pool with the cold zinc concentrations of the various blood cells mentioned in the 
literature. The PMNC showed the fastest uptake and the greatest exchangeable pool of 
zinc. The uptake of zinc by leucocytes after the first hour was about 34 times the uptake 
by erythrocytes, and during the third section the velocity of the uptake was about 24 times 
the uptake by erythrocytes. 
The process of zinc uptake of blood cells was studied in experiment 2, in human cells. 
Because more blood could be taken, we were also able to study the variations in results 
between individual persons. The results in human cells confirmed the results in cells taken 
from rats, although the size of the exchangeable pool and the maximum zinc uptake by the 
cell membrane was smaller compared to the cells taken from rats. The size of the exchan-
geable pool of intracellular zinc in erythrocytes found in our study shows a remarkable 
resemblance to the results found by Simons (16), total intracellular zinc 135.7 /<mol/10 
cells and an exchangeable component of 6.7 ^mol/10 cells (4.9%). The standard devia-
tion at the first hour of the experiment was very small compared to the quantity of zinc 
uptake after 24 h, indicating that the method has a. small intraindividual standard devia-
tion and that the standard deviation after 24 h was a result of the interindividual variation. 
The percentage of the standard deviation at a particular moment compared to the value at 
that particular moment was constant. 
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Figure 5 - Theoretical model to explain the phases in the uptake of zinc by bbodcetts. The dot-
ted line represents a fast uptake by the cell membrane, the interrupted line represents the upta-
ke by the intracellular pool and the uninterrupted line represents the sum of both lines and 
approximates the curves drawn in figure 1 and 2 
The in vitro uptake of zinc by various blood cells has been studied before in whole 
blood (17, 18), in erythrocytes (14,19,20) and in leucocytes (6,15,17,21,22). To our 
knowledge no study has been performed in which the uptake of zinc by the various blood 
cells in one experiment has been studied in a nearly physiologic standard medium. 
Moreover the results of these studies are not unanimous, because of variations in study 
design and incubation media. The in vitro uptake of ' Zn by whole blood has been exa-
mined by e.g. Berry et al (18) and Chester and Will (17), however, no physiologic stan-
dard incubation medium was used. Freshly drawn heparinized whole blood was incubated 
with Zn. The in vitro uptake of Zn by erythrocytes is inversely related to the albumin 
concentration in the medium (14), and consequently the uptake of ' Zn by these cells is 
influenced by the albumin concentration of the serum when incubation is performed in 
whole blood. Also, the higher specific activity of Zn owing to a decrease of serum zinc 
can in part account for the increase of Zn uptake. 
The uptake of zinc by erythrocytes was described by Sasser et al (19), both in plasma 
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and in saline during a period of 10 h. The rate of uptake was 0.6% of the total intracellu-
lar zinc concentration per hour for erythrocytes in plasma. This is in the same range as in 
our study. Also van Wouwe et al (14) described the zinc uptake by erythrocytes. The upta-
ke of zinc decreased after 10 h; a maximum uptake was reached after 24 to 30 h. In the 
study by Dennis et al (22) the in vitro and in vivo uptake of zinc by leucocytes was exa-
mined. The uptake in vivo and in vitro were parallel but in vitro the uptake was 1/10 of 
the in vivo effect. However, in this study it was not clear if the albumin concentration and 
specific activity of Zn in vivo and in vitro were identical. Contrary to our results, Chvapil 
et al (6) found that zinc uptake reached equilibration after 8 min but in his study the incu-
bation was performed in a synthetic medium with an unphysiologic high Zn concentra-
tion (82/<mol/L Z n C y . 
In experiment 3, the influence of the incubation temperature on the uptake of zinc 
was studied. With higher temperatures the velocity of the uptake of zinc was higher. At 
4°C only a small uptake was observed possibly because of a nonspecific binding of zinc on 
the cell membrane (see experiments 1 and 2). Higher uptake was seen in these human 
blood cells with temperatures increasing above 37°C. This suggests an active process for the 
uptake of zinc by blood cells (Figure 3), like that suggested by Torrubia (20). Probably 
fever is increasing the uptake of zinc, supporting the function of these blood cells. A con-
siderable uptake of zinc at 20"C by leucocytes compared to erythrocytes was observed, sug-
gesting that zinc uptake by leucocytes is less influenced by a decrease of temperature. If the 
uptake after 1 h, at 4"C in experiment 3 is compared with the results of experiment 2, espe-
cially the point of intersection of the extrapolation of the curve at the shoulder (t = 30 -
60 min) with the Y-axis (which probably gives an indication of the maximum uptake of 
zinc by the cell surface) we observe a great similarity, although the numerical figures of 
experiment 3 are only a rough estimation. In MNC the uptake in experiment 2 is 3.26 
pmol/10' cells and in experiment 3 (after 1 h of incubation) 3.47 pmol/10' cells. In eryth-
rocytes the uptake was 22.3 pmol/10 cells in experiment 2 (with a maximum uptake after 
24 h of 937 pmol/10 cells!) and 9.5 pmol/10 cells in experiment 3. These results strengt-
hen the hypothesis concerning the process of the uptake of zinc by blood cells explained 
in the discussion of experiment 1. 
The efflux of zinc during the procedure was studied in experiment 4. During the first 
separation and lysation procedure considerable activity was lost which was mostly owing 
to the loss of polluting cells, because the decrease of the intracellular zinc concentration 
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during the washing steps after incubation was small. Therefore, the washing steps have 
only a minor effect on the estimation of the size of the exchangeable pool. The separation 
and washing procedures were performed at 4°C. A larger but still small loss of activity was 
observed during incubation (Figure 2). This procedure was performed at 37°C. If one assu-
mes that the ' Zn activity in cell suspensions represents the cellular zinc concentration of 
MNC, PMNC and erythrocytes (see Materials and Methods), the loss of Zn represented 
the efflux of zinc in 1 h. In 1 h of incubation, MNC, PMNC, and erythrocytes lost 17%, 
19%, and 20%, respectively, of the intracellular zinc concentration. These results can be 
compared with the magnitude of the uptake of zinc during the first hour demonstrated in 
experiment 1 (23%, 23% and 16.4%, respectively), so in- and efflux are at the same mag-
nitude. The uptake of zinc by blood cells is part of an exchange process, rather than just 
zinc uptake. At low temperatures the efflux of zinc was very small during the washing pro-
cedures. 
The efflux of zinc by (red) blood cells was investigated in several studies (6, 15, 22 - 24), 
partly with in vitro incubated blood cells. The incubation time varied between 7 min (6) 
and 2 h (24). In one study, an in vivo labeling was performed (22); the time between the 
Zn injection and blood collection was 1 h. The interpretation of the results of these zinc 
efflux studies are difficult because owing to the short incubation period, probably most of 
the ' Zn was only bound to the cell membrane. It is not surprising that a rapid wash out 
of zinc was found (50%) in 1 h (22). 
The efflux during procedures at 4"C was small (washing procedures). So, the amount 
of efflux of zinc by blood cells is not only influenced by the time of incubation of the cells 
and the composition of the medium (15) but also by the temperature of the medium. 
The questions that have been raised concerning the uptake of zinc by blood cells can 
be answered by the studies described in this paper: the uptake of zinc is part of an exchan-
ge process of which the magnitude has been described; the process of the uptake of zinc 
can be divided in three phases and is influenced by the temperature. The magnitude of the 
interindividual and intra-individual standard deviation of the method has been described. 
Together with the physiologic importance of this study the results of this study, should be 
considered in case the in vitro uptake by blood cells is used as a method to determine the 
zinc status. 
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ABSTRACT 
A decrease of serum zinc can be caused by a real zinc deficiency but can also be caused by 
an apparent zinc deficiency, like in inflammatory stress. The aim of this study was to eva-
luate the diagnostic power of serum alkaline phosphatase activity in the discrimination 
between pathophysiologic states of'real' and 'apparent' zinc deficiency. A decrease of serum 
zinc was induced in growing and adult rats, by providing a diet low in zinc and by causing 
inflammatory stress. Alkaline phosphatase activity was determined using reagents low and 
enriched in zinc. Serum alkaline phosphatase was decreased in zinc-deficient adult rats 
(p<0.01). In zinc-deficient growing rats alkaline phosphatase activity was not different 
from normal rats but alkaline phosphatase activity decreased rapidly. In the same growing 
rats a significant difference was found in alkaline phosphatase activity determined using a 
buffer low and enriched in zinc (p<0.001). After inducing inflammatory stress a decrease 
of alkaline phosphatase activity (p<0.01) and serum zinc (p<0.001 between both groups of 
rats) was seen during the first few days. After the initial phase of inflammation alkaline 
phosphatase activity normalized, serum zinc showed a rise which and after correction for 
the decrease of serum albumin reached the level of the control rats. A difference in alka-
line phosphatase activity using a buffer low and enriched in zinc was observed, only during 
the first days after induction of inflammatory stress (p<0.001). Probably the method of 
measurement of the difference in enzyme activity, using buffers low and rich in zinc, can 
be used as an indication for zinc deficiency in situations with changing alkaline phospha-
tase enzyme concentrations. Alkaline phosphatase activity is decreased during the initial 
phase of inflammatory stress resulting from a decrease of serum zinc. 
INTRODUCTION 
Zinc deficiency is a serious disorder expressed by a variety of symptoms like delayed 
wound healing, dysfunction of the immune system, anorexia, decreased protein synthesis, 
night blindness, skin diseases, hair loss, and growth retardation (1). 
Usually the serum zinc concentration is used to determine the zinc status (2), but the 
serum zinc concentration is not only decreased in case of real zinc deficiency, but also in 
case of stress (3). During stress serum zinc is redistributed from the serum into the liver. 
In addition, the serum albumin concentration will decrease and since serum zinc is bound 
to albumin for about 75% (4), a decrease of serum albumin will result in a decrease of 
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serum zinc. Because the decrease of serum zinc during stressful events does not result in 
symptoms, characteristic of real zinc deficiency, this situation is called apparent zinc defi-
ciency. In conclusion serum zinc is not the perfect parameter for the zinc status. Several 
other methods are used to determine the zinc status, e.g. determination of zinc concentra-
tions in urine (5), in hair (6), and in blood cells (7). All of these methods have disadvan-
tages. 
Zinc is a component of more than 200 enzymes (8). In case of zinc deficiency, zinc 
containing metallo-enzymes often do not function optimally. Alkaline phosphatase (AP) is 
one of these zinc dependent metallo-enzymes. Serum AP activity may be used to determi-
ne the zinc status (9), but AP activity is also influenced by other factors, for instance 
growth. The aim of this study was to investigate the influence of a physiologically induced 
decrease of the serum zinc concentration, like in case of dietary induced zinc deficiency 
and inflammatory stress, on serum AP activity in growing and adult rats. The concentra-
tion of zinc in the reagents is of influence on the determination of AP activity (10-12). In 
general for complete expression of serum AP activity a reagent with a high concentration 
of zinc is used. We made the hypothesis that in case of real zinc deficiency the difference 
in AP activity using buffers low and rich in zinc is greater than in normal situations. 
MATERIAL AND METHODS 
Animak 
In all experiments male Wistar rats were used. The rats were housed separately in 
stainless steel metabolic cages. Before the adaptation period the rats were fed commercial 
chow. The diet on which the rats were raised contained variable amounts of zinc (< 2, 12 
or 92 mg/kg (IRI-OB, (13)). In experiments 1, 2, and 3, a diet containing 12 mg/kg zinc 
was given from 2 weeks before the start of the experiments, to adapt the animals to the diet 
and the metabolic cages. The zinc concentration of 12 mg/kg is considered sufficient to 
maintain a normal zinc status (14). All blood samples were taken under ether anaesthesia 
by heart puncture. The guidelines for the care and use of laboratory animals in the 
Netherlands were followed. 
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Design of the experiments 
Five experiments were performed to study the influence of physiologically induced 
variations in zinc concentration on the AP activity. In the first 2 experiments zinc defi-
ciency was induced in adult and, respectively, growing rats. The AP activity was studied. 
In the first experiment also the Zn retention was determined as a gold standard for the 
zinc status. In the third experiment adult rats were made zinc deficient and the AP activi-
ty was determined in buffers low and enriched in zinc. Because in the first experiment the 
effect of zinc supplementation in zinc deficiency was investigated, the fourth experiment 
was designed to study the influence of zinc supplementation in rats on a diet with a nor-
mal or a high zinc content. In the fifth experiment inflammatory stress was induced. 
Experiment 1 
Zinc deficiency in adult rats, AP activity and the effects of zinc supplementation. 
After adaptation (see above) 16 male rats (300 g) were injected intrapcritoneally with 
74 kBq (2 /<Ci) of Zn (day 0). Eight rats received a diet with an adequate amount of zinc 
(IRI-OB; 12 mg/kg Zn), 8 others were fed a zinc-deficient diet (<2 mg/kg Zn). After 1 
month all rats received a diet with an adequate amount of zinc (12 mg/kg). The control 
group received pair feeding throughout the experiment. Three mL blood were taken under 
ether anaesthesia by heart puncture on days 0, 7, 14, 21, 28 and 36. The serum was ana-
lyzed for zinc and magnesium concentration, albumin and for AP activity, in a buffer enri-
ched in zinc. The total body retention of i.p. administered ' Zn served as reference for the 
degree of zinc deficiency. Total body counting was performed after 4 hours and on days 0, 
1, 2, 5, 9, 14, 21, 28 and 35. The total body retention at day one was taken as 100%. 
Experiment 2 
Zinc deficiency in growing rats, AP activity using buffers low and rich in zinc. 
This experiment was identical to experiment 1, but it was performed in young rats 
with a body weight of about 100 grams at the start of the adaptation period. Blood samp-
les were taken at days 0, 17, 24, 37, 51, 65 for serum zinc and albumin assay, and for AP 
activity determination with reagents low or enriched in zinc. 
Experiment 3 
Zinc deficiency in adult rats, AP activity using buffers low and enriched in zinc. 
The difference was that serum AP activity was determined with reagents low or rich 
in zinc content. Blood was withdrawn on days 0, 3, 7, 14, 21, and 28. 
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•Experiment 4: 
Zinc supplementation in normal rats, AP activity. 
After an adaptation period of 2 weeks, 32 Wistar rats (250 g) were divided into 2 
groups. Sixteen rats received a diet with an adequate amount of zinc (IRI-OB; 12 mg/kg 
Zn). Sixteen others received a diet rich in zinc (92 mg/kg Zn). After the first day eight rats 
in both groups received a supplementation of 10 mg/kg of zinc (as zinc acetate) in the diet. 
Three mL blood were taken under anaesthesia by heart puncture on days 0, 7, and 14. The 
serum was analyzed for zinc, magnesium and albumin concentration and for AP activity 
determined with reagents low or enriched in zinc. 
Experiment 5: 
Inflammatory stress, AP activity using buffers low and enriched in zinc. 
After an adaptation period of 7 days in which 64 rats, with a mean body weight of 
200 g, were housed separately in stainless steel metabolic cages and raised on a standard 
IRI-OB diet, rats were divided into two groups of 32 animals of equal mean body weight. 
To induce stress in one of these groups turpentine was injected intramuscularly in a dose 
of 0.25 mL into both hind legs to induce a long-standing inflammation. Before turpenti-
ne was injected, blood was collected from 4 rats in the inflammation group and 4 rats in 
the control group. Four hours, 1 day, 2, 3, 4, 7 and 14 days after the turpentine injection 
2 mL of blood was taken under ether anaesthesia by heart puncture from 4 rats in the inf-
lammation group and from 4 rats in the control group, for determination of serum zinc, 
magnesium and albumin concentrations and determination of AP activity with reagents 
low or enriched in zinc. The control group was pair fed throughout the experiment. The 
total body retention of i.p. injected Zn served as a control to determine if zinc deficien-
cy occurred. All the rats were injected i.p. with 74 kBq (2 /<Ci) Zn seven days before the 
turpentine injection. The total body activity at the time of the turpentine injection was 
taken as 100%. Total body counting was performed after 4 hours and on days 1, 2, 3, 4, 
7, and 14. 
MateriaL· 
The diet (IRI-OB) was produced by Hope Farms (Woerden, the Netherlands) using 
components low in zinc (<2 mg/kg Zn, (13)). In the zinc-sufficient diet zinc was added as 
sulphate to a final zinc concentration of 12 mg/kg. Sufficient quantities of other trace ele-
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merits were also added. The Cu concentration in both versions of the diet was 9 mg/kg. 
Stainless steel needles and plastic syringes (Monoject, Sherwood, USA) were used. All 
solutions were prepared with deionized distilled water (resistance > 15 ΜΩ), processed 
through a Millipore system (Bedford, Massachusetts, USA). 
Only polypropylene pipet tips, plastic tubes (15 mL polystyrene, Greiner, Solingen, 
Germany and 50 mL polypropylene, Falcon, Becton Dickinson and Company, Lincoln 
Park, New Jersey, USA) and bottles (0.8 L, N U N C , Roskilde, Denmark) were used. All 
these material were free of zinc contamination. All chemicals were of analytical grade 
(Merck, Darmstadt, Germany). 
Determination of zinc 
All the determinations of zinc and AP activity were performed in a blinded fashion. 
Zinc was determined by flame atomic absorption spectrophotometry (AAS)(Pcrkin Elmer 
5000; Norwalk, Connecticut, USA). The lower limit of detection was 0.28 ^mol/L and 
the response was linear till at least 15 ^mol/L. Standard reference containing ZnCl 2 
(Tritisol, Merck, Darmstadt, Germany) was used in the concentrations expected to be 
found in the samples. No detectable zinc could be found in solutions and in deionized 
water used for the analytical experiments. 
Determination of alkaline phosphatase activity 
AP activity was determined at 30°C according to recommendations of the IFCC (15), 
except for the modification of the zinc concentration. A Multistat III centrifuged analyzer 
(Instrumentation Laboratory, IJsselstein, the Netherlands) was used. 4-nitrophcnylphosp-
hate and 2-amino-2-methyl-l-propanol (AMP) were provided by Instruchemie 
(Hilversum, the Netherlands). The AMP contained a relatively low concentration of zinc 
(1.6 ,wmol/L) and is used in clinical practice. Appropriate zinc suppletion for the zinc rich 
modification of the AP activity determination resulted in a zinc concentration of 1.0 
mmol/L in the test assay mixture. 
AMP-buffers contain a chelator (16), which inhibits the activity of AP by removing 
zinc. By addition of zinc, this inactivation can be inhibited. In case high concentrations of 
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the chelator are present in the buffer, more zinc should be added to compensate for the 
zinc inactivating properties of the chelator. So the increase of activity of AP by zinc is in 
part due to the inhibition of the chelator and in part because zinc is a structural compo­
nent in the enzyme. In the buffer used in the present experiments only a slight pollution 
was found using the method described by Derks et al. (17), implying that the low zinc con­
centration of the AMP-buffer was valid. A buffer with a low zinc concentration was used, 
to be able to detect small variations in serum zinc concentration by variations in the acti­
vity of the enzyme. In case high concentrations of zinc were present in the buffer small 
variations in the zinc concentration of the serum would not result in a variation in enzy­
me activity. 
Final concentrations of the other components in the test mixture were: AMP 350 
mmol/L, 4-nitrophenylphosphate 16 mmol/L, Na 140 mmol/L, CI 160 mmol/L, 
Phosphate 0.4 mmol/L, pH 10.3, magnesium as magnesium acetate 2.0 mmol/L. 
Total body counting 
The radio tracer Zn was supplied by Amersham International (Amersham, 
Buckinghamshire, U.K., code ZAS 2 , 3.7-37 GBq per mg of Zn as chloride in 0.1 mol/L 
HCl). Total body radioactivity of the rats was counted with a shadow shield counter con­
sisting of two Tl-activated Nal crystals (4 χ 6") connected to a Nuclear Data multi-chan­
nel analyzer N.D. 60 A (Nuclear Data; Schaumburg, Illinois, USA). 
Calculations 
Biological half-life of the ' Zn total body retention 
The biological half-life (T ] / 2) of 'Zn was calculated from the total body retention in 
% measured as a function of time. 
From the slope (γ) of the linear part of the line, which is calculated by the least square 
method from the natural logarithm of the total body data, the biological half-life (T1/2) of 
the Zn was calculated using T 1 / 2 = In 2/γ. 
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Estimation of the corrected serum zinc concentration in serum during stress. 
In case of inflammation the serum zinc concentration can be corrected for the decre­
ase of serum albumin by increasing that part of the serum zinc concentration that is bound 
to albumin, to the same extent as the concentration of albumin in the inflammation group 
has to be increased to reach the level of the control group. That part of the total serum 
zinc, that is transported by albumin, should be increased by the factor: 
Alb control/ Alb inflammation. 
The corrected serum zinc concentration can be calculated by the equation: 
Alb control 
Corr Zn tot (inflam) = 0.25 χ Zn tot (control) + χ ((Zn tot (inflam) - (0.25 χ Zn tot (control))) 
Alb inflam 
Where 
Zn tot (control) = total serum zinc concentration of the control group; 
Corr Zn tot (inflam) = corrected serum zinc concentration of the inflammationgroup; 
Alb control = serum albumin of the control group; 
Alb inflam = serum albumin of the inflammation group; 
Zn tot (inflam) = total serum zinc concentration of the inflammation group. 
The factor 0.25 represents the fraction of the serum zinc concentration that is mainly 
bound to the stable fraction of alpha macroglobulin, in rat alpha-1-macroglobulin (18) 
and in human alpha-2-macroglobulin. The concentration of this protein is not signifi­
cantly changed by stress (18,19) and affinity of zinc to this protein is high (20), so that the 
number of zinc molecules transported by alpha-1-macroglobulin in the inflammation 
group will be equal to that of the control group. Using this equation we postulate that the 
binding of zinc to the binding proteins (the number of zinc molecules transported by one 
protein molecule), in the normal situation and in case of an inflammation will be similar, 
and that zinc bound to alpha-1-macroglobulin is not affected by inflammation. In case a 
difference still remains between the corrected serum zinc concentration and the serum zinc 
concentration of the control group, this will be the result of other causes, e.g. redistribu­
tion of serum zinc into the liver. 
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Correction of alkaline phosphatase activity 
Although standard reference solutions were used for the determination of AP activi­
ty a difference was seen in AP activity in the serum of rats as determined with buffers low 
and high in zinc content. The results are provided without correction unless stated other­
wise. To calculate the difference between both methods the assumption was made that the 
AP activities should be identical on day 0. The AP activity determined using a buffer low 
in zinc was corrected by using the following equation for each serum sample: 
mean AP high Zn at day 0 
Corr AP = χ AP low Zn 
mean AP low Zn at day 0 
Statistics: 
Wilcoxon rank sum test was used to compare the results in both groups of rats during 
a period of the experiment. 
The Student t-test was performed on the data collected at time point; differences between 
two groups were considered significant if ρ < 0.05 (two tails). 
RESULTS 
Experiment 1: 
Normally in adult rats the total body retention of Zn is calculated as a percentage 
of injected dose immediately after administration. Because two rats lost a significantly lar­
ger quantity of "Zn (52% and 36%) compared to the other rats (5.55% sd 4.42%) during 
the first 24 hours, the total body retention at day one is taken as 100%. Probably this gre­
ater loss can be explained by a partial injection of the Zn into the gut. When plotting the 
natural logarithm of the total body data of experiment 1 versus time, a linear relation was 
found from day 7 on. Zinc-deficient rats retained more Zn compared to control rats (T 1 / ? 
= 176 days versus T 1 / 2 = 51 days; Figure la), confirming that these animals indeed had 
become Zn deficient. 
Serum zinc and AP activity decreased gradually in the zinc-deficient rats (zinc: 11.7 
versus 29.3 ^mol/L, p<0.001 on day 21, Figure lb and AP: 60 versus 77 U/L, p<0.01, 
Figure lc). On day 28 the serum zinc concentration was 40% ofthat of control rats. No 
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% Total body retention 
Figure 1 - zinc deficiency experiment in adult rats 
a: Total body retention of Zn in zinc-deficient adult rats (diet < 2 mglkg; closed dots) and 
control rats (12 mglkg; open dots). The total body retention of Zn one day after i.p. injection 
was taken as 100%. The error bars indicate standard deviations ( ***p-<0.001). 
b: Serum zinc in zinc-deficient adult rats (diet < 2 mglkg; closed dots) and control rats (12 
mglkg; open dots; **/>=< 0.01;*** p=<0.001). 
c: Serum alkaline phosphatase activity in zinc-deficient adult rats (diet < 2 mglkg; chsed dots) 
and control rats (12 mglkg; open dots, **p=< 0.01; ***p=<0.001). 
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Figure 2 - zinc deficiency experiment in growing rats. 
a: Serum zinc in zinc-deficient growing rats (diet < 2 mglkg; closed dots) and control rats (12 
mg/kg; open dots). The error bars indicate standard deviations (***p=<0.001). 
b: Serum alkaline phosphatase activity in zinc-deficient and control growing rats (diet < 2 
mg/kg; closed dots) and control rats (12 mglkg open dots). 
change was seen in the serum albumin concentration in the zinc-deficient rats. After 1 
month zinc was added to the diet. Serum zinc and AP activity were normalized after 1 
week. 
Experiment 2: 
In growing rats on a Zn-deficient diet, serum zinc gradually decreased to 8.0 //mol/1 
after 37 days (control group 24.7 /<mol/l, p<0.001, Figure 2a). No significant difference 
was observed in the activity of AP between normal and zinc-deficient rats (Figure 2b), but 
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Figure 3 - zinc deficiency experiment in growing rats. 
a: Serum alkaline phosphatase activity in zinc-deficient rats, using buffers low (closed dots) and 
rich (open dots) in zinc. The error bars indicate standard deviations (*p=< 0.05). 
b: Serum alkaline phosphatase activity in control rats, using buffers low (chsed dots) and rich 
(open dots) in zinc. 
c: Difference in alkaline phosphatase activity by using buffers low and rich in zinc, between 
zinc-deficient rats (closed dots) and control rats (open dots) (*p=< 0.05, **ƒ>=< 0.01; *** 
p=<0.001). 
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the activity decreased rapidly in both groups. In the zinc-deficient rats the lowest value was 
reached later. 
Also the activity was determined using a buffer low and enriched in zinc. At the first 
day (day 0) the difference between the AP activity using buffers with a low and an enri-
ched zinc content was, in the zinc-deficient group 21 U/L, and in the control group 24 
U/L. Serum AP activity using both methods should by definition be identical at day 0. 
Using the equation mentioned in 'Calculations', the AP activity using a buffer low in zinc 
was corrected. 
The AP activity in zinc-deficient rats, determined using a buffer low in zinc and a 
buffer high in zinc is shown (Figure 3a). The reagents low in zinc result in a lower AP acti-
vity during the study. In Figure 3b the same was shown for the control rats. Comparing 
Figure 3a and 3b the difference between both methods was greater in zinc-deficient rats 
than control rats. In Figure 3c this difference is shown. This difference was highly signifi-
cant on individual point after inducing zinc deficiency and for the total period using the 
Wilcoxon rank sum test (p < 0.001). 
Difference in activity U/L 
Figure 4: zinc deficiency experiment in adult rats 
Difference in alkaline phosphatase activity by using buffers low and rich in zinc, between zinc-
deficient adult rats (closed dots) and control rats (open dots). A significant difference was obser-
ved using a Wilcoxon rank sum test, and on day 20 using a Student t-test. The error bars indi-
cate standard deviations (**/>=< 0.01). 
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Figure 5: inflammatory stress experiment 
a: Total body retention oj Zn in rats with an inflammation (closed dots) and control rats (open 
dots) during the experiment. 
b: Serum albumin concentrations in rats with an inflammation (closed dots) and control rats 
(open dots) during the experiment (***ρκθ.001). 
с: Serum zinc concentrations in rats with an inflammation (closed dots) and control rats (open 
dots) and serum zinc concentrations corrected for the decrease of serum albumin (closed triang­
le) during the experiment. The error bars indicate standarddeviations (*p=< 0.05; **p<0.01; 
***p<0.001, for serum zinc in rats with an inflammation compared with control rats, and + + 
p<0.05; + + + ρ<0.01 for corrected serum zinc in rats with an inflammation compared with 
control rats). 
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Experiment 3: 
Because of the results in experiment 2 the difference in AP activity using buffers low 
and high in zinc was also studied in adult rats. The results of this experiment confirmed 
the results in experiment 1, especially the serum zinc and AP activity. 
After correction for the difference in AP activity with the reagents low and enriched in zinc 
at day 0, a significant difference was observed in AP activity for the total period using the 
Wilcoxon rank sum test (p = 0.01) and for individual sample times on day 20 (Figure 4). 
Experiment 4: 
In this experiment the results of zinc supplementation in normal quantities was stu­
died in rats raised on a diet with sufficient zinc and on a diet rich in zinc. No change in 
time or difference between the group supplemented by extra zinc and the control group 
was observed in serum zinc concentration and in AP activity. 
Experiment 5: 
The total body retention of Zn (Figure 5a) showed no difference between the 
groups, indicating that no zinc deficiency did occur during inflammatory stress (inflam­
mation groupT,,2=34 days, control groupT ] / 2=31.5 days). None of the rats showed symp­
toms of zinc deficiency like loss of hair. The serum albumin concentration decreased 
during the first day. 
Thereafter a constant difference persisted (23.8 versus 31.3 g/L, p<0.0005, Figure 
5b)). Using a Wilcoxon rank sum test a highly significant difference was calculated if all 
the data of both groups were compared (p<0.0001). Simultaneously during the first day a 
considerable decrease of serum zinc concentration was seen in the rats with stress (day one: 
inflammation group 10.3 /лпоІ/L and control group 23.0 /«nol/L, p=0.002) (Figure 5c). 
After the first few days a smaller difference persisted. A Wilcoxon rank sum test was per­
formed for comparison of the independent results of both groups of rats on all the data 
collected during the experiment. A highly significant difference was calculated (p<0.0001). 
When the serum zinc concentration of the rats with an inflammation was corrected for the 
decrease of serum albumin using the equation described in 'Methods', the differences 
between the groups largely disappeared, especially after the third day (Figure 5c). A decre­
ase of AP activity was only seen on the first two days (71 versus 115 U/L, p<0.05; Figure 
6a). Using the same method described in 'Calculations' and applied in experiments 2 and 
experiment 3, a significant difference was also observed in AP activity determined using a 
buffer low and high in zinc. This difference largely disappeared after the fourth day (Figure 
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Figure 6: inflammatory stress experiment 
a: Serum alkaline phosphatase activity in rats with an inflammation (closed dots) and control 
rats (open dots) during the experiment (**p<0.01). 
b: Difference in alkaline phosphatase activity by using buffers low and high in rich, between 
rats with inflammatory stress (closed dots) and control rats (open dots). The error bars indicate 
standard deviations (*p=< 0.05; **/>=< 0.01; ***p=<0.001). 
6b). During these experiments no changes in serum magnesium concentrations were 
demonstrated. 
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DISCUSSION 
The total body retention of Zn as a function of time served as an indication of the 
zinc status. In experiment 1, in which adult rats were made zinc deficient, the Zn total 
body retention confirmed that the animals had become zinc deficient. To detect eventual 
changes in zinc status during the first hours and days of the inflammatory stress experi-
ment (experiment 5), we preferred a linear decrease of the total body retention, so Zn was 
injected 7 days before the turpentine injection. During the inflammatory stress experiment 
no difference in Zn retention was observed between the rats with inflammatory stress and 
the control rats, indicating that no zinc deficiency occurred. 
After introduction of a zinc-deficient diet the serum zinc concentration fell in adult 
and more impressively in growing rats. Normalization of the diet resulted in an increase of 
serum zinc concentration. Supplementation of the same quantity of zinc in the diet of con-
trol rats did not influence the serum zinc concentrations. 
After induction of inflammatory stress the serum zinc concentration decreases rapidly. This 
decrease continued during the first 3 days, after which a smaller difference persists. The 
serum albumin concentration decreased within one day to a level which remained stable 
throughout the experiment. After correction of the serum zinc concentration for the decre-
ase of serum albumin no difference in serum zinc concentration was observed after the 
second day. This indicates that after the initial phase of inflammatory stress the decrease of 
serum zinc is mainly resulting from a decrease of serum albumin. Probably the initial rapid 
decrease of serum zinc is caused by an increase of zinc uptake by the liver, an observation 
that has been demonstrated by Solomons et al. (22). 
The determination of activity of zinc dependent enzymes has been used as a method 
to determine the zinc status, e.g. serum AP activity (21). The of AP activity is limited by 
the influence liver function and bone turnover, factors that influence the concentration of 
AP enzyme. The advantage of using AP activity as a method to determine the zinc status 
is that the determination of AP activity is possible in each clinical laboratory. Serum AP 
activity is the result of two factors: the protein concentration of the enzyme in the serum 
and the activity of the enzymatic molecules. The former factor is influenced by release of 
the enzyme by AP containing tissues, mainly liver and bone. The latter factor is influen-
ced by the number of zinc and magnesium atoms in the AP enzyme molecule (10-12). 
During the experiments no changes in magnesium concentration were observed. The zinc 
deficiency experiments in adult rats confirmed that serum AP activity is decreased in zinc 
deficiency. Sandstead (23) demonstrated an increase of serum zinc concentration and AP 
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activity during zinc deprivation in marginally zinc-deficient men. This was not confirmed 
in the present experiments. The increase of AP activity after zinc supplementation may be 
an indication of a preceding zinc deficiency (experiment 1). Our experiments confirmed 
studies in animals (24-26) and in patients (27,28). No increase was demonstrated in case 
of zinc sufficiency (experiment 4). Kasarkis (25) proposed the AP ratio (the magnitude of 
the increase of AP activity after zinc supplementation) as an indicator of the zinc status. 
Some criticism can be addressed to this method. The results of experiment 4 demonstra-
ted that this method, the AP ratio, cannot be used to differentiate between rats receiving 
food with a marginal but sufficient quantity of zinc and rats receiving a diet rich in zinc. 
In growing rats (experiment 2), no difference was observed between normal and zinc-
deficient rats. In a study in infants the same problem was observed; no correlation was 
demonstrated between serum zinc and AP activity (29). During growth the AP activity 
declines because of a decrease of concentration of the enzyme. In case of zinc deficiency 
growth is retarded. Maybe the concentration of the AP enzyme in the serum remains high 
in the zinc-deficient rats, which counteracts the decrease of activity of the enzyme due to 
a decrease of zinc concentration. In the zinc-deficient rats the lowest AP activity value was 
reached later. 
In the inflammatory stress experiment AP activity was decreased during the initial 
phase of inflammation, showing that AP activity is influenced by inflammatory stress. This 
is not known from clinical practice (30) although in physiological stress experiments 
published in veterinary journals, a decrease of AP activity has been observed (31) (without 
giving an explanation). After the initial phase no difference in AP activity was observed in 
the present experiment, although serum zinc was still decreased. The normalisation of the 
serum zinc concentration after correction for the decrease of serum albumin, indicates that 
after the second day the decrease of serum zinc was mainly the result of a decrease of serum 
albumin. Probably AP activity is influenced by the shift of serum zinc into the liver during 
the first days after inducing inflammatory stress, but not by an apparent decrease of serum 
zinc due to a decrease of serum albumin in long lasting inflammation. AP activity proba-
bly represents the serum concentration of free zinc. 
V/e postulated that in case of zinc deficiency the difference of AP activity, determined 
in a buffer low and a buffer rich in zinc, would be greater than in zinc sufficiency. This 
method would largely bypass the influence of the concentration of the enzyme on the 
assessment of AP activity and the influence of other minerals like magnesium and offers 
the opportunity of having a instantaneous monitor of the zinc status. This would be the 
case if the difference in activity would be greater than the difference in enzyme concentra-
199 
tion, because of liver or bone disorders. In our experiments the concentrations in the buffer 
were chosen within the range of zinc concentrations used in laboratory practice because it 
is well-known that very low (see 'Methods') and high concentrations in the AMP-buffer 
(several times higher than the concentrations used in clinical practice) added in vitro, will 
decrease serum AP activity (11,26,32). The hypothesis was confirmed by experiment 2 in 
zinc-deficient growing rats, experiment 5 in rats with inflammatory stress, and in experi-
ment 3 in zinc-deficient adult rats. On individual sample times this was highly significant 
in growing rats and rats with inflammatory stress. In zinc-deficient adult rats this diffe-
rence was smaller resulting from considerable standard deviations caused by physiological 
differences and the limited number of animals. The method could be improved by incre-
asing the difference of the AP activity. Essential for this method is the use of an AMP-
buffer with a low concentration of chelator and consequently low zinc concentration. To 
our knowledge only one study has suggested that manipulation of the method of determi-
nation of AP activity could be used for the diagnosis of zinc deficiency (41). In this study 
a method was described in which inactivated AP was re-activated by serum. Also in this 
study a greater difference was observed in case of zinc deficiency. 
We may conclude that the experiments demonstrate that, in case of a low serum zinc 
concentration, the difference in AP activity probably can differentiate between a true zinc 
deficiency and an apparent zinc deficiency resulting from a decrease of serum albumin; 
even if AP enzyme levels are changing. This method should be confirmed in humans. 
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CHAPTER 11 
SUMMARY 

Malnutrition is a status resulting from a (relative) shortage of nutrients which results 
in a decrease of biological functions (chapter 2) This suggests that malnutrition is caused 
by insufficient nutritional intake Also the disease process itself plays an important roll in 
malnutrition, therefore the expression nutritional depletion, in stead of malnutrition, cor-
responds better with the clinical condition of a patient The disease process exerts multip-
le effects on the nutritional status, especially by changing the metabolism Nutritional 
depletion can be divided into a syndrome resulting from depletion of energy or a syndro-
me resulting from depletion of proteins, resembling nutritional depletion of energy or pro-
teins in tropical medicine marasmus and kwashiorkor, respectively Both conditions have 
their own causes and clinical outcome, but in patients often a combination of both is seen 
protein-caloric nutritional depletion This condition carnes a high mortality risk 
Not only macronutnents (carbohydrates, fat and proteins), but also micronutnents, 
like zinc, can be depleted Zinc is active as part of many metallo-en7ymes Zinc deficien-
cy will cause a decrease of enzyme function A decrease of function of metallo-enzymes will 
result in symptoms of zinc deficiency A low serum zinc concentration may reflect real zinc 
deficiency but also inflammatory stress during inflammation the zinc transporting protein 
will decrease and subsequently total serum zinc concentration In addition there is a shift 
of zinc from the serum into the liver This decrease of serum zinc concentration does not 
result in classical symptoms of zinc deficiency, like hair loss and skin lesions This condi-
tion is called apparent zinc deficiency A decrease of serum zinc can be caused by real zinc 
deficiency or by inflammatory stress There is a need for a method that can distinguish 
between the two conditions 
The aim of this thesis was to study the prevalence of malnutrition and to study the 
validity of the methods to assess malnutrition in patients 
In chapter 3 we studied the prevalence of malnutrition in non-surgical hospitalized 
patients and its association with disease complications In a population of 155 non-surgi-
cal hospitalized patients the prevalence of energy-protein nutritional depletion, the asso-
ciation with the disease process, and complications arising during the course of the disea-
se were studied Three methods for the assessment of the nutritional status were used a 
subjective assessment based on the clinical picture the Subjective Global Assessment, and 
two methods based on weight and laboratory values the Nutritional Risk Index and the 
Maastricht Index According to these criteria the prevalence of nutritional depletion ran-
ged from 45% to 62% at admission In the first 90 patients the nutritional status at dis-
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charge was also studied. The Maastricht Index showed a significant improvement during 
admission in nutritional status, from 64% to 53%. At least 50% of the patients with acti-
ve inflammatory bowel disease were malnourished. Patients with nutritional depletion 
demonstrated a higher incidence of complications, with an Odds Ratio of about 3 (2.7-
3.1). A multivariate correction for the disease category and for the severity of the disease 
decreased the Odds Ratio to 1.6 (Nutritional Risk Index) and 2.4 (Maastricht Index). 
Because the parameters for severity of the disease are also influenced by the nutritional sta-
tus the real Odds Ratio's will be in between these figures. 
Because of the high prevalence of nutritional depletion the question was raised of a 
potential false positive misclassification. This was studied in 175 healthy blood donors and 
34 elderly volunteers attending the Nijmegen Four Days Walking Event (chapter 4). These 
volunteers were considered to be healthy on the basis of a questionnaire and simple medi-
cal examination. For the assessment of the nutritional status the objective parameters: the 
Nutritional Risk Index and the Maastricht Index, were applied. The figures for the preva-
lence of nutritional depletion for the whole population were 1.9% and 3.8% respectively, 
but in volunteers older than 70 years they were much higher: 5.9 and 20.6%, respective-
ly. In general the risk of false positive misclassification was very low, but in elderly persons 
the risk was high if the Maastricht Index was used, which limits the value of the Maastricht 
Index in these persons. 
Not only the prevalence of nutritional depletion of macronutrients (protein-energy 
malnutrition) in patients with chronic inflammatory bowel disease was studied (chapter 
5), but also the question of the prevalence of nutritional depletion of micronutrients espe-
cially of zinc, in patients with Crohn's disease. Various methods are used for the assessment 
of zinc deficiency. A "Gold Standard" for the assessment of the zinc status, which can be 
applied in clinical practice is not available. To compare the relative value of various fre-
quently used methods for assessment of zinc deficiency, these methods were correlated 
with the presence of possible factors inducing zinc deficiency: number of liquid stools, 
weight loss, bowel resection and the extent and severity of inflammation (Crohn's Disease 
Activity Index, van Hees Index). 
In 31 patients with more or less active Crohn's disease the zinc status was assessed by 
the serum zinc concentration, serum alkaline phosphatase activity and the zinc content of 
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blood cells. In 68% of the patients the serum zinc concentration was below normal. The 
serum zinc concentration was correlated with the extent of bowel resection and activity of 
the disease according to the van Hees Index. Serum alkaline phosphatase activity was also 
correlated with bowel resection. Zinc in erythrocytes and mononuclear blood cells was 
poorly correlated with factors inducing zinc deficiency. Only zinc in polymorphonuclear 
cells correlated with weight loss and the number of liquid stools. Because of these disap-
pointing results using the zinc content of blood cells this method was applied in an expe-
riment in which zinc-deficient and control rats were studied. No significant differences in 
the zinc content of blood cells, between zinc-deficient rats and control rats were observed. 
Determination of zinc in blood cells has no additional value for the assessment of the zinc 
status in individual patients. 
The previous study emphasizes the need for better methods to assess the zinc status. 
This method should be applicable in clinical practice and should distinguish real zinc defi-
ciency from apparent zinc deficiency caused by inflammation. 
In chapter 6 the changes in zinc metabolism during zinc deficiency and inflammato-
rion were studied in zinc-deficient rats and rats with a chronic inflammation. In both situ-
ations serum zinc concentrations are decreased but inflammation results in an apparent 
zinc-deficient status since no symptoms of zinc deficiency are present. 
In the first experiment a group of rats were fed a zinc-deficient diet and in the second 
experiment, inflammatory stress was induced by an intramuscular turpentine injection. In 
both studies, control rats were used. Zn was injected intraperitoneally to study the in vivo 
uptake and exchange of zinc in tissues by determination of the activity of ' Zn in blood 
cells and tissues. The Zn total body retention was determined to measure total body zinc 
changes and used as a reference. In the zinc deficiency experiment concentrations of cold 
zinc were determined, as well. 
Both in zinc-deficient rats and in rats with inflammatory stress serum zinc concen-
trations were decreased. The total body Zn retention was increased in case of zinc defi-
ciency, but no differences were observed between rats with stress and control rats. The 
uptake in Zn by erythrocytes and mononuclear cells in vivo was increased in zinc-defi-
cient rats, but not in rats with inflammatory stress. The uptake of Zn by cortical bone 
was very slow in zinc-deficient rats, and less in control rats. In zinc-deficient rats a decre-
ase of concentration of cold zinc was only seen in bone cortex. The uptake of zinc by the 
liver was increased during the initial phase of inflammation. 
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Bone appears to bc an important source of zinc, in case of zinc deficiency, and could 
be used to determine the zinc status. However, this is impractical in clinical practice. 
Contrary to the findings in zinc deficiency, no differences were observed in Zn uptake in 
vivo in blood cells in inflammatory stress, which offers an opportunity to distinguish real 
and apparent zinc deficiency. 
The results of the previous study could be used to develop new methods to determi-
ne the zinc status. 
In chapter 7 the in vitro uptake of Zn by blood cells was studied in zinc-deficient 
rats in chapter 7. Serum zinc decreased in zinc-deficient rats. A significant increase of upta-
ke of zinc by blood cells of zinc-deficient rats in vitro was observed. This was demonstra-
ted in successive blood samples in a period of 4 weeks, and was confirmed in a second 
experiment. This suggests that the in vitro uptake of zinc by blood cells could be used for 
determination of the zinc status. 
In a pilot experiment inflammation was induced in rats. After 2 days serum zinc was 
markedly decreased, but no difference was demonstrated in zinc uptake by erythrocytes 
and mononuclear cells. 
The previous study suggested that by the employment of the in vitro uptake of zinc 
by blood cells, real and apparent zinc deficiency could be distinguished. In chapter 8 the 
in vitro zinc uptake by blood cells in rats with inflammatory stress was studied. To valida-
te this hypothesis consecutive blood samples were taken from rats with chronic inflamma-
tion. Serum zinc was markedly depressed during the first few days after induction of the 
inflammation. Later on this decrease became less and attributable to a decrease of serum 
albumin, the zinc transporting protein. The in vitro uptake of zinc by erythrocytes was not 
increased in rats with inflammation. This study confirmed the previous experiment, and 
strengthened the hypothesis that by measuring the in vitro uptake of zinc by blood cells, 
zinc deficiency could be established, and real zinc deficiency distinguish from apparent 
zinc deficiency. 
The methodology of the assessment of the zinc status by measuring the in vitro uptake of 
zinc by blood cells was studied in detail in chapter 9. The influence of incubation time and 
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temperature revealed the physiological process of the uptake of zinc by (blood) cells. At 
least three phases were recognized in zinc uptake: a brief fast phase probably representing 
aspecific binding of zinc, a second slower phase probably representing the active uptake of 
zinc by the cell, and a slow phase in which the in- and efflux of zinc were more or less equi-
librated. In mononuclear and polymorphonuclear cells the exchangeable intracellular zinc 
pool was 40 and 53% respectively in rats. In erythrocytes this pool was much smaller: 
10%. The efflux of zinc from (blood) cells was also studied. The efflux of zinc was of the 
same magnitude as the influx. Both the influx and the efflux of zinc in blood cells were 
very small at 4°C, and of the same magnitude as in the first phase in the process of zinc 
uptake. This suggests that the first phase of zinc uptake is probably due to non-specific bin-
ding. 
The method of measuring the in vitro uptake of zinc by blood cells is an important 
new method to determine the zinc status but this method is rather time consuming and 
therefore especially of interest for research. 
Zinc deficiency will result in symptoms that are caused by suboptimal functioning of 
many metallo-enzymes. The function of metallo-enzymes is of interest, because it can pro-
bably be used as a method to determine the zinc status, and because if a suboptimal enzy-
me function due to zinc deficiency is demonstrated, this dysfunction is also directly rela-
ted to the mechanism by which symptoms of zinc deficiency are caused: malfunction of 
metallo-enzymes. Determination of the serum alkaline phosphatase activity is a daily rou-
tine in every clinical laboratory. Alkaline phosphatase is a zinc dependent metallo-enzyme. 
Therefore the influence of zinc deficiency, growth and inflammation on the serum alkaline 
phosphatase activity were studied (chapter 10). In zinc-deficient rats serum alkaline 
phosphatase activity was decreased. In zinc-deficient growing rats no decrease could be obser-
ved, probably because the decrease of alkaline phosphatase activity is compensated by an 
increase of alkaline phosphatase enzyme due to growth retardation in the zinc-deficient rats. 
Serum alkaline phosphatase activity was also determined in a buffer low and a buffer 
enriched in zinc. The difference in activity was greater in zinc-deficient growing rats than 
in the control rats. Serum alkaline phosphatase activity was decreased by inflammatory 
stress but only during the initial phase. This could be explained by the decrease of serum 
zinc concentration due to redistribution of zinc from serum into the liver. In the same ini-
tial period an increase of difference in alkaline phosphatase activity determined in a buffer 
low in zinc and a buffer enriched in zinc was demonstrated. So changes in serum alkaline 
209 
phosphatase activity in time, can be an indication fot changes in zinc status. The differen-
ce in alkaline phosphatase activity, using buffers low and enriched in zinc, can be an 
method that can instantaneously be used, and may differentiate between real zinc defi-
ciency and a decrease of serum zinc caused by an chronic inflammatory process. 
CONCLUDING REMARKS 
The aim of this thesis was the assessment of malnutrition, both of macronutrients and 
micronutrients, in patients. 
The following questions were derived from the aim of this thesis: 
- What is the prevalence of nutritional depletion? 
- Can the currently available methods to determine nutritional deficiency distinguish 
between nutritional depletion and a normal nutritional status? 
- Can the currently available methods to determine nutritional deficiency distinguish 
nutritional status from disease activity? 
In the first part of this thesis the association between the disease process and malnut-
rition of macronutrients was studied. In the second part the influence of a specific disea-
se process, inflammation, and a reduced intake of one of the micronutrients, zinc, was 
investigated. For both macronutrients and the micronutrient zinc, methods for the asses-
sment of malnutrition were studied and some showed to be applicable and reasonably spe-
cific for malnutrition, and in part independent of the disease process. 
Which answers can be drawn from the previous studies? 
Nutritional depletion of macronutrients is frequent, not only in surgical patients but also 
in non-surgical patients. Malnourished patients suffer a higher risk of complications, and 
this risk can be explained in part by the disease activity. Nutritional depletion assessed by 
the Maastricht Index showed the highest risk of complications even after correction for 
disease. These methods can at least in part distinguish nutritional status from disease activity. 
The methods to determine malnutrition do not lead to over-estimation of nutrition-
al depletion by false positive misclassification, except for the Maastricht index in elderly 
subjects, so these methods can distinguish between nutritional depletion and a normal 
nutritional status. 
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In patients with active Crohn's disease a decrease of serum zinc concentration was also 
frequently observed. This suggests that malnutrition of the micronutrient zinc is frequent. 
This decrease could be explained by real zinc deficiency but also by apparent zinc 
deficiency induced by the inflammatory process. In this study, it was not clear, by which 
method zinc deficiency should be established. There is a need for a method that reflects 
the zinc status and can distinguish between real and apparent zinc deficiency. The in vitro 
uptake of zinc by blood cells can be used to diagnose zinc deficiency so this method can 
distinguish between nutritional depletion and a normal nutritional status. By the use of 
erythrocytes real zinc deficiency can be distinguished from apparent zinc deficiency. 
Serum alkaline phosphatase activity is influenced the zinc status but also by the con-
centration of the enzyme. Partially this can be reconciled by the assessment of the diffe-
rence in serum alkaline phosphatase activity using two buffers, one low and one enriched 
in zinc. The difference in serum alkaline phosphatase activity is greater in case of zinc defi-
ciency. 
Serum alkaline phosphatase activity, and also the difference in alkaline phosphatase 
activity, is decreased during the initial phase of inflammation, but not in the phase of chro-
nic inflammation in which serum zinc is mainly decreased due to a decrease of serum albu-
min, so this method can distinguish nutritional status from disease activity. 
The results of the previous studies give rise to new questions and subsequent aims for 
studies in the future. 
The effect of nutritional intervention on the complication risk should be studied in 
malnourished non-surgical patients. It would be of interest to study false negative misclas-
sification by the methods used in the studies of chapters 2 and 3. The method of measu-
ring in vitro uptake of zinc by erythrocytes should be studied in patients. Actually, at this 
moment several groups, engaged in zinc research, are using this method. The assessment 
of the zinc status by determination of serum alkaline phosphatase activity, using buffers 
low and enriched in zinc is also of interest, but the method should be improved by the 
development of buffers with even lower zinc concentrations. 
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CHAPTER 12 
BESTAAT ER IN NEDERLANDSE ZIEKENHUIZEN ONDERVOEDING? 
Een samenvatting van dit proefschrift voor de geïnteresseerde leek 

Ondervoeding wordt vaak geassocieerd met de problematiek van mensen in derde-
wereldlanden. Dat ondervoeding ook in Nederlandse ziekenhuizen voorkomt is nagenoeg 
onbekend bij de gemiddelde Nederlander. Wat de medicus betreft, die weet weliswaar dat 
een patiënt na een operatie ondervoed kan raken maar is zich toch ook onvoldoende 
bewust van ondervoeding bij niet-chirurgische patiënten. Tekenen van ondervoeding wor-
den slechts gezien als een gevolg van de ziekte. Dat patiënten evenwel ook ondervoed kun-
nen raken door te weinig voedselinname of gebrekkige voedselopname door de darm 
wordt onvoldoende overwogen. Daarnaast verandert de ziekte ook vaak het stofwisselings-
proces waardoor een patiënt uiterlijk een beeld kan vertonen dat sterk lijkt op dat van per-
sonen in derdewereldlanden met eiwitondervoeding. 
Het is daarom dan ook van groot belang ondervoeding te kunnen herkennen en de 
omvang van het probleem van ondervoeding bij patiënten vast te leggen. In dit proefschrift 
is hiertoe een poging ondernomen, waarbij onderzoek is gedaan naar de bruikbaarheid van 
methoden om een dergelijke ondervoeding vast te stellen. Ondervoeding kan een tekort 
aan lichaamsmassa omvatten, veroorzaakt door een (relatief) tekort aan energie dragers als 
suikers en vetten alsmede de bouwstof eiwit, maar kan ook betrekking hebben op vitami-
nen, mineralen en sporenelementen. 
Uit dit proefschrift blijkt dat minimaal 40% van de patiënten bij opname op een 
afdeling interne geneeskunde in meer of mindere mate ondervoed is en dat een kleine 
10% zelfs ernstig ondervoed is. Indien een patiënt ondervoed is heeft hij een grotere kans 
op complicaties, nieuwe ziektebeelden of problemen tijdens het ziekenhuisverblijf. Zowel 
complicaties tijdens een ziekenhuisverblijf als ook ondervoeding worden door de artsen in 
het algemeen toegeschreven aan de primaire ziekte waarvoor de patiënt is opgenomen. Uit 
dit proefschrift blijkt dat de kans op complicaties maar ten dele door de ziekte zelf ver-
klaard kan worden en dat deze ook beïnvloed wordt door de voedingstoestand. Een van de 
methoden om ondervoeding vast te stellen is de Maastricht Index. Van de toegepaste 
methoden om ondervoeding vast te stellen, voorspelt de Maastricht Index het beste de kans 
op complicaties, ook na correctie voor de ziekte. De observatie dat de kans op complica-
ties gecorreleerd is met ondervoeding, onderstreept de noodzaak om aandacht te besteden 
aan de voedingstoestand van de patiënt. Het door ons gevonden percentage ondervoeding 
bij opname in een ziekenhuis werd door velen als hoog beschouwd. Een van de verklarin-
gen zou kunnen zijn dat patiënten ten onrechte als ondervoed werden beschouwd. Daarom 
werd met dezelfde methoden als waarmee de voedingstoestand bij de patiënten werd 
bepaald bij, in principe, gezonde vrijwilligers de voedingstoestand onderzocht. Voor de 
gehele groep gold dat bij minder dan 5% van de vrijwilligers ondervoeding werd gevon-
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den. Dit betekent dat het gevonden percentage ondervoeding bij patiënten waarschijnlijk 
niet te hoog is. Bij de groep oudere vrijwilligers lag de situatie iets anders. Wanneer de voe-
dingstoestand met de Maastricht Index bij ouderen werd bepaald, werd ruim 20% van de, 
in principe, gezonde ouderen als ondervoed beschouwd. Alhoewel de Maastricht Index het 
beste, onafhankelijk van de ziekte, toekomstige complicaties voorspelt, dient deze metho-
de niet gebruikt te worden in studies waarin een aanzienlijk deel van de patiënten 70 jaar 
of ouder is. Bij ouderen zou de bepaling van de voedingstoestand dan ook beter niet met 
behulp van de Maastricht Index moeten worden uitgevoerd. Patiënten met chronische dar-
montstekingen (ziekte van Crohn en colitis ulcerosa), bleken bij opneming in het zieken-
huis in meer dan 50% ondervoed. 
Alhoewel in onze studies de beschreven objectieve methoden om ondervoeding vast 
te stellen (waarvan de Maastricht Index er een is) goed bruikbaar bleken voor onderzoeks-
doeleinden, betekent dit niet dat men deze methoden ook voor de bepaling van de voe-
dingstoestand van een individuele patiënt kan gebruiken. Men zal dan altijd de laborato-
riumwaarden die deel uit maken van deze index, als ook het gewicht, moeten relateren aan 
het klinisch beeld van de patiënt. Het gewicht van de patiënt wordt bijvoorbeeld mede 
beïnvloed door een tekort of een overmaat aan vocht in het lichaam van de patiënt. De 
subjectieve klinische blik blijkt volgens ons onderzoek ook bruikbaar. 
Bij de ziekte van Crohn werden naast ondervoeding van macro-nutriënten (de hoofd-
bestanddelen van het voedsel die zorgen voor de energie en de opbouw van het lichaam) 
ook tekorten aan micro-nutriënten (de voedingsmiddelen die in geringe mate in de voe-
ding aanwezig zijn en verantwoordelijk zijn voor het goed functioneren van het lichaam) 
vastgesteld. Zo bleek de zinkconcentratie in het serum bij ruim tweederde van de patiën-
ten met een meer of minder actieve ziekte van Crohn verlaagd. Deze verlaging van de zink-
concentratie kan enerzijds verklaard worden door een reëel tekort aan zink, maar ander-
zijds ook door een verlaagde concentratie van het eiwit dat zink in het bloed transporteert: 
albumine. Bij ontstekingen daalt namelijk de albumineconcentratie in het bloed. 
Daarnaast is bekend dat zink bij ontstekingen, van het bloed naar de lever wordt verplaatst. 
Wij noemen deze situatie waarbij de scrum zinkconcentratie verlaagd is, maar er geen ver-
schijnselen van zinktekort zijn, een schijnbare zinkdeficiëntie. Al met al is het onduidelijk 
hoe groot het percentage patiënten met een echte zinkdeficiëntie is. Er bestaat daarom 
behoefte aan een methode die zinktekort zou kunnen vaststellen en die een reëel zinkte-
kort zou kunnen onderscheiden van een schijnbaar zinktekort. In dit proefschrift zijn een 
aantal methoden op hun bruikbaarheid getest. Zo wordt de concentratie van zink in weef-
sels, zoals spieren of bot, wel als maat gebruikt om de zinkstatus vast te stellen. Het is cch-
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ter erg belastend voor een patiënt om door een arts een stukje spier of bot uit het lichaam 
te laten nemen. Weefsels bestaan uit cellen. In het bloed zitten ook cellen. Men zou het 
bloed als een soort weefsel kunnen zien. Wellicht zou de concentratie van zink in deze cel-
len de zinkstatus kunnen representeren. Omdat er geen 'Gouden Standaard' voor de zink-
status van deze patiënten bestaat werd in het bovenstaande onderzoek bij patiënten met de 
ziekte van Crohn de methoden om een zinktekort vast te stellen gecorreleerd aan factoren 
die een reëel zinktekort zouden kunnen veroorzaken zoals diarree en vermagering. De con-
centratie van zink in bloedcellen bleek geen sterk verband met deze factoren te hebben. Dit 
suggereerde dat de bepaling van de zinkconcentratie in bloedcellen onvoldoende gevoelig 
zou zijn om zinktekort vast te stellen. Ter bevestiging van dit vermoeden werden ratten 
zinkdeficiënt gemaakt. De zinkconcentratie in bloedcellen van deze ratten werd onder-
zocht en deze bleek niet te verschillen van de concentratie in bloedcellen van normale rat-
ten. Geconcludeerd kan worden dat bepaling van zink in bloedcellen geen aanvullende 
waarde heeft op de normale methode om de zinkstatus vast te stellen: de serum of plasma 
zinkconcentratie. 
Wíj moesten daarom op zoek naar andere methoden om een zinktekort vast te stel-
len. Daartoe werden ratten zinkdeficiënt gemaakt. De concentratie van zink in de weefsels 
werd bepaald. Hierbij bleek dat een daling van de zinkconcentratie lang niet in alle weef-
sels kon worden waargenomen. De zinkconcentratie in bot leek nog het beste te correleren 
met de verminderde zink-inname en het ontstaan van verschijnselen van zinktekort zoals 
haaruitval. Bot is echter in de klinische praktijk niet makkelijk te verkrijgen. In het lichaam 
circulerende bloedcellen, met name rode bloedcellen en mononucléaire bloedcellen, ble-
ken in geval van een zinktekort juist een sterk verhoogde opname van zink te vertonen. Dit 
werd niet gezien bij ratten met een chronische ontsteking. Een verhoogde zinkopname 
door bloedcellen lijkt dus specifiek voor zinktekort. Een ontstekingsproces zorgt niet voor 
een fout-positieve uitslag. 
Bij het bovenstaande experiment werd de zinkopname door bloedcellen gemeten ter-
wijl deze cellen zich in het lichaam bevonden. De vraag was nu of deze bloedcellen van 
zinkdeficiënte ratten buiten het lichaam een zelfde verhoogde opname van zink zouden 
laten zien. Indien dit het geval was, dan zou dit wellicht een methode kunnen zijn om een 
reëel zinktekort vast te stellen. Wederom werden ratten zink deficiënt gemaakt. De bloed-
cellen werden uit het lichaam gehaald en de opname van zink door deze cellen, buiten het 
lichaam, werd gemeten. Eenzelfde verhoogde opname van zink door de bloedcellen werd 
vastgesteld. Ter controle van deze methode werd een chronische ontsteking bij ratten opge-
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wekt, om de invloed van een schijnbare zinkdefkiëntie te onderzoeken. Rode bloedcellen 
bleken geen verhoogde opname te vertonen, alhoewel de serum zinkconcentratie sterk 
daalde. Met deze methode kan blijkbaar worden vastgesteld dat er een zinktekort is en dat 
dit niet wordt beïnvloed door een ontsteking die een schijnbare ondervoeding veroorzaakt. 
De methode werd in detail onderzocht. Vastgesteld kon worden dat de opname van zink 
door bloedcellen een onderdeel was van een uitwisselingsproces van zink door deze cellen 
met hun omgeving. Verschillende stappen in dit opnameproces konden worden onder-
scheiden. Er werden aanwijzingen gevonden voor zowel een aspecifieke temperatuur onaf-
hankelijke binding van zink aan de cellen, alsmede een temperatuur afhankelijk actief 
opname proces. De aspecifieke binding was echter van beperkte omvang. De uitwisseling 
van zink door bloedcellen kon bij 40C vrijwel volledig worden stopgezet. 
De methode om de zink status vast te stellen door middel van de verhoogde opname 
van zink door bloedcellen lijkt veelbelovend. Een nadeel is echter de bewerkelijkheid van 
de procedure: het vergt ongeveer een dag werk. Dit hoeft geen bezwaar te zijn bij research 
maar is in de klinisch praktijk niet optimaal. Daarom is door ons ook onderzoek gedaan 
naar een andere methode, die beter aansluit bij de routinematige laboratoriumbepalingen. 
De bepaling van de activiteit van het enzym alkalische fosfatase wordt dagelijks verricht op 
een klinisch chemisch laboratorium. Alkalische fosfatase is een enzym dat zink nodig heeft 
om optimaal te werken. Het is bekend dat het enzym bij een lage zinkspiegel minder actief 
is. Men zou dus de activiteit van dit enzym als maat voor de zinkstatus kunnen gebruiken. 
Daarom werd onderzoek gedaan naar de toepasbaarheid van serum alkalische fosfatase 
activiteit als maat voor de zinkstatus. Daarbij moeten wij ons realiseren dat de activiteit van 
dit enzym, zoals dit in een klinische chemisch laboratorium wordt gemeten, het resultaat 
is van de activiteit van de individuele enzymmoleculen en de concentratie van het enzym. 
Wederom werden ratten zinkdeficiënt gemaakt. Tevens werd in een andere groep ratten 
een chronische ontsteking opgewekt. De alkalische fosfatase activiteit bleek te worden 
beïnvloed door de zinkstatus, maar ook door de concentratie van het enzym zelf: de acti-
viteit van het enzym nam, bij ratten die in de groei waren, in de loop van de tijd af. Het 
is bekend dat de botaanmaak op later leeftijd afneemt en daarmee de concentratie van dit 
enzym. Om de invloed van de concentratie van het enzym op de gemeten activiteit te ver-
minderen werd het verschil in activiteit bepaald wanneer er weinig en wanneer er veel zink 
aan het serum werd toegevoegd. Men zou verwachten dat indien in het serum zelf weinig 
zink aanwezig is het verschil in activiteit groter is dan wanneer reeds veel zink in het bloed 
serum aanwezig is. Het verschil in enzymactiviteit bleek inderdaad groter te zijn in bloed 
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van zinkdeficiënte ratten. Bij ratten met een ontsteking kon deze toename van het verschil 
in enzymactiviteit alleen gedurende de eerste dagen worden waargenomen. Dit is de fase 
waarin zink van het bloed naar de lever wordt getransporteerd. In deze fase werd naast een 
toename van het verschil in enzymactiviteit, een verlaging van de absolute enzymactiviteit 
waargenomen. 
Samenvattend kunnen wij stellen dat ondervoeding frequent wordt gevonden bij zie-
kenhuispatiënten; dat ondervoeding gepaard gaat met een verhoogde kans op complicaties 
en dat deze verhoogde kans op complicaties maar gedeeltelijk door de ziekte zelf kan wor-
den verklaard. In het algemeen zijn de methoden waarmee ondervoeding kan worden vast-
gesteld goed bruikbaar om tot een juiste classificatie van de voedingstoestand bij patiënten 
te komen. Bij een actieve vorm van de ziekte van Crohn komt niet alleen ondervoeding 
van macro-nutriënten maar ook een verlaagde serumconcentratie van het micro-nutriënt 
zink voor. Het vaststellen van een tekort aan zink is moeilijk. Zowel de opname van zink 
door rode bloedcellen als de bepaling van de serum alkalische fosfatase activiteit volgens 
een specifieke methode lijken veelbelovende nieuwe methoden om de zinkstatus vast te 
stellen. 
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taken te verrichten, laat staan om zelf wetenschappelijk onderzoek in het laboratorium te 
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De opleiding gastroenterologie werd gevolgd in het Radboud Ziekenhuis tussen 1986 en 
1989 onder de toenmalige leiding van Dr. J.H.M, van Tongeren. In deze periode werd een 
begin gemaakt met het beschreven onderzoek. Sinds april 1996 is de promovendus geregi­
streerd als gastroenteroloog. Op dit moment is hij werkzaam als staflid op de afdeling 
Maag-, darm- en leverziekten van het Radboudziekenhuis in Nijmegen. 
Hij is lid van de doelgroep commissie voeding van het PAOG/NIKOG, een commissie die 
nascholing op het gebied van voeding initieert. Hij is als organisator en spreker betrokken 
geweest bij diverse nascholingscursussen en congressen. Hij was, mede met de apotheker 
drs. H. Bakker en de verpleegkundige P. Verbroekken, organisator van patiëntendagen voor 
de patiënten die thuis totale parenterale voeding ontvangen; een initiatief waaruit later de 
patiëntenvereniging voor patiënten met thuis parenterale voeding is voortgekomen. Hij 
was initiatiefnemer tot het oprichten van een voedingsteam in het Radboudziekenhuis te 
Nijmegen en was lid van de voorbereidingscommissie. Tevens is hij lid van het bestuur van 
de SVEM (Sectie Voeding En Metabolisme), een onderdeel van de Nederlandse Vereniging 
voor Gastroenterologie en is hij voorzitter van de Nederlands Voedingsteams Overleg, een 
overleg waaraan voedingsteams die werkzaam zijn in de Nederlandse ziekenhuizen, deel-
nemen. Hij is 'council member' voor Nederland bij het ESPEN (European Society of 
Parenteral and Enteral Nutrition). De promovendus geeft gastcolleges "entérale en paren-
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cerale voeding", alsmede colleges betreffende "voeding en stress", aan studenten van de stu-
dierichting voeding en gezondheid van de Landbouw Universiteit te Wageningen. Hij 
heeft de afgelopen 5 jaar een drietal subsidies verkregen waarop drie promovendi werkzaam 
zijn. 
De promovendus is gehuwd, heeft twee kinderen en hoopt op dezelfde dag te promoveren 
als zijn vrouw. 
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STELLINGEN 
behorende bij het proefschrift 
The assessment of 
MALNUTRITION IN NON-SURGICAL PATIENTS 
from macronutrient to micronutrient, 
with special emphasis on zinc 
Ton Naber 
Nijmegen, 15 september 1997 
1. In Nederland komt ondervoeding frequent voor bij patiënten die 
opgenomen worden op een afdeling voor inwendige ziekten. 
Dit proefschrift 
2. Een schijnbaar zinktekort veroorzaakt door een ontstekingsproces kan 
d.m.v. de bepaling van de in-vitro opname van zink door bloedcellen 
worden onderscheiden van een reëel zinktekort. 
Dit proefschrift 
3. De serum alkalische fosfatase activiteit is verlaagd tijdens de initiële fase 
van een ontstekingsproces, hetgeen verklaard kan worden door een 
vermindering van de serum zinkconcentratie. 
Dit proefschrift 
4. Promoveren na beoordeling van het proefschrift door een 
manuscriptcommissie is een archaïsche gewoonte indien men als 
voorwaarde voor goedkeuring van het proefschrift een tevoren 
vastgesteld aantal artikelen in internationale tijdschriften hanteert. 
5. De kwaliteit van de vanuit het ziekenhuis naar de thuiszorg verplaatste 
zorg kan worden verbeterd indien deze zorg vanuit het ziekenhuis zou 
worden gecoördineerd, waardoor geldverslindende activiteiten kunnen 
worden voorkomen. 
6. De clusterstructuur als organisatievorm van grote ziekenhuizen bemoei-
lijkt in sterke mate de invoering van een ziekenhuisbreed functionerend 
voedingsteam. 
7. A short bowel is not equal to a short life. 
8. Voor langdurige toediening van parenterale voeding in de thuissituatie is 
een arterio-veneuze shunt een veiliger toedieningsweg dan een centraal 
veneuze catheter. 
Naber AHJ, van Tongeren JHM. 
Clin Nutr 1989. 
9. Bij hyperthyreoidie en een hoog 'FSH gehalte dient aan een verlaagde 
gevoeligheid van de hypofyse/hypothalamus voor het schildklierhormoon 
te worden gedacht. 
Hermus A, Ross H, van Liessum P, Naber A, et al, 
NethJ Med 1991. 


